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Childhood malarial anemia (MA) remains a global health burden with the vast morbidity and 
mortality occurring mostly in sub-Saharan Africa.  Although design and testing of malaria 
vaccines is currently underway, the pattern of inflammatory mediator production that predicts a 
protective immune response against severe malaria, which would dramatically enhance vaccine 
testing, is largely unknown.  Protective malarial immunity is regulated in part by cytokines, such 
as interleukin (IL)-12, IL-10, and tumor necrosis factor (TNF)-α, and effector molecules, such as 
prostaglandin E2 (PGE2) and nitric oxide (NO).  Previous studies have illustrated that children 
with severe MA have lower levels of circulating IL-12p70 and PGE2, and increased plasma 
levels of IL-10, TNF-α, and NO relative to children with mild malaria, however, the 
mechanism(s) responsible for this pattern of immune production is unknown.  Phagocytosis of 
parasitic products, such as hemozoin, by cultured peripheral blood mononuclear cell (PBMC) 
elicits dysregulation of inflammatory mediator production, therefore, the regulation and 
interactions of cytokines and effector molecules was investigated during acute childhood malaria 
and in cultured PBMC stimulated with Plasmodium falciparum-derived hemozoin.  Children 
with high-density parasitemia had decreased IL-12p70 and increased levels of IL-10 and TNF-α.  
Experiments in cultured PBMC from malaria-naïve donors revealed that hemozoin suppressed 
IL-12p70 through induction of IL-10, but not over-expression of TNF-α transcripts and protein, 
which was independent of suppressor of cytokine signaling (SOCS)-3 induction.  Hemozoin 
 iii
suppressed cyclooxygenase (COX)-2-dependent PGE2 production through reductions in COX-2 
transcript and protein formation, and inhibition of COX-2 enzymatic activity.  Suppression of 
PGE2, which was independent of hemozoin-induced IL-10, resulted in over-production of TNF-
α.  The ratio of plasma PGE2/TNF-α was decreased in children with severe disease.  Cultured 
PBMC from children with severe malaria had elevated nitric oxide synthase (NOS)2 enzyme 
activity, which occurred at least in part through PBMC ingestion of hemozoin.  Thus, ingestion 
of hemozoin by PBMC elicits a similar pattern of inflammatory mediator production to that 
observed in children with severe MA.  Results presented here are of significant public health 
relevance in that understanding the regulation of cytokine and effector molecule production 
during severe malaria will vastly improve vaccine design and testing. 
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1. CHAPTER 1:  INTRODUCTION 
 
 
1.1. MALARIA PATHOGENESIS 
 
Malaria continues to represent a global health threat, with current estimates of clinical infections 
at 300-500 million per year, resulting in 1.5-2.7 million deaths (World Health Organization 
1997).  In areas of hyperendemic malaria transmission, children under the age of 5 are most 
affected by malaria, mainly due to a lack of malarial immunity, and in these areas, mortality rates 
can reach 20% (Breman et. al. 2001).  Due to overwhelming antimalarial drug resistance, current 
efforts involve design of vaccines and novel therapeutic strategies to combat malaria.  Despite 
these efforts, our current understanding of the development of immunity to malaria, and the 
immune response(s) that leads to pathogenesis and/or protection is largely unknown.  As such, 
immune markers and/or mediators which define protection to malaria are needed to determine 
the efficacy of vaccines and antimalarial compounds.   
 
 The clinical manifestations of severe malaria are disparate in different geographical areas, 
due to factors such as the intensity of transmission (Cook et. al. 1996), and include; severe 
anemia, hyperparasitemia, hypoglycemia, respiratory distress, renal failure, and cerebral malaria 
(CM) (Cook et. al. 1996).  In areas of hyperendemic and holoendemic malaria transmission, such 
1 
 as Gabon and Kisumu, Kenya, respectively, the primary clinical manifestations of severe disease 
are hyperparasitemia and severe anemia, with CM occurring rarely (Bloland et. al. 1999, Breman 
et. al. 2001, Kun et. al. 1998).  Although the clinical manifestations of severe malaria are similar 
in hyper- and holoendemic areas, in Gabon, children under the age of 5 years suffer the most 
malaria-related morbidity and mortality, whereas in Kisumu, severe malarial anemia [SMA, 
defined by hemoglobin (Hb) < 5.0 g/dL in the presence of any density parasitemia, (World 
Health Organization 1990)] occurs mainly in children less than 2 years of age (Bloland et. al. 
1999, Kun et. al. 1998).  The underlying causes which contribute to anemia in these children are 
multifactorial and include: maternal deficiency states resulting in low birth weight infants, iron 
and folate deficiency, nutritional deficiencies, presence of parasitic infections such as hookworm, 
bacterial infections with post-infective malabsorption, and the presence of hemoglobinopathies 
(Hillman et. al. 1996).  Although the above mentioned factors contribute to the development of 
malarial anemia [MA, defined by Hb < 8.0 g/dL in the presence of any density parasitemia, 
(Abdallah 1990)], acute loss of red blood cells (RBC) from repeated cycles of parasite invasion 
and replication is one of the primary determinants of MA.   This is compounded by intravascular 
and extravascular hemolysis of both parasitized RBC (pRBC) and non-pRBC (Hillman et. al. 
1996).  Due to the loss of RBC in these already anemic children, increases in erythropoiesis are 
essential for recovery from MA.   
 
 Resolution of MA in children who survive infection typically occurs about seven to 
fourteen days following initiation of antimalarial administration.  During this time, immature 
hematopoietic stem cells are mobilized and differentiate into burst forming unit-erythroid (BFU-
E) cells, and ultimately into mature RBC (Hillman et. al. 1996).  Although parasitemia is 
2 
 resolved during this time, parasitic products released during acute malaria, such as hemozoin 
(malarial pigment), can persist in mononuclear cells for prolonged periods (Day et. al. 1996).  
Hemozoin is formed during the erythrocytic stage of the malaria lifecycle, when parasite-specific 
enzymes, plasmepsin and falcipain, digest host RBC Hb in order to obtain essential amino acids 
from globin [for review see (Francis et. al. 1997)].  The process of Hb digestion causes the 
release of heme, which is highly toxic to parasites through inhibition of enzyme function 
(Ginsburg et. al. 1992, Vander Jagt et. al. 1986), peroxidation of membranes (Tappel 1953), and 
production of free radicals (Atamna et. al. 1996).  To avoid the toxic effects of heme, parasites 
polymerize heme into a non-toxic insoluble compound, hemozoin (Slater 1992).  Upon rupture 
of infected erythrocytes, hemozoin is released into the blood stream and avidly phagocytosed by 
circulating monocytes and tissue macrophages (Schwarzer et. al. 1998).  Hemozoin is also 
acquired by monocytes/macrophages through phagocytosis of parasitized erythrocytes (Arese et. 
al. 1997).  In vivo, hemozoin exists as a coordinated polymer of ferriprotoporphyrin-IX (FP-IX) 
subunits containing a conglomeration of host- and parasite-derived lipids and proteins (Ashong 
et. al. 1989, Goldie et. al. 1990), however, the core FP-IX structure of protease- and acetone-
purified preparations of hemozoin are structurally identical to synthetically prepared β-hematin 
(Egan et. al. 2001).  Previous studies in malaria-infected adults showed evidence of 
dyserythropoiesis and dysplastic erythroid maturation in bone marrow, in association with high 
levels of hemozoin deposition (Abdallah 1990), suggesting that hemozoin may negatively impact 
the formation of new erythrocytes.  Furthermore, circulating levels of cytokines and effector 
molecules released during the inflammatory response(s) to malaria and malarial products, such 
as hemozoin, may contribute to the regulation of erythropoiesis during childhood malaria.   
 
3 
  
1.2. MALARIA LIFECYCLE 
 
As shown in Figure 1, P. falciparum infection in humans begins when an infected female 
Anopheles mosquito injects sporozoites into the host during a blood meal.  The sporozoites 
rapidly migrate to the liver and infect hepatocytes where they undergo asexual replication into 
merozoites.  After a period of about 5 days, the merozoites burst from the infected hepatocyte 
and enter the circulating blood where they rapidly infect RBC.  This process involves attachment 
and orientation of the merozoite to the RBC surface, and active invasion into the host cell.  The 
parasites mature into ring forms (trophozoites) within the first 12 hours of the erythrocytic stage, 
digesting host RBC hemoglobin for essential nutrients, forming hemozoin to detoxify the 
released heme.  After 36 hrs from the initial merozoite invasion of RBC, the parasite forms a 
schizont containing between 6 and 36 merozoites.  The pRBC then ruptures after 48 hrs, 
releasing the merozoites, as well as hemozoin, into circulation.  The released merozoites rapidly 
invade new RBC to start a new asexual phase of replication.  After several asexual cycles 
(approximately 5 cycles, or 10 days of infection), a small number of parasites develop into 
gametocytes.  These forms are ingested by uninfected female mosquitoes during a blood meal, 
and migrate to the midgut where they fuse into a zygote.  Within 24 hrs of the sexual phase of 
replication, the zygote pierces the midgut wall, forming an oocyst where thousands of 
sporozoites are formed.  The oocyte then bursts from the midgut, releasing the sporozoites.  
When the female Anopheles mosquito takes a subsequent blood meal, these sporozoites are 
inoculated into the vertebrate host. 
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Figure 1.  Lifecycle of P. falciparum.  An infected female Anopheles mosquito injects 
sporozoites into the host, which infect hepatocytes and undergo asexual replication into 
merozoites.  Merozoites burst from the liver and infect circulating RBC.  The parasites mature 
into ring forms (trophozoites), and then schizonts that contain new merozoites.  The infected 
RBC ruptures, releasing the merozoites into circulation which infect new RBC.  After several 
asexual cycles a few parasites develop into gametocytes which are ingested by an uninfected 
female mosquito during a blood meal.  The gametocytes undergo sexual replication, forming 
sporozoites which are inoculated into the vertebrate host. 
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1.3. HOST INNATE IMMUNE RESPONSES TO MALARIA 
 
Host immunoprotection against malaria is regulated by the production of pro-inflammatory 
molecules, such as interferon (IFN)-γ, interleukin (IL)-12, tumor necrosis factor (TNF)-α, IL-1β, 
and nitric oxide (NO), as well as anti-inflammatory cytokines, such as IL-10 and transforming 
growth factor (TGF)-β, which down-regulate the pro-inflammatory response [for review see 
(Stevenson et. al. 2004)].  Initiation of the immune cascade in murine models of malaria is 
dependent on IL-12 production from monocytes and other cells types (Crutcher et. al. 1995).  A 
protective role for IL-12 is further evidenced by the sterile protection of mice and monkeys from 
malaria infection following treatment with recombinant IL-12 prior to infection (Hoffman et. al. 
1997, Sedegah et. al. 1994).  IL-12 then activates T helper cells to secrete IFN-γ driving 
immunity towards a type 1 (pro-inflammatory) response.  IFN-γ in turn promotes secretion of 
TNF-α from monocytes, which can act in an autocrine and paracrine fashion to stimulate the 
production of effector molecules, such as nitric oxide (NO) and prostaglandin E2 (PGE2).  NO 
has potent antiplasmodial properties through inhibition of parasite growth in vitro and in vivo 
(Anstey et. al. 1996, Gyan et. al. 1994, Mellouk et. al. 1994, Rockett et. al. 1991).  Although the 
protective versus pathogenic role of PGE2 is largely unknown in the context of malaria, PGE2 
regulates macrophage function, vascular permeability, extracellular adhesion molecules, fever, 
and cytokine production (Vane et. al. 1998). 
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1.4. CYTOKINE AND EFFECTOR MOLECULE DYSREGULATION IN MALARIA 
 
Despite the identification of protective immune responses in animal models of malaria, little is 
known about the development of protective immune responses in children with SMA.  Our 
previous studies (Luty et. al. 2000), as well as those of others (Grau et. al. 1989, Kwiatkowski et. 
al. 1990), have shown that children with SMA have high systemic production of TNF-α, which 
can serve as a protective factor by decreasing parasite clearance time (Kremsner et. al. 1995), but 
can also be pathogenic by promoting anemia (Clark et. al. 1988).  TNF-α production during 
malaria is influenced by IL-10, which we and others have shown to be increased in plasma from 
children with MA (Perkins et. al. 2001, Perkins et. al. 2000, Peyron et. al. 1994).  Previous 
studies in our laboratory show that, relative to children with mild MA, children with SMA have 
suppressed plasma levels of IL-12 (Luty et. al. 2000), which may limit the immune response to 
blood-stage malaria.  Our previous results show that healthy, malaria-exposed Gabonese children 
with a history of mild malaria have significantly elevated levels of peripheral blood mononuclear 
cell (PBMC) NO production and nitric oxide synthase (NOS) enzyme activity compared to their 
age-matched cohorts with a history of severe malaria (Perkins et. al. 1999), suggesting a 
protective role of elevated NO production in MA.  The protective role of increased NO during 
acute malaria, however, does not appear to be universal, since previous reports in Tanzanian 
children with CM showed that PBMC NOS2 expression and peripheral levels of NO metabolites 
(NO2- and NO3-, total NO: NOx) are inversely related to disease severity (Anstey et. al. 1996).  
Although the role of PGE2 in malaria remains to be defined, elevated production of PGE2 may 
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 serve as a protective factor in malaria as evidenced by our previous results illustrating that 
children with MA have suppressed PBMC COX-2 transcript and protein levels, and lower 
plasma PGE2 relative to healthy children (Perkins et. al. 2001).  Thus, although protective 
immunity against malaria appears to require the appropriate timing and level of cytokine (i.e. 
TNF-α, IL-10, and IL-12) and effector molecule (NO and PGE2) release, particularly in animal 
models, protective immune responses in human malaria are largely unknown. 
 
As part of our ongoing studies on the genetic basis of SMA in Gabonese and Kenyan 
children, we have developed a model to investigate the role of immune regulation as a 
determinant of MA.  As shown in Figure 2, parasites and parasitic products, such as hemozoin, 
stimulate monocytes to release IL-12, which induces IFN-γ production from lymphocytes.  IFN-γ 
stimulates monocytes to release both pro-inflammatory cytokines, such as TNF-α, and anti-
inflammatory cytokines, such as IL-10 and TGF-β.  This cytokine network regulates the 
production of effector molecules, such as NO and PGE2, which may influence erythropoiesis, 
and ultimately, malaria disease outcomes. 
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Figure 2.  Regulation of erythropoiesis by the immune cascade to malaria.  In response to pRBC 
or hemozoin, monocytes secrete IL-12, which activates CD4+ T cells to produce IFN-γ, a 
cytokine that promotes monocytes to secrete pro-inflammatory cytokines, such as TNF-α, and 
anti-inflammatory cytokines, such as IL-10 and TGF-β.  This network of cytokine production 
regulates effector molecules, such as NO and PGE2, which influence malaria disease outcomes 
through modulation of erythropoiesis.  
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1.5. ROLE OF HEMOZOIN IN SEVERE MALARIA 
 
Hemozoin was first described by Laveran in 1880, which enabled the diagnosis of malaria 
infection in humans.   As mentioned previously, parasite-derived hemozoin is phagocytosed by 
circulating monocytes upon rupture of infected erythrocytes (Schwarzer et. al. 1998).  As shown 
in Figure 3, once hemozoin is phagocytosed, it remains within human mononuclear cells for 
extended periods of time (i.e., 48 hrs).  In adult patients with repeated exposure to malaria, 
accumulation of hemozoin in the reticuloendothelial system has been associated with slate-gray 
to black appearance of the liver and spleen (Edington 1967) and bone marrow (Abdallah 1990).  
In Gabonese children diagnosed with severe malaria, 24% of monocytes were reported to contain 
hemozoin, compared to 7% pigmented monocytes in children with mild disease (Metzger et. al. 
1995).  Previous studies demonstrate that both plasma and mitogen-stimulated IL-12 levels are 
suppressed in children with elevated numbers of pigmented monocytes and neutrophils, 
suggesting that acquisition of hemozoin can suppress the formation of some immuno-regulatory 
cytokines (Luty et. al. 2000).  Dysregulation of innate immunity in children with SMA may, 
therefore, be a consequence of mononuclear cell ingestion of parasitic products such as 
hemozoin.    
 
Although historically, ingestion of hemozoin by circulating phagocytes served as a marker of 
malaria infection, and was believed to have no impact on cellular function, previous in vitro 
studies have shown that hemozoin causes dysregulation of monocyte/macrophage cytokine 
production.  For example, experiments in cultured human blood mononuclear cells illustrated 
that hemozoin augments the release of cytokines and chemokines, such as IL-1β (Biswas et. al. 
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 2001, Pichyangkul et. al. 1994), IL-10 (Mordmuller et. al. 1998), IL-12p70 (Mordmuller et. al. 
1998), MIP-1α (Sherry et. al. 1995), MIP-1β (Sherry et. al. 1995), and TNF-α (Biswas et. al. 
2001, Mordmuller et. al. 1998, Pichyangkul et. al. 1994, Sherry et. al. 1995), and decreased 
mononuclear cell oxidative burst (Schwarzer et. al. 1993) (Table 1).  Similar experiments in 
cultured murine macrophages illustrated that hemozoin did not alter IL-1β production (Taramelli 
et. al. 1995), decreased IL-6 (Prada et. al. 1995) and NO production (Prada et. al. 1996, 
Taramelli et. al. 1995), and increased MIF (Martiney et. al. 2000).  Furthermore, the effects of 
hemozoin on TNF-α production have yielded conflicting results (Prada et. al. 1995, Taramelli et. 
al. 1995), suggesting an anti-inflammatory affect of hemozoin ingestion in murine malaria 
(Table 1).  Additional effects of hemozoin on human blood mononuclear cells include; inhibition 
of oxidative burst and protein kinase C activity (Schwarzer et. al. 1993), reduction of 
microbicidal and anti-tumor capabilities (Fiori et. al. 1993), impaired expression of MHC class II 
and CD54 expression in monocytes (Schwarzer et. al. 1998), and an inability of monocytes to 
undergo repeated phagocytosis (Schwarzer et. al. 1992). 
 
 
 
 
 
 
Figure 3.  Phagocytosed hemozoin in cultured monocytes.  Cultured monocytes were treated 
with hemozoin for 48 hrs and then stained with Giemsa.  Left panel: 60X magnification, black 
arrows indicate monocytes which have ingested hemozoin.  Right panel: 100X magnification, 
black arrows indicate hemozoin within a monocyte. 
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 Table 1.  Effect of hemozoin ingestion on cytokine and effector molecule production in cultured 
mononuclear cells 
 
Cytokine Cell Type Effect of Hz Reference 
IL-1β Murine No affect (Taramelli et. al. 1995) 
 Human Increase (Pichyangkul et. al. 1994) 
 Human Increase (Biswas et. al. 2001) 
IL-6 Murine Decrease (Prada et. al. 1995) 
IL-10 Human Increase (Mordmuller et. al. 1998) 
IL-12p70 Human Increase (Mordmuller et. al. 1998) 
MIF Murine Increase (Martiney et. al. 2000) 
MIP-1α Human Increase (Sherry et. al. 1995) 
MIP-1β Human Increase (Sherry et. al. 1995) 
NO Murine Decrease (Taramelli et. al. 1995) 
 Murine Decrease (Prada et. al. 1996) 
Oxidative burst Human Decrease (Schwarzer et. al. 1993) 
TNF-α Murine Increase (Prada et. al. 1995) 
 Murine Decrease (Taramelli et. al. 1995) 
 Human Increase (Sherry et. al. 1995) 
 Human Increase (Mordmuller et. al. 1998) 
 Human Increase (Pichyangkul et. al. 1994) 
 Human Increase (Biswas et. al. 2001) 
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2. CHAPTER 2:  SPECIFIC AIMS 
 
 
Malaria is responsible for 300-500 million new clinical cases and 1.5 to 2.7 million deaths each 
year.  In areas where Plasmodium falciparum transmission is high, the primary clinical 
manifestations of severe malaria are malarial anemia (MA) and hyperparasitemia.  Children 
under the age of 5 are most affected by severe malaria, mainly due to a lack of acquired 
immunity, and in holoendemic transmission areas, the mortality rate attributed to severe malaria 
can be as high as 25-30%.  Since P. falciparum is an intracellular pathogen, cell-mediated 
immunity is essential for protection from severe disease.  Although previous studies in our 
laboratory have shown that children with severe malaria have dysregulation of cytokines, such as 
interleukin (IL)-12, IL-10, and tumor necrosis factor (TNF)-α, and effector molecules, such as 
nitric oxide (NO) and prostaglandin E2 (PGE2) during acute disease, the underlying molecular 
basis responsible for this dysregulation is largely unknown.  Ingestion of parasitic products, such 
as hemozoin (malarial pigment), is known to influence mononuclear cell activities, such as 
impairment of phagocytosis, inhibition of oxidative burst and protein kinase C activity, and 
reduced microbial killing.  Furthermore, experiments in cultured human mononuclear cells 
indicate that hemozoin enhances the release of pro-inflammatory cytokines such as TNF-α and 
IL-1β.  We therefore postulate that ingestion of hemozoin by peripheral blood mononuclear cells 
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 (PBMC) is a major contributory factor of immune dysregulation through altered production of 
cytokines and effector molecules during childhood P. falciparum malaria. 
 
Specific Aim 1:  To determine if hemozoin alters IL-12, IL-10, and TNF-α production in 
cultured human PBMC, and to determine if increased IL-10 and/or TNF-α are responsible 
for suppression of IL-12. 
 
Hypothesis 1: Acquisition of hemozoin suppresses IL-12 production and augments both IL-10 
and TNF-α production in cultured human PBMC. 
 
Cultured PBMC from healthy, malaria-naïve U.S. donors were stimulated with LPS and IFN-γ, 
to induce IL-12, IL-10, and TNF-α production, in the absence or presence of hemozoin or β-
hematin.  IL-12p70, IL-10, and TNF-α production was determined by ELISA.  Temporal profiles 
of gene expression for IL-12p35, IL-12p40, IL-10, and TNF-α were quantified by real time RT-
PCR at 2, 4, 8, 24, and 48 hrs. 
 
Hypothesis 2: Hemozoin-induced IL-10 and/or TNF-α production is responsible for suppression 
of IL-12 production in PBMC. 
 
To investigate the effect of IL-10 and TNF-α on IL-12 production, cultured PBMC from healthy, 
malaria-naïve U.S. donors were stimulated with LPS and IFN-γ, to induce IL-12, IL-10, and 
TNF-α production, in the presence or absence of hemozoin.  Cultures were incubated with 
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 varying concentrations of neutralizing IL-10 or TNF-α antibodies, or exogenous addition of 
recombinant IL-10 or TNF-α followed by measurement of IL-12p70 by ELISA. 
 
Hypothesis 3: Hemozoin suppresses IL-12 production through dysregulation of JAK/STAT 
signaling. 
 
Induction of IL-12 gene expression is enhanced by JAK/STAT signaling.  The suppressor of 
cytokine signaling (SOCS) gene family consists of nine currently identified genes which 
suppress the JAK/STAT signaling cascade.  To determine if hemozoin suppresses IL-12 
production through dysregulation of JAK/STAT signaling, we investigated the effects of 
hemozoin on cultured PBMC on the temporal profile of SOCS-3 gene expression using real time 
RT-PCR, since SOCS-3 is induced by IL-10 and TNF-α.  To determine if SOCS-3 is responsible 
for inhibition of IL-12, cultured PBMC from healthy, malaria-naïve U.S. donors were stimulated 
with hemozoin, and cells were nucleofected with SOCS-3 short interfering RNA (siRNA) to 
ablate SOCS-3 signaling.  IL-12p40 transcripts were determined by real time RT-PCR in PBMC 
in which SOCS-3 has been suppressed by SOCS-3-specific siRNA. 
 
Specific Aim 2:  To determine if hemozoin decreases COX-2 gene expression and the 
subsequent production of PGE2 in cultured human PBMC. 
 
Hypothesis 1: Hemozoin suppresses COX-2-derived PGE2 production in cultured human PBMC 
by suppressing de novo COX-2 transcripts and protein, and/or inhibiting COX-2 enzymatic 
activity. 
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To investigate the effects of hemozoin on mononuclear cell PGE2 production, PBMC from 
healthy, malaria-exposed children and children with mild MA were cultured under baseline- and 
stimuli-induced conditions, followed by measurement of PGE2 using an enzyme immunoassay 
(EIA).  To examine the direct effect(s) of hemozoin and β-hematin on COX-2 and PGE2 
production, PBMC from healthy, malaria-naïve U.S. adults were stimulated with hemozoin or β-
hematin.  COX-2 protein was determined by immunoblot and COX-2 transcripts were quantified 
by Taqman real time RT-PCR.  PBMC PGE2 production was determined by EIA.  The effect of 
hemozoin on cell viability was examined by the MTT assay.  The effects of hemozoin-induced 
anti-inflammatory cytokines (i.e., IL-10), which are known to decrease COX-2 gene expression, 
were determined by examining PGE2 formation in the presence of IL-10 neutralizing antibodies.  
The effect of hemozoin or β-hematin on COX-2 enzymatic activity was examined using a COX 
inhibitor screening assay. 
 
Hypothesis 2:  Acquisition of hemozoin by mononuclear phagocytes causes overproduction of 
TNF-α through suppression of COX-2 gene expression. 
 
Since PGE2 can inhibit TNF-α transcription, we examined the effect of hemozoin on TNF-α 
production in the presence of exogenous PGE2.  PBMC from healthy, malaria-naïve U.S. adults 
were stimulated with hemozoin or β-hematin, and PGE2 and TNF-α production was determined 
by EIA and enzyme-linked immunosorbent assay (ELISA), respectively.  The effects of 
exogenous PGE2 on TNF-α production was determined in cultured PBMC stimulated with 
hemozoin or β-hematin. 
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Hypothesis 3: The relative production of PGE2 to TNF-α (PGE2/TNF-α ratio) is associated with 
disease severity in children with MA. 
 
The relative production of cytokines and effector molecules can serve as correlates of disease 
severity.  Therefore, we examined the plasma PGE2/TNF-α ratio in healthy, malaria-exposed 
children, and children with mild and severe MA.  To examine the association of the PGE2/TNF-
α ratio with MA, the PGE2/TNF-α ratio was correlated with hemoglobin concentrations in 
children with MA.  To determine if ingestion of hemozoin by mononuclear cells suppresses the 
PGE2/TNF-α ratio, PBMC from healthy, malaria-naïve U.S. adults were stimulated with 
hemozoin, and PGE2 and TNF-α production was determined by ELISA. 
 
Hypothesis 4: Polymorphisms in the promoter of COX-2 condition the clinical outcomes in 
children with MA. 
 
We have recently identified a novel polymorphism in the COX-2 promoter (COX-2 -512 C→T) 
in children with MA.  The prevalence of the COX-2 C-512T polymorphism was determined in 
DNA from a large cohort of children with varying degrees of malaria disease severity using a 
novel restriction fragment length polymorphism (RFLP) assay.  Using multivariate logistic 
regression analyses, we examined the association of the COX-2 C-512T polymorphism with 
high-density parasitemia (HDP), MA, or SMA. 
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 Specific Aim 3:  To determine if children with MA have altered NO production and to 
determine if ingestion of malarial products (hemozoin) regulates NO production through 
changes in induction of de novo NOS2 transcripts. 
 
Hypothesis 1: Increased production of NO from circulating mononuclear cells is associated with 
increasing severity of MA. 
 
To determine the effect of acute malaria on mononuclear cell NO production, NOS enzyme 
activity was measured in ex vivo isolated PBMC from healthy, malaria-exposed children and 
children with mild or severe MA.  To investigate the association between NO production and 
anemia, ex vivo PBMC NOS enzyme activity was compared with hemoglobin measurements 
(MA outcomes) in children with mild and severe MA.   Furthermore, the cellular source of NO 
was examined by measuring NOS enzyme activity in cultured PBMC from healthy children and 
children with acute MA.   
 
Hypothesis 2: Hemozoin induces NO production through de novo induction of NOS2 transcripts 
in cultured human PBMC. 
 
Since parasitic products may influence PBMC NO production, the effect of hemozoin on NO 
production was determined.  Cultured PBMC from healthy, malaria-naïve U.S. adults were 
stimulated with hemozoin followed by measurement of total NO (NOx: NO2- and NO3-) by the 
Griess reaction and de novo NOS2 transcript formation by Taqman real time RT-PCR. 
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3. CHAPTER 3:  SPECIFIC AIM 1 
 
 
Specific Aim 1:  To determine if hemozoin alters IL-12, IL-10 and TNF-α production in 
cultured human PBMC, and to determine if increased IL-10 and/or TNF-α are responsible 
for suppression of IL-12. 
 
 Previous observations in our laboratories have shown that Gabonese children with severe 
malaria have suppressed plasma levels of IL-12 relative to children with mild disease (Perkins et. 
al. 2000).  Although several studies have examined the cellular mechanism of this suppression in 
murine models of malaria (Stevenson et. al. 1995, Xu et. al. 2001), no studies to date have been 
performed in human malaria.  The aim of the experiments described in this chapter was to 
determine the cellular source and/or mechanism responsible for suppression of IL-12 production 
in human malaria.  To accomplish Hypothesis 1, plasma levels of IL-12p70, IL-10, and TNF-α 
were examined from children with varying degrees of malaria disease severity, which was 
defined according to the density of parasitemia.  To examine the cellular sources involved in IL-
12p70, IL-10, and TNF-α production, the effect of P. falciparum malaria and malaria products 
(hemozoin) on mononuclear cell IL-12p70, IL-10, and TNF-α mRNA and soluble protein 
production was determined.  To examine Hypothesis 2, the ability of endogenously produced IL-
10 and TNF-α to suppress IL-12p70 production was examined using neutralizing antibodies 
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 against IL-10 and TNF-α, respectively.  Hypothesis 3 was examined by investigating the 
contribution of JAK/STAT signaling in the malaria-associated suppression of IL-12 using 
SOCS-3-specific siRNA.  The Hypotheses of Specific Aim 1 have been addressed in the 
following manuscript which has been submitted to the Journal of Immunology. 
 
 
3.1. PRESENTATION OF MANUSCRIPT: HEMOZOIN-INDUCED IL-10 
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†Department of Psychology, College of Charleston, Charleston, SC 
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 3.1.1. Abstract 
 
Protective immunity to malaria is regulated in part by cytokines, such as interleukin (IL)-12, 
which is a pro-inflammatory cytokine important for initiating cell-mediated immunity.  We have 
previously shown that children with severe malaria have suppressed systemic IL-12 production, 
and elevated levels of cytokines known to inhibit IL-12 such as, IL-10 and tumor necrosis factor 
(TNF)-α.  Therefore, the production of IL-12, IL-10, and TNF-α in children with high-density 
parasitemia was investigated.  Children with high-density parasitemia had decreased IL-12p70 
and increased levels of IL-10 and TNF-α.  Parasitic products such as hemozoin (malarial 
pigment) are known to increase monocyte-derived TNF-α and IL-10 production in vitro.  We 
therefore investigated if ingestion of hemozoin by monocytes suppresses IL-12p70 through 
increased synthesis of IL-10 and/or TNF-α.  Peripheral blood mononuclear cells (PBMC) and 
CD14+ monocytes from healthy donors were stimulated with media alone (controls), 
lipopolysaccharide (LPS) and interferon (IFN)-γ, or LPS and IFN-γ in the presence of hemozoin 
(malarial pigment) or a synthetically prepared hemozoin, β-hematin.  Ingestion of hemozoin and 
β-hematin by LPS- and IFN-γ-stimulated cells suppressed soluble IL-12p70 and augmented 
soluble IL-10 and TNF-α.  Real time RT-PCR showed that hemozoin suppressed induction of 
IL-12p40 transcripts, and increased IL-10 and TNF-α gene expression.  Addition of IL-10 
neutralizing antibodies restored hemozoin-induced suppression of IL-12p70, while TNF-α 
neutralizing antibodies had no effect on IL-12p70 production.  Blockade of IL-10 in cultured 
PBMC from children with malaria increased IL-12p70 production.  Hemozoin increased gene 
expression of suppressor of cytokine signaling (SOCS)-3, however, silencing of SOCS-3 
expression using siRNA did not alter hemozoin-induced suppression of IL-12p40 transcripts.  
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 The ratio of IL-10/IL-12 production was inversely related to malaria severity and dose-
dependently associated with hemozoin.  Taken together, these results suggest that ingestion of 
hemozoin by monocytes inhibits IL-12 gene products via up-regulation of IL-10 gene 
expression. 
 
3.1.2. Introduction 
 
Malaria continues to represent a global health threat and is estimated to cause 1.5 to 2.7 million 
deaths annually (World Health Organization 1997).  The majority of these deaths occur in 
children less than 5 years of age, due to their lack of naturally acquired immunity to malaria 
(Breman et. al. 2001).  In areas of holoendemic Plasmodium falciparum transmission the 
primary clinical manifestations of severe malaria in young children are anemia, 
hyperparasitemia, and respiratory distress, and the mortality rate can be as high as 25-30% 
(Breman et. al. 2001).  Furthermore, the prevalence of malaria in children 1 to 4 years of age 
residing in these areas is 83%, with malarial anemia (MA) being the most common clinical 
manifestation of malaria and CM occurring rarely (Bloland et. al. 1999).   
 
The innate immune response to malaria is characterized by the production of interleukin 
(IL)-12 from mononuclear cells (Crutcher et. al. 1995).  IL-12 is a pro-inflammatory cytokine 
important for the early activation of a type I immune response through enhanced differentiation 
of CD4+ T cells into TH1 cells, and the subsequent production of interferon (IFN)-γ (Crutcher et. 
al. 1995, Stevenson et. al. 1995).  In circulating blood, monocytes are the primary producers of 
bioactive IL-12p70 (D'Andrea et. al. 1992), a heterodimer of IL-12p35 and IL-12p40 subunits 
encoded by separate genes (Kobayashi et. al. 1989).  In cultured monocyte-derived macrophages, 
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 IL-12p70 production is negatively regulated by pro-inflammatory cytokines, such as tumor 
necrosis factor (TNF)-α (Ma et. al. 2000), and anti-inflammatory cytokines, such as IL-10 (Aste-
Amezaga et. al. 1998), at the level of p40 gene transcription. 
 
The ability to produce IL-12 appears to be protective in animal models of malaria.  An 
early and sustained induction of IL-12 mediates resistance to severe malaria in mice infected 
with P. chabaudi (Sam et. al. 1999), which occurs, at least in part, through enhancement of 
erythropoiesis (Mohan et. al. 1998).  Furthermore, administration of recombinant IL-12 (rIL-12) 
to mice infected with P. yoelli or rhesus macaques infected with P. cynomolgi results in 100% 
protection (Hoffman et. al. 1997, Sedegah et. al. 1994).  Mice deficient for the IL-12p40 gene 
are unable to resolve parasitemia, and following treatment with rIL-12, the ability to clear 
parasitemia is restored (Su et. al. 2002).  In murine splenic cells, suppression of IL-12 appears to 
be mediated by increased IL-10 production (Xu et. al. 2001), however, the regulatory effect of 
IL-10 on IL-12 production during human malaria is currently undefined. 
 
Previous studies from our laboratories illustrated that Gabonese children with severe 
malaria [characterized primarily as high-density parasitemia (HDP)] have suppressed systemic 
production of IL-12, and elevated production of both TNF-α and IL-10, relative to children with 
mild disease (Luty et. al. 2000).  Suppression of systemic IL-12 in individuals with severe 
malaria has recently been reported by others (Chaiyaroj et. al. 2004, Malaguarnera et. al. 2002, 
Malaguarnera et. al. 2002, Musumeci et. al. 2003).  Furthermore, our studies in Gabonese 
children demonstrated that the ratio of IL-10/IL-12 is significantly higher in children with severe 
malaria compared to children with mild malaria (Perkins et. al. 2000), suggesting that the 
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 relative production of these cytokines may be a pathogenic determinant in disease severity.  
Suppression of systemic IL-12 in children with severe malaria may be a consequence of reduced 
peripheral blood mononuclear cell (PBMC) IL-12 production; baseline and mitogen-stimulated 
IL-12 production is significantly lower in cultured PBMC from children with severe malaria 
relative to PBMC from children with mild disease (Luty et. al. 2000). 
 
Phagocytosis of parasitic products, such as hemozoin (malarial pigment), influences 
cytokine and effector molecule production in cultured human PBMC (Biswas et. al. 2001, Keller 
et. al. 2004, Keller et. al. 2004, Mordmuller et. al. 1998, Pichyangkul et. al. 1994, Sherry et. al. 
1995).  Hemozoin is an insoluble coordination polymer of heme subunits formed during 
plasmodia-specific hemoglobin catabolism to avoid the toxic effects of heme (Slater 1992).  
Blood mononuclear cells rapidly phagocytose free hemozoin, which is released into the blood 
stream upon rupture of parasitized red blood cells (RBC) (Schwarzer et. al. 1998).  Studies by 
Mordmuller et al. illustrate that monocytes stimulated with high concentrations of hemozoin 
have elevated TNF-α and IL-10 production (Mordmuller et. al. 1998).  Suppression of systemic 
IL-12 in Gabonese children with malaria is also significantly associated with the number of 
hemozoin-containing circulating neutrophils and monocytes (Luty et. al. 2000).  
 
Previous studies have examined several transcription factors, such as c-Rel, NF-kappaB, 
IFN regulatory factor-1, and ets-2, which are not involved in IL-10- and/or TNF-α-mediated 
suppression of IL-12p40 gene expression (Ma et. al. 2000).  More recently, a family of Jak/Stat 
suppressors, collectively known as suppressors of cytokine signaling (SOCS), has been identified 
which can suppress LPS- or IFN-γ-induced gene transcription, such as IL-12p40, through 
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 blockade of the Jak/Stat signaling cascade [for review see (Larsen et. al. 2002)].  Furthermore, it 
has been shown that IL-10 inhibits activation of STAT1, which may occur through induction of 
SOCS-3 (Ito et. al. 1999), however, the association of SOCS-3 with suppression of IL-12p70 
production has not been examined. 
 
Since at the time of these experiments specific inhibitors of SOCS-3 were not available, 
we utilized small interfering RNA (siRNA) technology to silence SOCS-3 gene expression.  
siRNA relies on the binding of a complementary sequence of nucleotides to the transcript of 
interest, which targets the double stranded mRNA for degradation by the RNA-induced silencing 
complex (RISC) (Hammond et. al. 2001).  This relies on 21-23mers which do not trigger the 
antiviral response in mammalian cells (Elbashir et. al. 2001, Elbashir et. al. 2001). 
 
We hypothesized that hemozoin ingestion by circulating mononuclear phagocytes is a 
contributing factor of IL-12 suppression in malaria, which may be due to excessive IL-10 and/or 
TNF-α production.  To examine this potential mechanism, plasma levels of IL-12p70, IL-10, and 
TNF-α were determined in aparasitemic children and children with low- or high-density 
parasitemia.   Soluble IL-12p70, IL-10, and TNF-α production and the temporal profile of IL-
12p35, IL-12p40, IL-10, and TNF-α mRNA induction was determined in PBMC stimulated with 
physiologic concentrations of hemozoin.  We further characterized the regulatory effects of IL-
10 and TNF-α on IL-12p70 production in cultured PBMC from healthy, malaria-naïve US 
donors stimulated with hemozoin, and from children with acute malaria, by blocking endogenous 
IL-10 or TNF-α with neutralizing antibodies.  Silencing of suppressor of cytokine signaling 
(SOCS)-3 with small interfering (si)RNA on IL-12p70 production was also investigated.  
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 3.1.3. Subjects and Methods 
 
3.1.3.1. Study Participants:  Children (n = 128, age 0 to 3 years) were recruited from a 
hospital-based longitudinal study at the Siaya District Hospital in Siaya District, western Kenya 
as part of our ongoing activities examining the genetic basis of severe malarial anemia 
(manuscript submitted).  In this holoendemic area of malaria transmission, residents receive 
approximately 100-300 infective mosquito bites per year (Bloland et. al. 1999).  The primary 
clinical manifestations of severe childhood malaria are severe anemia and hyperparasitemia 
(Bloland et. al. 1999).  Children with cerebral malaria, a rare event in this high transmission 
setting (Bloland et. al. 1999), were excluded from the study.  Heel/finger-prick blood (~100 µL) 
was obtained to determine parasitemia status and Hb concentration.  Peripheral blood smears 
were prepared and stained with Giemsa reagent and examined under oil immersion for malaria 
parasites.  Asexual malaria parasites were counted against 300 leukocytes and parasite densities 
estimated assuming a count of 8,000 white blood cells per microliter of blood.  Hb levels were 
measured using a HemoCue® system (HemoCue AB, Angelholm, Sweden).  Children with 
malaria were given antimalarials and the appropriate supportive therapy as required.  All blood 
samples were obtained prior to treatment with antimalarials.  Based upon the presence and 
density of parasitemia, children were categorized into three groups; 1) healthy controls (HC, no 
detectable peripheral parasitemia and hemoglobin [(Hb) ≥ 11.0 g/dL], low-density parasitemia 
(LDP, parasitemia < 10,000 parasites/µL and any Hb concentration), high-density parasitemia 
(HDP, parasitemia ≥ 10,000 parasites/µL and any Hb concentration).  Informed consent was 
obtained from the parents/guardians of participating children. 
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  Healthy, malaria-naïve adult donors (n = 21) were recruited from the University of 
Pittsburgh, U.S.A.  The study was approved by the ethics committees of the University of 
Pittsburgh Institutional Review Board and the Kenya Medical Ethical Board.   
 
3.1.3.2. Isolation and Culture of Peripheral Blood Mononuclear Cells and CD14+ and 
CD14- Cells:  For in vitro experiments in cells from U.S. adults (n = 21) or children with 
malaria (n = 12), venous blood (40 mL and < 3 mL, respectively) was drawn into EDTA-
containing vials.  PBMC were prepared using ficoll/Hypaque as described earlier (Weinberg et. 
al. 1981), and, for experiments in cells from U.S donors, CD14+ cells were isolated from PBMC 
fractions using CD14+ magnetic beads (Miltenyi Biotech, Auburn, CA) as per the 
manufacturer’s protocol.  PBMC and monocytes were plated at 1 X 106 cells per mL in 
Dulbecco’s modified Eagles medium (DMEM) containing 10% pooled human serum (heat 
inactivated at 56˚C for 30 min).  Cultures were stimulated with media alone (controls) or LPS 
[100 ng/mL (Alexis Corp., San Diego, CA)] and IFN-γ [200 U/mL (BD Pharmingen, San Diego, 
CA)].  Cultured PBMC from healthy U.S. adults were also stimulated with LPS and IFN-γ in the 
presence of hemozoin (10, 1.0, and 0.1 µg/mL) or β-hematin (10 µg/mL).  The effect of 
endogenous IL-10 and TNF-α on IL-12p70 production was determined by the addition of 
neutralizing antibodies for IL-10 [0.1, 0.5, and 1.0 µg/mL (R&D Systems, Minneapolis, MN)] 
and TNF-α [1.0, 10, and 100 ng/mL (R&D Systems, Minneapolis, MN)] or exogenous IL-10 
[0.2, 2.0, and 20 ng/mL (Endogen, Woburn, MA)] and TNF-α [0.2, 2.0, and 20 ng/mL (BD 
Pharmingen, Bedford, MA)].  Concentrations of hemozoin used in the present studies were 
comparable to those in children with severe (10 µg/mL hemozoin) and mild (1.0 µg/mL 
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 hemozoin) malaria based on our previously calculated results (Keller et. al. 2004).   Hemozoin 
and β-hematin preparations were extensively sonicated prior to addition to the cultures.  
 
3.1.3.3. Hemozoin and β-hematin Preparation:  Crude hemozoin was isolated as previously 
described (Keller et. al. 2004).  Briefly, in vitro cultures of P. falciparum-infected red blood cells 
were cultured to a parasitemia of 3-5% containing predominately late trophozoites and early 
schizonts.  Cultured red blood cells (RBC) were isolated and spun at 2,000 rpm for 10 min, and 
the resulting pellet was resuspended in 40 mL of 0.01 M PBS (pH 7.2) with 2 mL saponin for 10 
min.  The solution was then spun at 14,000 rpm for 15 min, and the pelleted material was washed 
in PBS until the resulting pellet was dark red and free from the white-colored RBC cellular 
components (4-7 times).  The final pellet was dried, weighed, and resuspended in filter-sterilized 
H O at a final concentration of 1.0 mg/mL.  The final solution was extensively sonicated to 
disperse the hemozoin. 
2
 
β-hematin was formed in a 4.5 M acidic acetate solution at pH 4.5 by the method of Egan 
et al. (Egan et. al. 2001).  Briefly, hemin chloride (Sigma, St. Louis, MO) was added to a 0.1 M 
solution of NaOH followed by the addition of HCl at 60oC.  A solution of acetate was then 
added, and the mixture was incubated for 150 min at 60oC without stirring.  The β-hematin was 
then spun at 14,000 rpm in a microcentrifuge, washed 3X with filter-sterilized H2O, and dried at 
60oC under vacuum.  The final pellet was weighed and then resuspended at 1.0 mg/mL in filter-
sterilized H2O.  The resuspended β-hematin was sonicated extensively to disperse the 
preparation.  Under these preparation conditions, β-hematin has an identical infrared 
spectroscopy pattern as detergent-purified hemozoin, and β-hematin crystals appear 
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 morphologically similar to natural hemozoin crystals as evidenced by scanning electron 
microscopy (Egan et. al. 2001).  Endotoxin levels were found to be less than 0.01 EU/mL using 
the Limulus Amebocyte Lysate test (BioWhittaker, Walkersville, MD).   
 
3.1.3.4. IL-12p70, IL-10, and TNF-α Determination:  Plasma and supernatant 
concentrations of IL-12p70, IL-10, and TNF-α were determined by quantitative sandwich 
ELISA (BD Pharmingen, San Diego, CA), with a sensitivity of detection ≥ 7.8 pg/mL for each of 
the cytokines.  96-well plates were coated with an anti-cytokine specific monoclonal antibody 
followed by blocking for 1 hr and subsequent washing.  Samples were incubated at room 
temperature for 2 hrs, washed, and incubated with a biotin-conjugated cytokine-specific 
detection antibody and a horseradish peroxidase-streptavidin conjugate.  Plates were washed and 
incubated with TMB Substrate Solution (Pharmingen, San Diego, CA) for 30 min with 
protection from light.  Absorbance was determined at 450 nm. 
 
3.1.3.5. Quantitative real time RT-PCR:  Total RNA was isolated from PBMC by the GITC 
method (Chomczynski et. al. 1987).  Total RNA (1 µg) was reverse transcribed into cDNA, and 
cytokine gene expression was analyzed by quantitative real time RT-PCR on an ABI Prism 7700 
sequence detection system (Applied Biosystems, Foster City, CA).  cDNA (100 ng) was 
amplified in duplicate with specific primer/probe sets for IL-12p35, IL-12p40, IL-10, TNF-α, 
and SOCS-3 [Ascession Numbers NM_008351, NM_002187, NM_000572, NM_000594, and 
NM_003955, respectively (Applied Biosystems, Foster City, CA)].  To control for non-specific 
background fluorescence, no template controls were included in triplicate.  An endogenous 
control gene, β-actin [Ascession Number NM_001101 (Applied Biosystems, Foster City, CA)], 
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 was used as a reference gene to normalize cDNA loading between samples.  Data were compared 
using the -∆∆CT method as previously described (Keller et. al. 2004). 
 
3.1.3.6. Preparation and Nucleofection of siRNA:  GAPDH siRNA was prepared in vitro 
using the Silencer siRNA Construction Kit following the manufacturer’s instructions (Ambion, 
Austin TX).  SOCS-3 siRNA (target sequence: 3’-AAG ACC CAG TCT GGG ACC AAG AA-
5’) was purchased from Qiagen Inc. (Valencia, CA).  PBMC were nucleofected using the Human 
T Cell Nucleofector Kit according to the manufacturer’s specifications (Amaxa Biosystems, 
Gaithersburg, MD).  PBMC were suspended in 100 µL of nucleofection reagent and 
nucleofected with 5 µg of SOCS-3 or GAPDH siRNA on the Nucleofector I (Amaxa 
Biosystems, Gaithersburg, MD).  Nucleofected cells were then transferred to pre-warmed 
DMEM containing 10% pooled human serum.  Cultures were stimulated with LPS and IFN-γ, or 
LPS and IFN-γ in the presence of a high dose (10 µg/mL) of hemozoin.   
 
3.1.3.7. Statistical Analyses:  Supernatant concentrations of IL-12p70, IL-10, and TNF-α 
(pg/mL) and plasma concentrations of IL-12p70 (pg/mL) and IL-10 (pg/mL) were measured in 
triplicate at several different dilutions.  IL-12p35, IL-12p40, IL-10, TNF-α, and SOCS-3 mRNA 
expression was measured in duplicate.  Pairwise comparisons between conditions were 
performed by the Mann-Whitney U test.   Multiple group comparisons were performed by the 
Kruskal-Wallis test.  Chi-square analysis was used to determine differences between proportions.  
All tests were deemed significant at the P ≤ 0.05 level (all P values corrected for multiple 
comparisons when appropriate).  
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 3.1.4. Results 
 
3.1.4.1. Participant Characteristics:  Children were enrolled as part of a longitudinal cohort 
study and categorized according to density of parasitemia.  We have found that parasite density 
does not correlate with the degree of anemia in our current study population (Ong'echa et. al. 
2005), and as such, these studies examine malaria disease severity based on hyperparasitemia.  
The clinical and laboratory characteristics of the study participants are shown in Table 2.  There 
was no significant difference in age (mos) or gender between the groups (Table 2).  Children in 
the LDP and HDP groups had significantly elevated admission temperatures (oC) and 
significantly lower Hb concentrations (g/dL) than the HC group (P < 0.01, and P < 0.001, 
respectively), however, these variables did not differ between the LDP and HDP groups (Table 
2).  Parasite density was significantly higher in the HDP group relative to the LDP group (P < 
0.001, Table 2). 
 
3.1.4.2. Plasma Levels of IL-12p70, IL-10, and TNF-α in Children with Malaria:    We 
have previously observed suppression of IL-12p70 and increased IL-10 and TNF-α in plasma 
from children with severe malaria, where the primary determinant of severe disease was HDP 
(Luty et. al. 2000, Perkins et. al. 2000).  Therefore, we examined the relationship between 
disease severity (i.e., HDP) and cytokine levels in plasma from children with malaria.  Plasma 
levels of IL-12p70 were significantly lower in the HDP group relative to HC group (P < 0.01), 
and non-significantly lower than the LDP group (Figure 4A).  Plasma IL-10 levels were 
significantly higher in the LDP and HDP groups relative to the HC group (P < 0.01 and P < 0.01, 
respectively, Figure 1B).  Furthermore, IL-10 was significantly elevated in the HDP group 
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 relative to LDP (P < 0.05, Figure 1B).   TNF-α was significantly elevated in the LDP and HDP 
groups relative to HC (P < 0.01 and P < 0.01, respectively, Figure 4C), and significantly 
increased in the HDP group relative to LDP (P < 0.05, Figure 4C). 
 
3.1.4.3. Effect of Hemozoin on IL-12p70, IL-10, and TNF-α Production:  Since children 
with HDP had decreased IL-12p70 and increased IL-10 and TNF-α, we hypothesized that 
parasitic products, such as hemozoin, may be responsible for dysregulation of cytokine 
production.  To examine the effect of hemozoin on bioactive IL-12p70, IL-10, and TNF-α, 
PBMC or CD14+ monocytes were cultured from healthy, malaria-naïve adults and stimulated 
with media alone (control), LPS (100 ng/mL) and IFN-γ (200 U/mL), or LPS and IFN-γ in the 
presence of physiologically relevant concentrations of hemozoin (10, 1.0, and 0.1 µg/mL) or β-
hematin (10 µg/mL).  Since PBMC from healthy individuals cultured under baseline conditions 
produce negligible amounts of IL-12, cell cultures were stimulated with LPS and IFN-γ to 
promote IL-12 synthesis.  Stimulation of PBMC or monocytes with LPS and IFN-γ significantly 
elevated IL-12p70 production at 48 hrs in culture (P < 0.01 and P < 0.01, respectively), and the 
addition of a high dose (10 µg/mL) of hemozoin or β-hematin significantly decreased LPS- and 
IFN-γ-promoted IL-12p70 production (P < 0.05 and P < 0.05, respectively, Figures 5A and B).  
IL-12p70 was not detectable in culture supernatants from hemozoin- or β-hematin-treated PBMC 
in the absence of LPS and IFN-γ stimulation (data not shown).  LPS and IFN-γ stimulation 
significantly elevated PBMC- and monocyte-derived IL-10 production (P < 0.01 and P < 0.01, 
respectively), and a high dose of hemozoin or β-hematin significantly augmented LPS- and IFN-
γ-induced IL-10 (P < 0.05 and P < 0.05, respectively, Figures 5C and D).  Stimulation of PBMC 
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 and monocytes significantly augmented TNF-α production (P < 0.05 and P < 0.05, respectively), 
and addition of a high dose of hemozoin or β-hematin significantly increased TNF-α in cultured 
PBMC and monocytes (P < 0.05 and P < 0.05, respectively, Figures 5E and F).  IL-12p70 and 
IL-10 were not detectable in cultured CD14- cells (Figures 5B and D), and CD14- cell TNF-α 
production was not altered in any culture condition examined (Figure 5E).  Results presented 
here illustrate that physiological concentrations of hemozoin and β-hematin suppress PBMC- 
and monocyte-derived IL-12p70 production, and augment IL-10 and TNF-α. 
 
3.1.4.4.  Effect of Hemozoin on the Time-dependent Production of IL-12p35, IL-12p40, IL-
10, and TNF-α Transcripts:  Regulation of cytokine production during an inflammatory event 
occurs primarily at the level of de novo transcription, therefore, the effect of hemozoin on the 
induction and temporal profile of PBMC mRNA expression for IL-12p35, IL-12p40, IL-10 and 
TNF-α was examined using real time RT-PCR.  PBMC were stimulated with media alone 
(controls), LPS and IFN-γ, or LPS and IFN-γ in the presence of hemozoin (10 µg/mL).  
Stimulation of PBMC with LPS and IFN-γ significantly augmented IL-12p35 mRNA expression 
at all time points examined (P < 0.05, Figure 6A), and the addition of hemozoin did not 
significantly alter IL-12p35 mRNA production at any time point examined (Figure 6A).  
Stimulated PBMC produced significantly higher levels of IL-12p40 mRNA at 8 and 24 hrs (P < 
0.01), and hemozoin significantly suppressed IL-12p40 mRNA at these time points (P < 0.01, 
Figure 6B).  LPS- and IFN-γ significantly augmented IL-10 mRNA at 8, 24, and 48 hrs (P < 
0.01), and hemozoin significantly enhanced IL-10 transcript expression at 24 hrs (P < 0.01, 
Figure 6C).  TNF-α mRNA expression was significantly enhanced in LPS- and IFN-γ-stimulated 
PBMC at 2, 4, and 8 hrs (P < 0.01), and hemozoin significantly elevated TNF-α mRNA 
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 expression at these time points (P < 0.01, Figure 6D).  Taken together, results presented here 
illustrate that dysregulation of soluble IL-12p70, IL-10, and TNF-α production by hemozoin is a 
consequence of suppressed IL-12p40 mRNA expression and increased IL-10 and TNF-α mRNA 
expression. 
3.1.4.5. Effect of IL-10 and TNF-α on Hemozoin-induced IL-12p70 Suppression:  Since 
exogenous IL-10 and TNF-α suppress IL-12 production in monocyte-derived macrophages 
(Aste-Amezaga et. al. 1998, Ma et. al. 2000), we postulated that hemozoin-induced increases in 
endogenous IL-10 and/or TNF-α may suppress IL-12p70 production in cultured PBMC.  To test 
this, neutralizing antibodies for IL-10 (0.1, 0.5, and 1.0 µg/mL) and TNF-α (1.0, 10, and 100 
ng/mL), or exogenous IL-10 (0.2, 2.0, and 20 ng/mL) and TNF-α (0.2, 2.0, and 20 ng/mL), were 
added to LPS- and IFN-γ-stimulated PBMC in the presence of a high dose (10 µg/mL) of 
hemozoin, and IL-12p70 production was measured in culture supernatants at 48 hrs.  Stimulation 
of PBMC with LPS and IFN-γ significantly increased IL-12p70 production (P < 0.05), which 
was significantly decreased by hemozoin (P < 0.05, Figure 7A).  In both LPS- and IFN-γ-
stimulated cells, and stimulated cells treated with hemozoin, IL-12p70 production was 
significantly increased upon the addition of an intermediate (0.5 µg/mL) and a high (1.0 µg/mL) 
dose of IL-10 neutralizing antibody (P < 0.05 and P < 0.05, respectively), and these levels did 
not significantly differ from each other (Figure 7A).  Supernatant IL-10 levels were dose-
dependently lower in the presence of increasing doses of IL-10 neutralizing antibody in 
stimulated cells and stimulated cells treated with hemozoin (Figure 7B).  The addition of 
exogenous IL-10 dose-dependently suppressed IL-12p70 production in LPS- and IFN-γ-
stimulated PBMC in the presence and absence of hemozoin (Figure 7C).   
34 
  
The addition of all examined doses of TNF-α neutralizing antibody to LPS- and IFN-γ-
stimulated PBMC, and stimulated cells treated with hemozoin, did not significantly alter IL-
12p70 production compared to stimulated conditions, and stimulated cells treated with 
hemozoin, in the absence of antibody, respectively (Figure 7D).  Addition of hemozoin to LPS- 
and IFN-γ-stimulated PBMC significantly suppressed IL-12p70 production in the presence of all 
examined doses of TNF-α neutralizing antibody (P < 0.05 for all conditions, Figure 7D).  
Supernatant TNF-α levels were dose-dependently decreased by increasing doses of TNF-α 
neutralizing antibody in both stimulated cells and stimulated cells in the presence of hemozoin 
(Figure 7E).  Addition of hemozoin to LPS- and IFN-γ-stimulated PBMC in the presence of all 
examined doses of exogenous TNF-α significantly suppressed IL-12p70 production (P < 0.05 for 
all conditions, Figure 7F).  Taken together, these results illustrate that IL-12p70 production in 
hemozoin-treated PBMC is restored by neutralizing endogenously produced IL-10, but not by 
blocking endogenous TNF-α. 
 
3.1.4.6. Effect of IL-10 on IL-12p70 in Cultured PBMC from Children with Malaria:    
Since hemozoin-induced IL-10 production mediated the suppression of IL-12p70 in cultured 
PBMC from healthy, malaria-naïve donors, we wished to determine if neutralizing IL-10 in 
cultured PBMC from children with malaria would also cause increased IL-12p70 production.  To 
examine this potential mechanism, PBMC were cultured from children with malaria and 
stimulated with media alone (controls), LPS (100 ng/mL) and IFN-γ (200 U/mL), or LPS and 
IFN-γ in the presence of IL-10 neutralizing antibodies (0.5 µg/mL) or exogenous IL-10 (2.0 
ng/mL).  LPS and IFN-γ significantly increased IL-12p70 production (P < 0.05, Figure 8).  
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 Addition of IL-10 antibodies caused a significant increase in IL-12p70 over stimulated 
conditions (P < 0.05), and exogenous IL-10 significantly decreased IL-12p70 production (P < 
0.05, Figure 8).  Thus, neutralizing endogenously produced IL-10 in cultured PBMC from 
children with malaria augments IL-12p70 production. 
 
3.1.4.7. Effect of Hemozoin on SOCS-3 Transcripts:  Previous studies have shown that IL-
10 induces SOCS-3 (Ito et. al. 1999), which is known to suppress the induction of inflammatory 
genes in response to LPS (Berlato et. al. 2002) or IFN-γ (Ito et. al. 1999), via blockade of the 
JAK-STAT signaling cascade [for review see (Larsen et. al. 2002)].  To determine if hemozoin 
upregulates SOCS-3 gene expression, real time RT-PCR was used to examine the temporal 
profile of SOCS-3 message in PBMC stimulated with media alone (controls), LPS and IFN-γ, or 
LPS and IFN-γ in the presence of hemozoin (10 µg/mL).  LPS and IFN-γ stimulation 
significantly induced SOCS-3 mRNA at 8 and 24 hrs (P < 0.05 and P < 0.05, respectively), and 
the addition of hemozoin significantly augmented SOCS-3 message at these time points (P < 
0.05 and P < 0.05, respectively, Figure 9). 
 
3.1.4.8. Effect of SOCS-3 siRNA on Hemozoin-induced Suppression of IL-12 
Transcripts:  Since hemozoin induced SOCS-3 transcripts, we postulated that suppression of 
SOCS-3 may restore IL-12p40 transcripts in hemozoin-treated PBMC.  Using siRNA 
technology, we determined the effect of silencing SOCS-3 expression on hemozoin-induced 
suppression of IL-12p40 transcripts at 24 hrs in culture, the time when SOCS-3 was induced by 
hemozoin.  PBMC were nucleofected with siRNA specific for SOCS-3 or a control siRNA 
specific for GAPDH.  Nucleofected cells and nucleofection control cells (i.e., PBMC 
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 nucleofected in the absence of siRNA) were stimulated with media alone (controls), LPS and 
IFN-γ, or LPS and IFN-γ in the presence of hemozoin (10 µg/mL).  PBMC were harvested at 24 
hrs for determination of SOCS-3, GAPDH, and IL-12p40 transcripts using real time RT-PCR.  
Stimulation of PBMC with LPS and IFN-γ significantly augmented SOCS-3 transcripts (P < 
0.05), and the addition of hemozoin further increased SOCS-3 expression (P < 0.05, Figure 
10A).  SOCS-3 siRNA significantly decreased SOCS-3 transcripts in both LPS and IFN-γ-
stimulated cells, and stimulated cells treated with hemozoin (P < 0.05 and P < 0.05, respectively, 
Figure 5A).  GAPDH siRNA did not significantly alter SOCS-3 transcripts under any condition 
examined (Figure 10A). 
 
 LPS and IFN-γ, or LPS and IFN-γ in the presence of hemozoin, did not significantly alter 
GAPDH transcripts, and nucleofection of PBMC with SOCS-3 siRNA did not significantly alter 
GAPDH gene expression under any condition examined (Figure 10B).  GAPDH transcripts were 
significantly lower in both stimulated PBMC and hemozoin-treated PBMC nucleofected with 
GAPDH siRNA (P < 0.05 and P < 0.05, respectively, Figure 10B).   
 
 LPS and IFN-γ significantly augmented IL-12p40 gene expression (P < 0.05), and 
hemozoin significantly decreased IL-12p40 transcript levels (P < 0.05, Figure 11C).  IL-12p40 
gene expression was not significantly altered by SOCS-3 or GAPDH siRNA in LPS- and IFN-γ-
stimulated PBMC, or stimulated PBMC treated with hemozoin (Figure 11C).  Data presented 
here illustrate that hemozoin-induced suppression of IL-12p40 transcripts is not mediated 
through increased SOCS-3 gene expression. 
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 3.1.5. Discussion 
 
High IL-12 production in malaria appears to promote a protective response, at least in part, 
through activation of IFN-γ which initiates the immune cascade (Crutcher et. al. 1995, Stevenson 
et. al. 1995).  Decreased production of IL-12 in murine models of malaria has been associated 
with severe disease and higher mortality (Sam et. al. 1999), and reduced erythropoiesis (Mohan 
et. al. 1998).  In human malaria, plasma levels of IL-12 are lower in patients with severe malaria 
relative to patients with mild malaria (Chaiyaroj et. al. 2004, Luty et. al. 2000, Malaguarnera et. 
al. 2002, Malaguarnera et. al. 2002, Musumeci et. al. 2003, Perkins et. al. 2000), which as 
reported here appears to be due, at least in part, to increased levels of parasitemia.  In our 
previous study, suppression of IL-12 was associated with an increased percentage of neutrophils 
and monocytes containing hemozoin (Luty et. al. 2000).  This is further illustrated by the fact 
that cultured PBMC from children with severe malaria, who had higher density parasitemias than 
age-matched children with mild malaria, produced lower levels of baseline- and mitogen-induced 
IL-12 (Luty et. al. 2000), suggesting that a phagocytosed parasitic product(s) encountered in vivo 
may be responsible for suppression of IL-12.   
 
Since monocytes are one of the major cellular sources of systemic IL-12p40, and thus of 
circulating IL-12p70 (D'Andrea et. al. 1992), we hypothesized that ingestion of hemozoin by 
blood mononuclear cells was responsible for suppression of IL-12p70.  Here we show that 
ingestion of physiologically relevant concentrations of crude hemozoin significantly reduced 
LPS- and IFN-γ-promoted PBMC production of bioactive IL-12p70 at the level of p40 
transcription.  Furthermore, hemozoin suppressed IL-12p70 production in freshly isolated 
CD14+ monocytes, while cultured CD14- cells (mainly CD4 and CD8 T cells and B cells) failed 
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 to produce detectable amounts of IL-12p70 in response to LPS and IFN-γ.  Previous studies have 
shown that ingestion of detergent purified hemozoin by activated dendritic cells (DCs) 
upregulates IL-12 production (Coban et. al. 2002), however, our unpublished observations have 
shown that hemozoin inhibits maturation and cytokine production in cultured monocyte-derived 
DC (Keller et. al., unpublished observations).  Also, it is important to note that mature DCs 
comprise approximately 0.7% of blood mononuclear cells in children with severe malaria (Urban 
et. al. 2001), and would likely not contribute to the overall circulating IL-12p70 production in 
children with severe disease.  Furthermore, recent studies have shown that DC maturation is 
inhibited by crude lysates of hemozoin (Skorokhod et. al. 2004), suggesting negative 
implications of hemozoin on DCs during human malaria. 
 
 Regulation of IL-12 production appears to be important for the immunopathogenesis of 
other protozoan infections.  The Leishmania major cell surface molecule lipophosphoglycan 
(LPG) selectively inhibits IL-12p40 transcription in activated murine macrophages independent 
of NF-κB signaling, but does not alter production of other pro-inflammatory mediators, such as 
TNF-α (Piedrafita et. al. 1999).  In murine models of Toxoplasma gondii, early mortality of IL-
10-deficient mice is delayed by neutralizing endogenous IL-12 (Neyer et. al. 1997).  Viral 
infections, such as measles and HIV, are also associated with suppressed IL-12 production 
(Chehimi et. al. 1994, Chougnet et. al. 1996), and in the case of measles virus, can actively 
inhibit IL-12 production in mononuclear cells (Karp et. al. 1996).  Therefore, hemozoin-induced 
suppression of IL-12p70 may serve to protect Plasmodium parasites from immune clearance by 
down-regulating Type 1-mediated responses. 
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  In agreement with previous studies (Biswas et. al. 2001, Mordmuller et. al. 1998, 
Pichyangkul et. al. 1994, Sherry et. al. 1995), results presented here show that ingestion of 
hemozoin or β-hematin by cultured PBMC augments TNF-α and IL-10 production.  Hemozoin-
induced increases in IL-10 and TNF-α production appear to be regulated at the level of 
transcription.  Furthermore, the present studies show that hemozoin augments LPS- and IFN-γ-
induced TNF-α and IL-10 production in isolated CD14+ monocytes, while the CD14- fraction of 
cultured PBMC do not produce these cytokines in response to LPS and IFN-γ or hemozoin 
stimulation.  Although CD3+ T-cells have been shown to influence the early immune response to 
P. falciparum-infected RBC (Scragg et. al. 1999), the response to phagocytosis of free hemozoin 
appears to be independent of direct T-cell interactions with monocyte/macrophages.  Therefore, 
it appears that phagocytosis of hemozoin by cultured human monocytes suppresses IL-12p70, 
and augments TNF-α and IL-10 production. 
 
 IL-12 synthesis is inhibited by pro- and anti-inflammatory cytokines, such as TNF-α and 
IL-10, respectively (Aste-Amezaga et. al. 1998, Ma et. al. 2000).  Here we show for the first 
time in human mononuclear cells that hemozoin-induced over-expression of IL-10, but not TNF-
α, is responsible for suppression of IL-12p70.  Previous studies in cultured murine splenic cells 
from mice infected with malaria showed that suppression of IL-12 was due to increased IL-10 
production (Xu et. al. 2001), which, as suggested by the present studies, may have been due to 
ingestion of hemozoin by these cells.  The negative regulatory action of IL-10 on IL-12 
production is also evident in chronic diseases, such as systemic lupus erythematosus (SLE), 
where suppressed IL-12 production in PBMC from patients with SLE is restored by blocking 
endogenous IL-10 (Liu et. al. 1998).   
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 Although we found that overproduction of IL-10 is responsible for suppression of IL-
12p70, other factors may still be involved in dysregulation of IL-12 during human malaria.  
Cytokines such as TGF-β1 [for review see (Wahl 1994)], and effector molecules such as PGE2 
[for review see (van der Pouw Kraan et. al. 1995)], are known to down-regulate the pro-
inflammatory response, however, our previous studies show that both molecules are suppressed 
in children with severe malaria (Perkins et. al. 2001, Perkins et. al. 2000), suggesting that 
increased production of these anti-inflammatory cytokines is not responsible for suppression of 
IL-12 in childhood malaria.  Furthermore, our previous in vitro studies show that hemozoin 
significantly suppressed LPS- and IFN-γ-promoted PGE2 production in PBMC from healthy 
donors (Keller et. al. 2004).  Therefore, the cellular mechanism of IL-12 suppression in malaria 
is most likely not due to increased TGF-β1 or PGE2 production.  Taken together, these results 
illustrate that hemozoin-induced IL-10 overproduction from human PBMC suppresses IL-12p70 
production. 
 
 Increased production of bioactive IL-12p70 is dependent on de novo induction of IL-
12p40 gene expression (Kobayashi et. al. 1989), therefore, we postulated that hemozoin-induced 
IL-10 overproduction was suppressing IL-12 through dysregulation of a transcription factor(s).  
Previous studies have identified several transcription factors, such as c-Rel, NF-κB, IFN 
regulatory factor-1, and ets-2, which are not involved in suppression of IL-12p40 (Ma et. al. 
2000).  More recently, a family of Jak/Stat suppressors, collectively known as SOCS, has been 
identified which can suppress LPS- or IFN-γ-induced genes through blockade of the Jak/Stat 
signaling cascade [for review see (Larsen et. al. 2002)].  Furthermore, it has been shown that IL-
10 inhibits activation of STAT1, which may occur through induction of SOCS-3 (Ito et. al. 
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 1999).  Using real time RT-PCR, we show here that hemozoin augments levels of SOCS-3 
transcripts, however, silencing of SOCS-3 expression using siRNA illustrated that hemozoin-
induced expression of SOCS-3 was not responsible for suppression of IL-12p40 transcripts.  
Although SOCS-3 was not responsible for suppression of IL-12p40 transcripts, it is likely that 
alterations in signaling cascades, such as the JAK/STAT pathway, by over-expression of IL-10 
may be responsible for suppression of IL-12p70 in hemozoin-treated PBMC. 
 
 In the present studies, we propose a model of IL-12 suppression in human malaria in 
which ingestion of hemozoin, as a consequence of elevated parasitemia, by circulating 
monocytes induces over-expression of IL-10 which in turn inhibits de novo IL-12p40 
transcription.  Although other factors likely play a role in suppression of IL-12 during human 
malaria, results presented here illustrate that hemozoin-induced suppression of IL-12 can be 
corrected by blocking endogenous levels of IL-10.   Although current research is focused on 
designing/implementing vaccines towards malaria, the present studies suggest that suppression 
of IL-12 by hemozoin may hinder the efficacy of novel vaccines. 
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 Table 2.  Clinical and laboratory characteristics of study participants.  
 
 HC LDP HDP P 
No. of participants 28 35 65  
Age, mos. 11.86 (1.39) 12.90 (1.17) 11.60 (0.76) 0.62a
Sex, no. (%)     
Male 12 (43) 19 (54) 27 (42) 
Female 16 (57) 16 (46) 38 (58) 
0.45b
Admission temperature, oC 36.84 (0.17) 37.81 (0.19) 37.58 (0.13) < 0.01a
Hemoglobin, g/dL 11.53 (0.17) 7.45 (0.38) 7.57 (0.28) < 0.001a
Parasitemia, parasites/µL 0 4,636 (498) 41,121 (4,012) < 0.001c
Children (n = 128) were recruited as part of a hospital-based longitudinal study and categorized 
according to parasitemia status; healthy controls (HC, absence of peripheral parasitemia and Hb 
≥ 11.0 g/dL), low-density parasitemia (LDP, parasitemia < 10,000 parasites/µL and any Hb 
concentration), high-density parasitemia (HDP, parasitemia ≥ 10,000 parasites/µL and any Hb 
concentration). Heel/finger-prick blood (~100 µL) was obtained to determine parasitemia status 
and Hb concentration.  Peripheral blood smears were prepared and stained with Giemsa reagent 
and examined under oil immersion for malaria parasites.  Asexual malaria parasites were counted 
against 300 leukocytes and parasite densities estimated assuming a count of 8,000 white blood 
cells per microliter of blood.  Hb levels were measured using a HemoCue® system (HemoCue 
AB, Angelholm, Sweden).  Data are presented as the mean (SEM) unless otherwise noted. 
aStatistical significance determined by Kruskal-Wallis test. 
bStatistical significance determined by Chi-square analysis. 
cStatistical significance determined by Mann-Whitney U test. 
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 Figure 4. IL-12p70, IL-10, and TNF-α levels in plasma from children with varying degrees of 
malaria severity.   
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Figure 4.  IL-12p70, IL-10, and TNF-α levels in plasma from children with varying degrees of 
malaria severity.  Plasma was obtained from malaria-exposed, healthy children (n = 28), children 
with low-density parasitemia (LDP, n = 35), or children with high-density parasitemia (HDP, n = 
65) for (A) IL-12p70, (B) IL-10, and (C) TNF-α determination.  The box represents the 
interquartile range, the line represents the median, the whiskers represent 95% CI, and the 
symbols are outliers.  Statistical significance was determined by the Mann-Whitney U test, *P < 
0.05, **P < 0.01, (all P values corrected for multiple comparisons).  
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Figure 5.  Effect of hemozoin on IL-12p70, IL-10, and TNF-α production in cultured 
PBMC and monocytes.   
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Figure 5.  Effect of hemozoin on IL-12p70, IL-10, and TNF-α production in cultured 
PBMC and monocytes.   
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Figure 5.  Effect of hemozoin on IL-12p70, IL-10, and TNF-α production in cultured PBMC and 
monocytes.  (A, C, and E) PBMC (1x106 cells/mL, n = 15) or (B, D, and F) CD14+ and CD14- 
cells (1x106 cells/mL, n = 3) from healthy, malaria-naïve donors were stimulated with media 
alone, LPS (100 ng/mL) and IFN-γ (200 U/mL), or LPS and IFN-γ in the presence of varying 
concentrations of hemozoin (10, 1.0, and 0.1 µg/mL) or β-hematin (10 µg/mL).  Supernatants 
were removed at 48 hrs for (A and B) IL-12p70, (C and D) IL-10, and (E and F) TNF-α 
determination. Values are the mean ± SEM.  Statistical significance was determined by Mann-
Whitney U test, *P < 0.05 compared to unstimulated conditions, **P < 0.05 compared to LPS 
and IFN-γ stimulation.      
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Figure 6.  Temporal effect of hemozoin on IL-12p35, IL-12p40, IL-10, and TNF-α transcripts.  
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Figure 6.  Temporal effect of hemozoin on IL-12p35, IL-12p40, IL-10, and TNF-α transcripts.  
PBMC (1x106 cells/mL) were stimulated with media alone (dashed black line), LPS (100 ng/mL) 
and IFN-γ [200 U/mL, (dashed gray line)], or LPS and IFN-γ in the presence of hemozoin [10 
µg/mL, (solid black line)].  Cells were collected at 2, 4, 8, 24, and 48 hrs for (A) IL-12p35, (B) 
IL-12p40, (C) IL-10, and (D) TNF-α mRNA determination by real time RT-PCR.  Values are 
the mean ± SEM, n = 3.  Statistical significance was determined by Mann-Whitney U test. *P < 
0.01 compared to unstimulated conditions, **P < 0.01 compared to LPS and IFN-γ stimulation. 
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Figure 7.  Effect of IL-10 and TNF-α on hemozoin-induced IL-12p70 suppression.  
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Figure 7.  Effect of IL-10 and TNF-α on hemozoin-induced IL-12p70 suppression.   
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Figure 7.  Effect of IL-10 and TNF-α on hemozoin-induced IL-12p70 suppression.  PBMC 
(1x106 cells/mL) were stimulated with media alone, LPS (100 ng/mL) and IFN-γ (200 U/mL), or 
LPS and IFN-γ in the presence of hemozoin (10 µg/mL).  IL-10 neutralizing antibodies (0.1, 0.5, 
and 1.0 µg/mL) were added to LPS- and IFN-γ-stimulated PBMC (dashed black line) and 
stimulated PBMC in the presence of hemozoin (solid black line), and supernatant concentrations 
of (A) IL-12p70 and (B) IL-10 were measured at 48 hrs.  (C) Exogenous IL-10 (0.2, 2.0, and 20 
ng/mL) was added to LPS- and IFN-γ-stimulated PBMC and stimulated PBMC treated with 
53 
 hemozoin, and supernatant IL-12p70 was measured at 48 hrs.  TNF-α neutralizing antibodies 
(1.0, 10, and 100 ng/mL) were added to LPS- and IFN-γ-stimulated PBMC and stimulated 
PBMC treated with hemozoin, and supernatant (D) IL-12p70 and (E) TNF-α was measured at 48 
hrs.  (F) Exogenous TNF-α (0.2, 2.0, and 20 ng/mL) was presented to LPS- and IFN-γ-
stimulated PBMC and stimulated PBMC treated with hemozoin, and supernatant IL-12p70 was 
measured at 48 hrs.  Values are the mean ± SEM, n = 3.  Statistical significance was determined 
by Mann-Whitney U test. *P < 0.01 compared to unstimulated conditions, **P < 0.01 compared 
to LPS and IFN-γ stimulation. ***P < 0.01 compared to LP- and IFN-γ- or hemozoin-stimulated 
conditions in the absence of antibody. 
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Figure 8.  Effect of IL-10 on IL-12p70 in cultured PBMC from children with malaria.  PBMC 
(1x106 cells/mL) were obtained from children with acute SMA (n = 12) and cultured in the 
presence of media alone (controls), LPS (100 ng/mL) and IFN-γ(200 U/mL), or LPS and IFN-γ 
in the presence of IL-10 neutralizing antibodies (0.5 µg/mL) or exogenous IL-10 (2.0 ng/mL).  
IL-12p70 production was determined in plasma at 48 hrs.  Statistical significance determined by 
the Mann-Whitney U test, *P < 0.05 (corrected for multiple comparisons). 
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Figure 9.  Temporal effect of hemozoin on SOCS-3 transcripts.  PBMC (1x106 cells/mL) were 
stimulated with media alone (dashed black line), LPS (100 ng/mL) and IFN-γ [200 U/mL, 
(dashed gray line)], or LPS and IFN-γ in the presence of hemozoin [10 µg/mL, (solid black 
line)].  Cells were collected at 2, 4, 8, 24, and 48 hrs for SOCS-3 mRNA determination by real 
time RT-PCR.  Values are the mean ± SEM, n = 3.  Statistical significance was determined by 
Mann-Whitney U test. *P < 0.01 compared to unstimulated conditions, **P < 0.01 compared to 
LPS and IFN-γ stimulation. 
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Figure 10.  Effect of SOCS-3 siRNA on hemozoin-induced suppression of IL-12 transcripts
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Figure 10.  Effect of SOCS-3 siRNA on hemozoin-induced suppression of IL-12 transcripts 
PBMC (1x106 cells/mL) were nucleofected with siRNA for SOCS-3 or GAPDH (control siRNA) 
and stimulated with media alone, LPS (100 ng/mL) and IFN-γ (200 U/mL), or LPS and IFN-γ in 
the presence of hemozoin [10 µg/mL].  Cells were collected at 48 hrs for (A) SOCS-3, (B) 
GAPDH, (C) IL-12p40, and (D) IL-10 mRNA determination by real time RT-PCR.  Values are 
the mean ± SEM, n = 3.  Statistical significance was determined by the Mann-Whitney U test. *P 
< 0.05 compared to unstimulated conditions, **P < 0.05 compared to LPS and IFN-γ stimulated 
conditions, ***P < 0.05 compared to stimulated conditions in the presence of hemozoin.  
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4. CHAPTER 4:  SPECIFIC AIM 2 
 
 
Specific Aim 2:  To determine if hemozoin decreases COX-2 gene expression and 
the subsequent production of PGE2 in cultured human PBMC. 
 
Hypothesis 1: Hemozoin suppresses COX-2-derived PGE2 production in cultured human PBMC 
through suppression of de novo COX-2 transcripts and protein, and/or inhibition of COX-2 
enzyme activity. 
 
 Previous studies in Gabonese children with malaria illustrated that COX-2 gene products, 
and subsequent PGE2 production, were significantly lower in children with severe disease 
(Perkins et. al. 2001), however, the mechanism of COX-2-derived PGE2 suppression in malaria 
remains unknown.  To investigate Hypothesis 1, PGE2 production was examined in cultured 
PBMC from healthy, malaria-exposed children and children with mild MA, and cultured PBMC 
from healthy, malaria-naïve U.S. adults stimulated with hemozoin or β-hematin.  Further 
experiments in hemozoin-stimulated PBMC examined COX-2 protein and transcripts, and the 
effects of IL-10 on hemozoin-induced suppression of PGE2 production.  The effect of hemozoin 
on COX-2 enzymatic activity was examined using a COX inhibitor screening assay. 
 
59 
 The first part of Hypothesis 1 of Specific Aim 2 has been addressed in the following 
manuscript which has been published in the journal Molecular Medicine.  The second part of 
Hypothesis 1 examining the effect of hemozoin on inhibition of COX-2 enzymatic activity has 
been addressed following presentation of the manuscript. 
 
 
4.1. HYPOTHESIS 1: PRESENTATION OF MANUSCRIPT: REDUCED PERIPHERAL 
PGE2 BIOSYNTHESIS IN PLASMODIUM FALCIPARUM MALARIA OCCURS 
THROUGH HEMOZOIN-INDUCED SUPPRESSION OF BLOOD MONONUCLEAR 
CELL COX-2 GENE EXPRESSION VIA AN IL-10-INDEPENDENT MECHANISM. 
 
Christopher C. Keller1, James B. Hittner4, Ben K. Nti1, J. Brice Weinberg5, Peter G. Kremsner2,3, 
and Douglas J. Perkins1
 
1Department of Infectious Diseases and Microbiology, Graduate School of Public Health, 
University of Pittsburgh, Pittsburgh, Pennsylvania 
2Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon 
3Department of Parasitology, Institute for Tropical Medicine, University of Tubingen, Tubingen, 
Germany  
4Department of Psychology, College of Charleston, Charleston, South Carolina 
5Department of Medicine, Durham VA and Duke University Medical Centers, Durham, North 
Carolina 
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 4.1.1. Abstract 
 
Molecular immunologic determinants of disease severity during Plasmodium falciparum malaria 
are largely undetermined.  Our recent investigations showed that peripheral blood mononuclear 
cell (PBMC) COX-2 gene expression and plasma PGE2 production are suppressed in children 
with falciparum malaria relative to healthy, malaria-exposed children with partial immunity.  
Furthermore, decreased COX-2/PGE2 levels were significantly associated with increased plasma 
IL-10, an anti-inflammatory cytokine that inhibits the expression of COX-2 gene products.  To 
determine the mechanism(s) responsible for COX-2-derived PGE2 suppression, PBMC were 
cultured from children with falciparum malaria.  PGE2 production was suppressed under baseline 
and COX-2-promoting [stimulation with lipopolysaccharide (LPS) and interferon (IFN)-γ] 
conditions over prolonged periods, suggesting that an in vivo-derived product(s) was responsible 
for reduced PGE2 biosynthesis.  Hemozoin (malarial pigment) was investigated as a source of 
COX-2/PGE2 suppression in PBMC from healthy, malaria-naïve adults. In addition, synthetically 
prepared hemozoin, β-hematin, was used to investigate the effects of the core iron component of 
hemozoin, ferriprotoporphyrin (FP)-IX.  Physiologic concentrations of hemozoin or β-hematin 
suppressed LPS- and IFN-γ-induced COX-2 mRNA in a time- and dose-dependent manner 
resulting in decreased COX-2 protein and PGE2 production.  Suppression of COX-2/PGE2 by 
hemozoin was not due to decreased cell viability as evidenced by examination of mitochondrial 
bioactivity.  These data illustrate that ingestion of FPIX by blood mononuclear cells is 
responsible for suppression of COX-2/PGE2.  Although hemozoin induced over-production of 
IL-10, neutralizing IL-10 antibodies failed to restore PGE2 production.  Thus, acquisition of 
hemozoin by blood mononuclear cells is responsible for suppression of PGE2 in malaria through 
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 inhibition of de novo COX-2 transcripts via molecular mechanisms independent of increased IL-
10 production.  
 
4.1.2. Introduction 
 
Although the underlying pathophysiologic determinants of severe malaria are only partially 
defined, cytokines and effector molecules are important immunologic determinants for 
regulating disease susceptibility.  Our recent investigations have focused on defining the role of 
prostaglandins (PGs) as immunomodulatory factors in malaria.  Eicosanoids, such as 
prostaglandin E2 (PGE2) regulate macrophage function, vascular permeability, extracellular 
adhesion molecules, fever, and cytokine production (Vane et. al. 1998).  PGE2 formation is 
initiated by the actions of phospholipase A2 (PLA2) which releases arachidonic acid (AA) from 
the membrane phospholipid bilayer in response to inflammatory stimuli (Murakami et. al. 1997).  
Free AA is rapidly metabolized to PGH2 via the enzymatic activity of the cyclooxygenase (COX) 
enzymes, of which there are two distinct isoforms encoded by separate genes: COX-1 and COX-
2 (Appleton et. al. 1996, Vane et. al. 1998).  COX-1 is constitutively expressed in most tissues 
and generates PGs for physiologic homeostasis, while COX-2 is an inducible gene that generates 
high levels of PGs during an inflammatory event (Seibert et. al. 1994).  Following formation of 
PGH2 by COX, PGE2 synthase converts PGH2 to PGE2 (Smith et. al. 1991). 
 
Our previous studies showed that plasma levels of PGE2 were significantly reduced in 
children with malaria, and were significantly associated with increased plasma interleukin (IL)-
10 levels (Perkins et. al. 2001).  Furthermore, peripheral blood mononuclear cell (PBMC) COX-
2 gene products were inversely related to disease severity (Perkins et. al. 2001).  We have also 
62 
 shown that children with cerebral malaria (CM) have suppressed systemic levels of PGE2 
(Perkins et. al. 2005).  Although suppression of COX-2/PGE2 in our previous studies was 
associated with enhanced severity of falciparum malaria, the mechanism(s) for decreased PGE2 
synthesis remain undefined. 
 
During the erythrocytic stage of malaria, Plasmodia digest host hemoglobin, releasing 
heme in the process.  To avoid the toxic effects of heme, enzymes within the parasitiphorus 
vacuole catalyze the polymerization of heme into a non-toxic insoluble compound, hemozoin 
(malarial pigment) [for review see (Francis et. al. 1997)].  Hemozoin is composed predominately 
of protein and a smaller fraction of carbohydrates, lipids, and nucleic acids which are attached to 
the polymerized iron core structure, ferriprotoporphyrin (FP)-IX (Goldie et. al. 1990).  Upon 
rupture of infected erythrocytes, hemozoin is released into the blood stream and phagocytosed by 
circulating monocytes and tissue macrophages (Schwarzer et. al. 1998).  Hemozoin is also 
acquired by monocytes/macrophages through phagocytosis of parasitized erythrocytes (Arese et. 
al. 1997).  Experiments in cultured blood mononuclear cells illustrate that hemozoin augments 
the release of both pro-inflammatory cytokines, such as TNF-α (Pichyangkul et. al. 1994), and 
anti-inflammatory cytokines such as IL-10 (Mordmuller et. al. 1998).  This appears important in 
the current context since TNF-α induces high levels of sustained COX-2 gene expression 
(Perkins et. al. 1997), while IL-10 decreases COX-2 gene expression through de-stabilization of 
COX-2 message (Niiro et. al. 1995).  Additional affects of hemozoin on blood mononuclear cells 
include; inhibition of oxidative burst and protein kinase C activity (Schwarzer et. al. 1993), 
reduction of microbicidal and anti-tumor capabilities (Fiori et. al. 1993), impaired expression of 
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 MHC class II and CD54 expression (Schwarzer et. al. 1998), and an inability of monocytes to 
undergo repeated phagocytosis (Schwarzer et. al. 1992).   
 
In the present investigations, PGE2 production was examined in cultured PBMC from 
children with falciparum malaria under baseline conditions and following treatment with COX-
2/PGE2 inducing stimuli: LPS and IFN-γ.  In addition, COX-2 mRNA and protein, and PGE2 
formation were examined in cultured PBMC from malaria-naïve healthy donors stimulated with 
LPS and IFN-γ in the presence of physiologically relevant doses [10, 1.0, and 0.1 µg/mL, (Keller 
et. al. 2004)] of hemozoin or β-hematin (synthetic malarial pigment).  The effect of hemozoin on 
IL-10 production and the ability of IL-10 to down-regulate PGE2 biosynthesis were also 
investigated. 
 
4.1.3. Subjects and Methods 
 
4.1.3.1. Study Participants:  Children (n = 30, age 2 to 7 years) were recruited from a 
longitudinal prospective study at the Albert Schweitzer Hospital in Lambaréné, Gabon in the 
Province of Moyen Ogooue.  In this hyperendemic area of malaria transmission, the primary 
clinical manifestations of severe childhood malaria is severe anemia and/or hyperparasitemia, 
with cerebral malaria rarely occurring (Kun et. al. 1998).  Classification of malaria was defined 
according to our previously published methods (Perkins et. al. 2001, Perkins et. al. 2000).  Only 
those children with mild malaria [defined by parasitemias < 100,000 parasites/µL and the 
absence of any signs or symptoms of severe malaria (Kun et. al. 1998, Perkins et. al. 2001)] were 
included in the present study due to the limited amount of blood available from severe cases.  
Healthy, malaria-exposed subjects were defined as participants with a previous episode(s) of 
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 malaria and the absence of a positive thick blood film for malaria, or any other illnesses, within 
the last 4 weeks.  All blood samples were obtained prior to treatment with antimalarials.  
Informed consent was obtained from the parents of participating children.   
 
 Healthy, malaria-naïve adult donors (n = 21) were recruited from the University of 
Pittsburgh, U.S.A.  The study was approved by the ethics committee of the International 
Foundation of the Albert Schweitzer Hospital, Duke University Medical Center, and the 
University of Pittsburgh Investigational Review Boards.   
 
4.1.3.2. Isolation and Culture of Peripheral Blood Mononuclear Cells:  For in vitro 
experiments in Gabonese children (n = 30) and U.S. adults (n = 21), venous blood (3 and 40 mL, 
respectively) was drawn into EDTA-containing vials.  PBMC were prepared using 
ficoll/Hypaque as described earlier (Weinberg et. al. 1981), and plated at 1 X 106 cells per mL in 
Dulbecco’s modified Eagles medium (DMEM) containing 10% pooled human serum (heat 
inactivated at 56˚C for 30 min).  Cells were incubated with media alone (controls) or 
concomitant stimulation with LPS [100 ng/mL (Alexis Corp., San Diego, CA)] and IFN-γ [200 
U/mL (BD Pharmingen, San Diego, CA)].  For experiments in healthy adults, cultures were 
incubated with varying concentrations of hemozoin (10, 1.0, and 0.1 µg/mL) or β-hematin (10, 
1.0, and 0.1 µg/mL) in the presence and absence of LPS and IFN-γ stimulation.  For 
neutralization of endogenous IL-10, cultures were stimulated with IL-10 neutralizing antibodies 
(1.0, 0.5, and 0.1 µg/mL). 
 
4.1.3.3. Hemozoin and β-hematin Preparation:  Crude hemozoin was isolated from in vitro 
cultures of P. falciparum-infected red blood cells (strain Pf-D6) according to our previously 
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 published methods (Keller et. al. 2004).  Briefly, cultured red blood cells (RBC) were treated 
with 2 mL saponin for 10 min and the solution was washed in PBS and spun at 14,000 rpm for 
15 min (4-7 times).  The final pellet was dried, weighed, and resuspended in filter-sterilized H2O 
at a concentration of 1.0 mg/mL.  As a control, a parasite-free RBC lysate was prepared from 
uninfected RBC following the protocol outlined above for the hemozoin preparation.  
 
 β-hematin was formed in a 4.5 M acidic acetate solution at pH 4.5 by the method of Egan 
et al. (Egan et. al. 2001).  Briefly, hemin chloride (Sigma, St. Louis, MO) was added to a 0.1 M 
solution of NaOH followed by addition of HCl and acetate.  The mixture was incubated for 150 
min at 60oC without stirring, spun at 14,000 rpm, washed 3X with filter-sterilized H2O, and dried 
at 60oC under vacuum.  The final pellet was weighed and resuspended at 1.0 mg/mL in filter-
sterilized H2O.  Resuspended β-hematin was sonicated extensively to disperse the preparation.  
Under these preparation conditions, β-hematin has an identical infrared spectroscopy pattern as 
detergent-purified hemozoin, and β-hematin crystals appear morphologically similar to natural 
hemozoin crystals as evidenced by scanning electron microscopy (Egan et. al. 2001).  
 
4.1.3.4. PGE2 and IL-10 Measurements:  Concentrations of PGE2 and IL-10 were measured 
in the supernatants of cultured PBMC using a quantitative indirect sandwich enzyme 
immunoassay (Cayman Chem., Ann Arbor, MI) and quantitative sandwich ELISA (Pharmingen, 
San Diego, CA), respectively, according to our previously defined methods (Perkins et. al. 
2003).  Sensitivity of detection for PGE2 and IL-10 was ≥ 7.8 pg/mL. 
 
4.1.3.5. MTT Assay:  Cell viability was determined by the MTT assay, which measures 
active mitochondrial conversion of MTT salt into formazan crystals.  Briefly, 20 µL of MTT salt 
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 [5 mg/mL in 1X PBS, (Sigma, St. Louis, MO)] were added to cultured cells 5 hrs prior to 
termination of cultures.  At the end of culture, supernatants were aspirated and 200 µL of DMSO 
were added to dissolve the formazan crystals.  Plates were incubated for 5 min at room 
temperature.  Absorbance was determined at 550 nm. 
 
4.1.3.6. Immunoblot Analyses:  Cellular extracts were prepared according to our previously 
defined methods (Perkins et. al. 1997).  Protein samples (30 µg) were fractionated on a 10% 
SDS-polyacrylamide gel, transferred to nitrocellulose membranes, and COX-2 antigen was 
measured by our previously defined methods (Perkins et. al. 2001).  Extracts of mouse 
macrophage cells (RAW 264.7), stimulated with lipopolysaccharide (E. coli LPS 0127B8, 1.0 
µg/mL) and IFN-γ (10 ng/mL) were used as a positive control.  Densitometry readings for COX-
2 protein expression were obtained using commercially available software (ScanImage, Scion 
Corporation).   
 
4.1.3.7. Quantitative real time RT-PCR:  Total RNA was isolated from PBMC by the GITC 
method (Chomczynski et. al. 1987).  Total RNA (1 µg) was reverse transcribed into cDNA, and 
COX-2 gene expression was analyzed by quantitative real time RT-PCR on an ABI Prism 7700 
sequence detection system (Applied Biosystems, Foster City, CA).  cDNA (100 ng) was 
amplified in duplicate with COX-2 specific primers and probe as follows: forward, 5'-CCT TCC 
TCC TGT GCC TGA TG-3'; reverse, 5'-ACA ATC TCA TTT GAA TCA GGA AGC T-3'; 
probe (FAM labeled), 5'-TGC CCG ACT CCC TTG GGT GTC A-3' [sequence information 
obtained from (Sales et. al. 2001)].  The COX-2 cDNA was amplified for 40 cycles following 
the parameters specified by the manufacturer (Applied Biosystems, Foster City, CA).  To control 
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 for non-specific background fluorescence, no template controls were included in triplicate.  An 
endogenous control gene, β-actin [Ascession Number NM_001101 (Applied Biosystems, Foster 
City, CA)], was used as a reference gene to normalize cDNA loading between samples.  Data 
was compared using the -∆∆CT method as previously described (Keller et. al. 2004). 
 
4.1.3.8. Statistical Analyses: Supernatant concentrations of PGE2 (pg/mL), and IL-10 
(pg/mL) were measured in triplicate and at several different dilutions.  COX-2 mRNA expression 
was measured in duplicate.  Pairwise comparisons between conditions, including pairwise tests 
of dose-dependent effects, were performed by the Mann-Whitney U test.  Multiple group 
comparisons for dose-dependent effects were performed using the Kruskal-Wallis test (statistical 
significance set at P ≤ 0.05).    
 
4.1.4. Results 
 
4.1.4.1. PGE2 Production in Cultured PBMC from Children with Malaria:  To determine 
if mononuclear phagocyte production of PGE2 is altered in children with falciparum malaria, 
PGE2 synthesis was determined in culture supernatants of PBMC from healthy, malaria-exposed 
children (control, n = 20) and children with malaria (malaria, n = 10).  To minimize the influence 
of the in vivo environment, PBMC were cultured for 120 hrs.  PGE2 synthesis was examined 
under baseline conditions (media alone) and in the presence of COX-2-promoting stimuli (LPS 
and IFN-γ).  Under baseline conditions, PGE2 production was lower in the malaria group 
compared to the control group (P < 0.05, Figure 11).  Stimulation of PBMC augmented PGE2 
production in the control group (P < 0.01), but failed to significantly elevate PGE2 formation in 
the malaria group (Figure 11).  Production of PGE2 in stimulated PBMC was lower in the 
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 malaria group relative to the control group (P < 0.05, Figure 10).  The percent of hemozoin 
containing monocytes in the cultured cells from children with malaria was 5.6%.  In addition, the 
relative percent of monocytes and lymphocytes in the two groups of children were equivalent 
(control: 7.1% monocytes and 54.3%, lymphocytes, and malaria group: 7.9% monocytes and 
51.0% lymphocytes).  The relative proportion of monocytes and lymphocytes remained 
comparable when determined in a subset of the healthy controls (n = 10) and children with 
malaria (n = 10) following ficoll/Hypaque separation.  These results suggest that monocyte-
derived PGE2 synthesis is significantly suppressed in children with malaria and is refractory to 
COX-2 promoting stimuli.    
 
4.1.4.2. Effect of Hemozoin on PGE2 Production:  Since PBMC from children with malaria 
had significantly reduced baseline and stimulated PGE2 synthesis over a 120 hr period, we 
postulated that an in vivo parasite-driven event induced PGE2 suppression.  As such, a crude 
hemozoin preparation, representing that most closely observed during a natural infection, was 
added to cultured PBMC.  Since these experiments required larger volumes of blood than were 
available in anemic children, PBMC were cultured from healthy, malaria-naive adult US donors, 
followed by stimulation with media alone, LPS  and IFN-γ, and LPS and IFN-γ in the presence 
of physiologic concentrations of hemozoin [10, 1.0, and 0.1 µg/mL, (Keller et. al. 2004)].  LPS- 
and IFN-γ-stimulation increased PGE2 levels over baseline conditions at 24 hrs (P < 0.05), with 
hemozoin having no effect on PGE2 production (Figure 12).  However, at 48 hrs, and at all 
subsequent time points examined, a high and intermediate concentration of hemozoin reduced 
PGE2 production (P < 0.05, Figure 12).  Treatment of cultures with a RBC lysate did not alter 
PGE2 production at any of the time points examined (Figure 12). 
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Since suppression of PGE2 by hemozoin could result from hemozoin-induced cell death, the 
temporal profile of cell viability was examined using the MTT assay.  LPS and IFN-γ stimulation 
decreased cell viability at 72, 96, and 120 hrs (P < 0.05), with the addition of hemozoin having 
no affect on cell viability (Figure 13).  Thus hemozoin significantly suppresses PGE2 through 
mechanisms independent of altering cell viability. 
 
Because PGE2 production varied in different individuals, we investigated the effect of 
hemozoin on a larger cohort of malaria-naïve healthy adults (n = 18) at 48 and 72 hrs, the time at 
which the greatest reductions in PGE2 were observed (see Figure 12).   Cultures were also 
stimulated with β-hematin to determine the effects of the core malarial pigment compound, 
FPIX, on PGE2 synthesis in the absence of host- and parasite-derived products.  PBMC were 
stimulated with LPS and IFN-γ in the presence of hemozoin or β-hematin, and data were 
expressed as percent change in PGE2 production in hemozoin-treated cells relative to cells 
stimulated with LPS and IFN-γ.  The addition of both hemozoin and β-hematin to PBMC caused 
a dose-dependent decrease in PGE2 production (Figure 14), suggesting that FPIX is responsible 
for suppression of PBMC-derived PGE2 production.   
 
4.1.4.3. Effect of Hemozoin and β-hematin on COX-2 Gene Products: Because 
inflammatory-derived PGE2 is dependent on de novo COX-2 mRNA and protein, we 
hypothesized that hemozoin suppresses PGE2 through blockade of COX-2 gene expression.  As 
such, COX-2 protein expression was determined by immunoblot analysis, using a COX-2-
specific monoclonal antibody, in stimulated cells in the presence and absence of hemozoin or β-
hematin.  Stimulation of cells increased COX-2 protein levels at 48 hrs (Figures 15A - D) with 
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 the addition of hemozoin or β-hematin causing a dose-dependent reduction in COX-2 protein 
(Figures 15A - 4D).   
 
To establish if hemozoin caused a decrease in COX-2 transcripts, COX-2 message was 
examined using quantitative real time RT-PCR.  At 48 hrs in culture, LPS- and IFN-γ-stimulated 
PBMC produced higher levels of COX-2 mRNA (P < 0.01, Figure 16).  The addition of a high 
and intermediate concentration of hemozoin or β-hematin reduced COX-2 transcript formation 
(P < 0.01, Figure 16). 
 
To determine the kinetics by which COX-2 transcripts are suppressed by hemozoin, the 
time-dependent induction of COX-2 mRNA was examined.  LPS- and IFN-γ-stimulation 
increased COX-2 mRNA by 8 hrs, which peaked at 24 hrs (P < 0.01, Figure 17).  The addition of 
hemozoin deceased COX-2 transcript formation at 24 and 48 hrs (P < 0.01, Figure 17).  Taken 
together, results presented here demonstrate that decreased PGE2 production occurs in hemozoin-
treated cells through reductions in COX-2 transcripts and protein.   
 
4.1.4.4. Effect of Endogenous IL-10 on Hemozoin-induced PGE2 Suppression:  Anti-
inflammatory cytokines, such as IL-10, suppress de novo COX-2 transcription in monocytes 
(Niiro et. al. 1995).  Moreover, we have previously shown that decreased PGE2 production in 
children with falciparum malaria was significantly associated with increased plasma IL-10 
production (Perkins et. al. 2001).  We, therefore, investigated if hemozoin-induced suppression 
of COX-2/PGE2 was a consequence of increased IL-10 production.  IL-10 was determined in 
PBMC stimulated with media alone, LPS and IFN-γ, and LPS and IFN-γ in the presence of 
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 hemozoin.  At 48 hrs, stimulation increased IL-10 production (P < 0.05), which was further 
augmented by the addition of hemozoin (P < 0.05, Figure 18A). 
 
Since addition of hemozoin to PBMC increased IL-10 production, and suppressed COX-
2-derived PGE2 formation, we determined if neutralizing antibodies to IL-10 could restore 
hemozoin-induced reductions in PGE2.  As shown in Figure 18B, addition of IL-10 neutralizing 
antibodies failed to restore PGE2 production.  Measurement of IL-10 confirmed that 
endogenously produced IL-10 was dose-dependently reduced in culture supernatants with 
increasing concentrations of IL-10 neutralizing antibodies (Figure 18C).   Determination of IL-
10 transcripts by real time RT-PCR showed that the addition of IL-10 neutralizing antibodies had 
no affect on IL-10 transcript levels (data not shown).  In addition, the addition of isotype-
matched control antibodies had no effect on IL-10 levels (data not shown).  Thus, suppression of 
COX-2-derived PGE2 occurs through an IL-10-independent mechanism.       
 
4.1.5. Discussion 
 
Our previous studies demonstrated that plasma bicyclo-PGE2 and ex vivo blood mononuclear cell 
COX-2 levels are suppressed in children with malaria (Perkins et. al. 2001).  In the present study, 
we extend those findings by showing that cultured PBMC from children with malaria have 
reduced baseline and stimulated PGE2 production.  Since cells were cultured for 120 hrs to avoid 
influence of host-derived in vivo regulatory factors, we postulated that suppression of PGE2 was 
due to a phagocytosed parasitic product(s).  Because hemozoin can persist in mononuclear cells 
for prolonged periods (Day et. al. 1996), the effect of hemozoin on PGE2 was examined.  A 
crude hemozoin isolate was used since this preparation mimics the hemozoin moiety acquired 
during a natural infection.  Consistent with studies illustrating that phagocytosis of hemozoin by 
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 monocytic cells occurs within 24 hrs with the biologic effects occurring over prolonged periods 
(Olliaro et. al. 2000, Schwarzer et. al. 2001), hemozoin significantly decreased PGE2 synthesis 
in PBMC from 48 hrs onward.  
 
The molecular mechanism responsible for hemozoin-induced PGE2 suppression does not 
occur through reduced cell viability, since the addition of hemozoin to stimulated PBMC did not 
alter mitochondrial bioactivity (i.e., MTT assay) at the time points selected for the mechanism-
based studies (48 and 72 hrs).  It is important to note that after 72 hrs in culture, hemozoin 
reduced cell viability, which was further reduced by LPS and IFN-γ treatment.  Thus, it was 
difficult to interpret experimental results in which cells were pretreated with hemozoin followed 
by stimulation.  Although results presented here clearly illustrate that hemozoin suppresses 
COX-2-derived PGE2 biosythesis, it appears that the natural acquisition of hemozoin in the 
cytokine-activated in vivo milieu differs slightly from that offered by the in vitro environment.   
This rationale is supported by the fact that hemozoin reduced PGE2 biosynthesis by 15 to 53% in 
cells from healthy donors versus the 70% reduction observed in children with malaria.  The 
apparent discrepancy between in vitro hemozoin-induced reductions in PGE2 and naturally 
acquired hemozoin in mononuclear cells from children with malaria may be due to additional 
host- and/or parasite-derived factors independent of hemozoin.  We are currently investigating 
the effects of additional host immune factors and parasitic products that may alter PGE2 
synthesis during acute malaria. 
 
While we consistently observed PGE2 suppression in PBMC stimulated with hemozoin, 
there was substantial variation in PGE2 production in different individuals.  To address this 
73 
 variation, data were expressed as percent reduction in PGE2 relative to stimulated conditions in a 
larger number of individuals (n = 18) at time-points when the cell viability was greatest (i.e., 48 
and 72 hrs).  Expression of data in this manner “normalized” individual variation and 
demonstrated a dose-dependent suppressive effect of hemozoin on PGE2 biosynthesis.  These 
experiments further demonstrated that β-hematin dose-dependently reduced PGE2 production.  
Since β-hematin is a synthetically prepared compound of FPIX, which lacks host- and parasite-
derived proteins and lipids, and is structurally identical to purified (detergent-treated) hemozoin 
(Pagola et. al. 2000, Slater et. al. 1991),  it appears that FPIX is responsible for suppression of 
PGE2. 
Our previous results showed that ex vivo PBMC COX-2 protein and mRNA were 
decreased in children with malaria (Perkins et. al. 2001).  This, along with our previous data 
showing that de novo induction of COX-2 message is required for high levels of sustained PGE2 
production (Perkins et. al. 1997), prompted us to investigate hemozoin-induced changes in COX-
2 expression.  Hemozoin and β-hematin dose-dependently suppressed COX-2 mRNA and 
protein, indicating that PGE2 suppression is due to reduced levels of COX-2 gene products.  
Results from kinetic experiments illustrated that hemozoin inhibits de novo COX-2 message at 8 
and 24 hrs.  Thus, reductions in COX-2 protein and PGE2 formation at 48 hrs is consistent with 
decreased COX-2 transcripts at earlier time points. 
 
Previous studies in individuals with CM showed increased COX-2 protein in Durck’s 
granulomas within the central nervous system (Deininger et. al. 2000).  However, our results in 
plasma and PBMC from children with malaria (Perkins et. al. 2001), and here in hemozoin-
treated PBMC, illustrate that COX-2/PGE2 is suppressed in circulating blood mononuclear cells 
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 and plasma.  Our recent results in Tanzanian children with CM also show that peripheral PGE2 
levels are decreased during acute disease, with the most profound reductions in PGE2 being 
associated with increased disease sequeale (Perkins et. al. 2005).  We have further shown that 
placental monocytes from women with malaria during pregnancy have decreased PGE2 
formation; there was a dose-dependent reduction in PGE2 with increasing amounts of naturally 
acquired hemozoin (Perkins et. al. 2003).  Recent studies in a murine model of CM also showed 
that COX-2 transcripts were significantly increased within the brain, but non-significantly 
decreased in PBMC (Ball et. al. 2004).  Furthermore, infection of mice with P. berghei K173, a 
parasite strain causing anemia in the absence of CM, significantly decreased peripheral COX-2 
transcripts (Ball et. al. 2004).  Thus, during acute malaria, COX-2/PGE2 regulation within the 
brain differs from COX-2/PGE2 regulation in the local tissue compartments and in circulating 
blood monocytes. 
 
Our previous studies showed that decreased plasma PGE2 levels were significantly 
associated with increased plasma IL-10 concentrations (Perkins et. al. 2001).  This is consistent 
with data illustrating that IL-10 decreases PGE2 through suppression and/or destabilization of 
COX-2 transcripts (Niiro et. al. 1995).  As such, we determined if hemozoin-induced PGE2 
suppression occurred through increased IL-10 production.  Hemozoin augmented LPS- and IFN-
γ-induced IL-10 production, however, hemozoin-induced IL-10 production does not appear 
responsible for PGE2 suppression since IL-10 neutralizing antibodies failed to restore PGE2.  
Thus, the molecular mechanism(s) by which hemozoin suppresses COX-2/PGE2 remains 
unclear.  Previous studies show that activation of the protein kinase C (PKC) signaling pathway 
is essential for COX-2 induction in human intestinal myofibroblasts (Mifflin et. al. 2002), and 
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 that inhibition of PKC attenuates IL-1β induction of COX-2/PGE2 in human pulmonary 
epithelial cells (Lin et. al. 2000).  This appears important for results presented here since 
previous studies found that hemozoin suppresses PKC activity in cultured monocytes (Schwarzer 
et. al. 1993).  We are currently determining if reduced levels of COX-2 in malaria occur through 
inhibition of PKC signal transduction pathways. 
 
Although decreased systemic PGE2 levels are associated with increasing disease severity, 
it is unclear how suppressed peripheral PGE2 promotes enhanced malaria pathogenesis.  Potential 
pathogenic effects may occur through suppression of erythropoiesis since previous studies 
demonstrate that PGE2 enhances burst forming unit erythroid formation (Dupuis et. al. 1998), 
suggesting that suppression of systemic PGE2 by hemozoin may reduce formation of new RBC.  
Additional mechanisms by which decreased systemic PGE2 could promote increased 
pathogenesis may occur through over-expression of the pro-inflammatory response.  For 
example, PGE2 is important for resolution of the late-phase immune response through promotion 
of TH2-derived cytokine production [for review see (Phipps et. al. 1991)].  PGE2 also regulates 
the pro-inflammatory response by suppressing de novo TNF-α transcription (Kunkel et. al. 
1988), and by modulating the secretion of soluble TNF-α receptors (Choi et. al. 1996).  PGE2 
may also alter malaria pathogenesis through modulation of lymphocytic activity.  Previous 
studies in cultured human mononuclear cells from individuals with acute falciparum malaria 
showed that the non-selective COX inhibitor, indomethacin, reversed malarial antigen-induced 
suppression of lymphoproliferation (Riley et. al. 1989).  However, levels of COX-2/PGE2 were 
not determined in these studies (Riley et. al. 1989).  Subsequent studies showed that exogenous 
addition of PGE2 failed to suppress T-cell proliferation (Alves et. al. 1992).  The apparent 
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 discrepancy in these results may be related to the fact that indomethacin alters a number of 
cellular functions in a COX-independent fashion [for review see (Tegeder et. al. 2001)].  We are 
currently investigating the effects of COX-2/PGE2 suppression on malaria pathogenesis in 
children with severe malarial anemia.   
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Figure 11.  PGE2 production in cultured PBMC from children with malaria.  PBMC (1 x 106 
cells/mL) from healthy malaria-exposed children (Control, n = 20) and children with malaria 
(Malaria, n = 10) were cultured in the presence and absence of LPS (100 ng/mL) and IFN-γ (200 
U/mL).  Supernatants were collected at 120 hrs for PGE2 determination.  Values are the mean ± 
SEM. Statistical significance was determined by the Mann-Whitney U test. *P < 0.01 compared 
to unstimulated conditions, **P < 0.05 compared to control. 
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Figure 12.  Temporal effect of hemozoin on PGE2 production.  PBMC (1 x 106 cells/mL) were 
stimulated with media alone, LPS (100 ng/mL) and IFN- γ (200 U/mL), and LPS and IFN-γ in 
the presence of hemozoin (10, 1.0, and 0.1 µg/mL) and an RBC lysate (10 µg/mL).  Supernatants 
were removed at 24, 48, 72, 96, and 120 hrs for PGE2 determination.  Values are the mean ± 
SEM and are representative of three independent experiments.  Statistical significance 
determined by the Mann-Whitney U test.  *P < 0.05 compared to control (media alone), **P < 
0.01 compared to stimulated conditions. 
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Figure 13.  Temporal effect of hemozoin on cell viability.  PBMC (1 x 106 cells/mL) were 
stimulated with media alone (solid gray line), LPS (100 ng/mL) and IFN-γ (200 U/mL) 
(dashed gray line), and LPS and IFN-γ in the presence of hemozoin [10 µg/mL, (solid black 
line)].  Cell bioactivity was determined by the MTT assay at 24, 48, 72, 96, and 120 hrs.  
Values are the mean ± SEM, n = 3.  Statistical significance was determined by the Mann-
Whitney U test. *P < 0.05. 
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Figure 14.  Effect of hemozoin and β-hematin on PGE2 production.  PBMC (1x106 cells/mL) 
were stimulated with LPS (100 ng/mL) and IFN-γ (200 U/mL) and LPS and IFN-γ in the 
presence of hemozoin (10, 1.0, and 0.1 µg/mL) or β-hematin (10, 1.0, and 0.1 µg/mL).  
Supernatants were removed at 48 and 72 hrs for PGE2 determination.  Values are the mean ± 
SEM, n=18.  Data are expressed as percent change over LPS and IFN-γ stimulation.  Statistical 
significance was determined by the Kruskal-Wallis test, *P < 0.05. 
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and IFN-γ in the presence of hemozoin (10, 1.0, and 0.1 µg/mL) or β-hematin (10, 1.0, and 0.1 
µg/mL).  Cells were harvested at 48 hrs for COX-2 protein determination by immunoblot 
analysis.  Shown above is a representative immunoblot of four independent experiments in 
different individuals for cells treated with hemozoin (A) or β-hematin (C).  As a positive control 
(+), extracts of mouse macrophage cells (RAW 264.7), stimulated
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  Effect of hemozoin and β-hematin on COX-2 protein expression.  PBMC (1x106 
cells/mL) were stimulated with media alone, LPS (100 ng/mL) and IFN-γ (200 U/mL), and LPS 
 with lipopolysaccharide (E. 
coli LPS 0127B8, 1.0 µg/mL) and IFN-γ (10 ng/mL) were included.  COX-2 antigen expression 
was quantified using commercially available software (ScnImage, Scion Corporation) in cells 
treated with (B) hemozoin or (D) β-hematin and expressed as relative arbitrary units.   
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Figure 16.  Effect of hemozoin on COX-2 mRNA expression.  COX-2 mRNA was quantified for 
four individuals by Real time RT-PCR.  PBMC (1x106 cells/mL) were stimulated with media 
alone, LPS (100 ng/mL) and IFN-γ (200 U/mL), and LPS and IFN-γ in the presence of hemozoin 
(10, 1.0, and 0.1 µg/mL) or β-hematin (10, 1.0, and 0.1 µg/mL).  Cells were collected at 48 hrs 
for COX-2 mRNA determination.  Values are the mean ± SEM, n=4.  Statistical significance was 
determined by the Mann-Whitney U test. *P < 0.01 compared to control (media alone), **P < 
0.01 compared to stimulated conditions. 
β-hematin - - - - - 10 1.0 0.1
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igure 17.  Temporal effect of hemozoin on COX-2 transcripts.  PBMC (1x106 cells/mL) were 
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stimulated with media alone (solid gray line), LPS (100 ng/mL) and IFN-γ (200 U/mL) (dashed 
gray line), and LPS and IFN-γ in the presence of hemozoin [10 µg/mL, (solid black line)].  Cells 
were collected at 2, 4, 8, 24, and 48 hrs for COX-2 mRNA determination.  Values are the mean ± 
SEM and are representative of three independent experiments.  Statistical significance was 
determined by the Mann-Whitney U test. *P < 0.01 compared to control (media alone), **P < 
0.01 compared to stimulated conditions. 
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Figure 18.  Effect of endogenous IL-10 on hemozoin-induced PGE2 suppression.  
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Figure 18.  Effect of endogenous IL-10 on hemozoin-induced PGE2 suppression.  PB
cells/mL) were stimulated with media alone, LPS (100 ng/mL) and IFN-γ (200 U/mL
and IFN-γ in the presence of hemozoin [10 µg/mL, (solid black line)].  (A) Supernatants were 
obtained at 48 hrs for IL-10 determination.  (B) Cultures were incubated in the presence of 
varying concentrations of an IL-10 neutralizing antibody (1.0, 0.5, and 0.1 µg/m
MC (1x106 
), and LPS 
L and 
supernatants were obtained at 48 hrs for PGE2 determination.  Values are the mean ± SEM, n=10 
and 5, respectively.  Statistical significance was determined by the Mann-Whitney U test. *P < 
0.01 compared to control (media alone), **P < 0.05 compared to stimulated conditions.  
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4.2. EFFECT OF HEMOZOIN ON COX-2 ENZYMATIC ACTIVITY 
.2.1. Introduction 
egulation of COX-2-dependent PGE2 production occurs at several levels, including suppression 
nd/or destabilization of de novo COX-2-transcripts and/or through inhibition of COX-2 
atic activity.  Data presented above illustrate that hemozoin suppresses PGE2 production 
rough reductions in de novo COX-2 mRNA and protein expression, however, inhibition of 
class II 
hibitors, such as NS-398, occurs by reversible binding of the inhibitor to COX-2, followed by 
e formation of a COX-2-inhibitor complex which slowly dissociates over time (Copeland et. 
l. 1994).  To determine if hemozoin interferes with COX-2 enzymatic activity, hemozoin and β-
ematin were added to an in vitro COX-2 Inhibitor Screening Assay (Cayman Chem. Ann Arbor, 
MI).  Furthermore, it has been proposed that hemozoin may bind to free heme (Schwarzer et. al. 
1999), a necessary co-factor for COX-2 activity.  Hemozoin binding to free heme may therefore 
 
 
4
 
R
a
enzym
th
COX-2 enzyme activity by hemozoin has not been investigated. 
 
 Inhibitors of COX-1 and COX-2 enzymatic activity have been placed into three classes; 
class I which act as competitive substrate inhibitors, class II which elicit conformational changes 
in the protein structure of the enzyme, and class III which irreversibly acetylate the enzyme 
(Smith et. al. 1996).  Inhibition of COX-2 enzymatic activity by specific COX-2 
in
th
a
h
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 decrease COX-2 enzymatic activity and the subsequent production of PGE2 through removal of a 
ritical co-factor required for optimal enzymatic efficiency.  As such, we examined the ability of 
hemozoin and β-hematin to bind free heme using an in vitro heme binding assay. 
 
.2.2. Methods 
 To determine if hemozoin interferes with COX-
atic activity, the COX-2 Inhibitor Screening Assay (Cayman Chem. Ann Arbor, MI) was 
H2 was then non-enzymatically 
onverted to PGF2α by the addition of stannous chloride.  PGF2α was determined by EIA, with a 
activity (i.e., PGF2α formation) relative to control (no inhibitor) conditions.  Statistical 
significance was determined by the Mann-Whitney U test at the P < 0.05 level. 
 
4.2.2.2. Heme Binding Assay:  To determine if hemozoin and β-hematin bind to heme, an in 
vitro heme-binding assay was conducted.  Briefly, 100 µL volumes of varying concentrations of 
an exogenous heme solution (100, 50, 25, 12.5, 6.25, 3.13, 1.66, and 0.78 µg/mL) were 
o
c
4
 
4.2.2.1. COX-2 Inhibitor Screening Assay:  
2 enzym
used following the manufacturer’s instructions.  Briefly, COX-2 recombinant human enzyme 
was incubated in the presence or absence of hemozoin (10, 1.0, 0.1 µg/mL), β-hematin (10, 1.0, 
0.1 µg/mL), or a COX-2-specific inhibitor, NS-398 (1 x 10-5 M, positive control), for 10 min at 
37oC.  Exogenous arachidonic acid was then added to the reactions for 2 min, and the reaction 
was terminated by the addition of 1M HCl.  The resultant PG
c
sensitivity of detection ≥ 15.6 pg/mL.  Data were expressed as percent of COX-2 enzyme 
incubated in the absence or presence of a high concentration (10 µg/mL) of hemozoin or β-
hematin for 48 hrs at 37 C and 5% CO2.  The plates were then centrifuged for 10 min at 3,000 
88 
 rpm to pellet the hemozoin and β-hematin, and 20 µL volumes of each sample were transferred 
to a 96-well plate, followed by the addition of 180 µL of heme quantitation reagent (250 µL of 
2.5% Triton-X100 dissolved in methanol into 9.75 mL ethanol).  Absorbance was obtained at 
05 nm on a plate reader.  Data were extrapolated against a freshly prepared standard curve of 
heme solution (serial dilutions of 100 µg/mL of heme) and expressed as heme units (µg/mL).  
4.2.3.2. Ability of Hemozoin and β-hematin to Bind Free Heme: The heme binding assay 
revealed that, relative to control (free heme incubated alone for 48 hrs), the addition of hemozoin 
or β-hematin significantly reduced the amount of heme detected at high doses (i.e., 100, 50, 25, 
and 12.5 µg/mL, P < 0.05 for all tests, Figure 20).  The addition of NS-398 (1 x 10-5 M) did not 
significantly alter free heme concentrations relative to control.  Taken together, results presented 
here suggest that hemozoin inhibits COX-2-dependent enzymatic conversion of arachidonic acid 
to PGH2, at least in part, through reductions in free heme. 
 
4
Statistical significance was determined by the Mann-Whitney U test at the P < 0.05 level. 
 
4.2.3. Results 
 
4.2.3.1. Effect of Hemozoin and β-hematin on COX-2 Enzymatic Activity:  COX-2 
enzyme activity was determined in the absence or presence of hemozoin (10, 1.0, 0.1 µg/mL), β-
hematin (10, 1.0, 0.1 µg/mL), or a COX-2 specific inhibitor, NS-398 (1 x 10-5 M).  Hemozoin 
and β-hematin dose-dependently suppressed COX-2 enzyme activity (P < 0.05 and P < 0.05, 
respectively, Figure 19).  The positive control, NS-398, significantly inhibited COX-2 enzyme 
activity (P < 0.01, Figure 19).  
89 
 4.2.4. Discussion 
 
the presence of inflammatory mediators (see Figures 12 - 17), it was important to determine if 
hemozoin inhibited PGE  formation through a mechanism such as enzymatic inhibition that was 
independent of down-regulation of de novo COX-2 transcripts.  It has been proposed that 
hemozoin may act as a “sink” for free heme (Schwarzer et. al. 1999), which is a necessa
Although hemozoin suppressed de novo COX-2 transcripts and subsequent PGE2 formation in 
2
ry co-
or ctivity.  Results presented here demonstrate that incubation of COX-2 lysates 
ith hemozoin and β-hematin dose-dependently inhibited COX-2 enzyme activity, suggesting 
s presented here support the notion that hemozoin binds to free 
heme in solution, thereby sequestering free heme that is required for COX-2 enzymatic function.  
factor f  COX-2 a
w
that the core iron component of hemozoin, FP-IX, can interfere with the enzymatic activity of 
COX-2.  However, high concentrations (10 µg/mL) of hemozoin and β-hematin did not inhibit 
COX-2 enzymatic activity to the level of suppression observed by the specific COX-2 inhibitor, 
NS-398.  These results are not unexpected since the mechanism of inhibition by NS-398 is direct 
binding to COX-2 versus removal of a critical co-factor (i.e., heme) through binding to 
hemozoin.  Experimental result
Taken together, these data suggest that hemozoin-induced suppression of PGE2 occurs at several 
levels; 1) reduction of de novo COX-2 transcripts and 2) inhibition of COX-2 enzymatic activity. 
90 
  
 
 
 
 
 
 
activity was determined in vitro in the presence of hemozoin (10, 1.0, 0.1 µg/mL) and β-
Whitney U test, *P < 0.05, **P < 0.01. 
 
 
 
 
 
 
 
 
Figure 19.  Effect of hemozoin and β-hematin on COX-2 enzymatic activity.  COX-2 enzymatic 
hematin (10, 1.0, 0.1 µg/mL), and a COX-2-specific inhibitor, NS-398 (1 x 10-5 M, positive 
control).  Values are the mean ± SEM, n = 3/condition, and are expressed as percent of 
enzymatic activity relative to control.  Statistical significance determined by the Mann-
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atin (dashed gray line).  Values are the mean ± SEM, n 
= 3, and are expressed as heme units (µg/mL).  Statistical significance was determined by the 
Mann-Whitney U test, *P < 0.05. 
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Figure 20.  Effect of hemozoin and β-hematin on free heme.  Varying concentrations of 
exogenous heme (100, 50, 25, 12.5, 6.25, 3.13, 1.66, and 0.78 µg/mL) were incubated for 48 
hrs in the absence (control, dashed black line) or presence of a high concentration (10 µg/mL) 
of hemozoin (solid black line) or β-hem
Exogenous Heme (µg/mL)
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 4.3. SPECIFIC AIM 2, HYPOTHESES 2 AND 3:  PRESENTATION OF 
MANUSCRIPT ENTITLED:  HEMOZOIN-INDUCED SUPPRESSION OF COX-2-
DERIVED PGE2 ALLOWS OVER-PRODUCTION OF TNF-α:  ASSOCIATION WITH THE 
PATHOGENESIS OF CHILDHOOD MALARIAL ANEMIA. 
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 4.3.1. Abstract 
 
Esta
have previously in E2 (bicyclo-
PGE2) are suppressed in children with malarial anemia (MA).  Furthermore, hemozoin (malarial 
pigment) suppressed monocyte/macrophage COX-2/PGE , which allowed over-expression of 
tumor necrosis factor (TNF)-α.  Because elevated TNF-α and reduced PGE2 are associated with 
determined if bicyclo-PGE2 relative to TNF-α (bicyclo-PGE2/TNF-
-α ratio was significantly lower in children with MA (P < 0.01), and significantly 
ntrations of hemozoin were dose-dependently 
late of MA, and 
tive to TNF-α.  
4.3.2. Introduction 
 
emia (MA) is a multifaceted clinical manifestation of malaria with varying etiologies 
including intravascular and extravascular hemolysis of infected and non-infected RBCs, and 
suppression of erythropoiesis (Hillman et. al. 1996).  Depending on previous exposure to malaria 
(number of episodes), malaria transmission rates within a given geographic location 
(holoendemic versus hyperendemic), and the age at which the first MA episode occurs, the 
underlying causes of decreased Hb concentrations (anemia) are likely different.  In areas with 
blishment of immune correlates based on molecular mechanisms involved in malaria 
pathogenesis will be useful in the development and testing of malaria vaccine candidates.  We 
 shown that cyclooxygenase (COX)-2 and bicyclo-prostagland
2
decreased erythropoiesis, we 
α ratio) was associated with childhood MA.  Relative to healthy subjects, the bicyclo-
PGE2/TNF
associated with hemoglobin levels (r = 0.653, P < 0.01).  In addition, the PGE2/TNF-α ratios 
examined in PBMC treated with physiologic conce
decreased.  Thus, the PGE2/TNF-α ratio is an important immunologic corre
ingestion of hemozoin by monocyte/macrophages appears responsible for decreased levels of 
PGE2 rela
 
Malarial an
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 high transmission rates of Plasmodium falciparum, mortality rates can be as high as 25-30% in 
children less than 5 years of age (Breman et. al. 2001).  The high mortality rate in this age group 
is primarily due to MA (Breman et. al. 2001).  Although the molecular immunologic basis that 
determines whether a child will develop mild versus severe forms of MA remains undefined, 
soluble mediators of immunity such as, cytokines and effector molecules appear to play an 
important role in the development of naturally acquired immunity.    
 
Acute P. falciparum malaria is characterized by high systemic levels of tumor necrosis 
factor (TNF)-α (Perkins et. al. 2000), a pro-inflammatory cytokine which is both protective by 
restricting parasitemia (Kremsner et. al. 1995) and pathogenic by promoting anemia (Clark et. al. 
2 2
2
etabolized to PGH2 via the enzymatic activity of the COX enzymes, 
OX-1 and COX-2, encoded by separate genes  (Appleton et. al. 1996, Murakami et. al. 1997, 
Vane et. al. 1998).  COX-1 is constitutively expressed in most tissues and generates 
1988).  Our previous studies showed that plasma levels of prostaglandin E  (PGE , determined as 
the stable end-product: bicyclo-PGE ) and peripheral blood mononuclear cells (PBMC) 
cyclooxygenase-2 (COX-2) gene products are significantly reduced in acute childhood 
falciparum malaria (Perkins et. al. 2001).   Eicosinoids such as PGE2 are formed when 
phospholipase A2 (PLA2) cleaves arachidonic acid (AA) from the phospholipid bilayer releasing 
free AA which is rapidly m
C
prostaglandins (PGs) for physiologic homeostasis, and COX-2 is an inducible early response 
gene that generates high levels of PGs during inflammation (Seibert et. al. 1994).  We have 
previously shown that TNF-α promotes stabilization of COX-2 transcripts and protein which 
generates high levels of sustained prostaglandin E2 (PGE2) biosynthesis (Perkins et. al. 1997).  
Once formed, PGE2 can limit the biologic activity of TNF-α by inhibiting TNF-α transcription 
95 
 and enhancing the release of soluble TNF-α receptors (Choi et. al. 1996, Kunkel et. al. 1988).  
Consistent with the fact that PGE2 down-regulates TNF-α, abrogation of PGE2 synthesis by 
indomethacin, a non-specific COX-1 and COX-2 inhibitor, promotes over-production of TNF-α 
from monocytes (Hart et. al. 1989).   
 
We have previously shown that mononuclear phagocyte ingestion of malarial pigment 
xamined as both a crude hemozoin preparation and as synthetically-derived β-hematin) 
supp 2
2 
shown to be associated with malaria disease severity (Kurtzhals et. al. 1998, Othoro et. al. 1999, 
Perkins et. al. 2000), biologically significant relationships between TNF-  and PGE2 have not 
previously been examined in malaria.   
(e
ress COX-2 transcripts and the subsequent formation of PGE  (Keller et. al. 2004).  
Hemozoin is formed during the erythrocytic stage of malaria when the parasite catalyzes heme, 
which is released upon digestion of host hemoglobin, into an insoluble polymer that is no longer 
toxic to the parasite (Slater 1992).  Hemozoin is acquired by circulating monocytes and 
neutrophils and tissue macrophages through phagocytosis of both parasitized erythrocytes and 
free hemozoin released upon erythrocytic lysis (Arese et. al. 1997, Schwarzer et. al. 1998).  Our 
previous results showed that increased numbers of pigment containing monocytes and 
neutrophils in circulation are associated increased TNF-α and interleukin (IL)-10, and decreased 
IL-12 acute-phase cytokine levels (Luty et. al. 2000).  Thus, phagocytosis of hemozoin by 
circulating monocytes and neutrophils appears to induce immunologic dysregulation during 
acute malaria by promoting over-production of TNF-α, IL-10, and suppression of PGE and IL-
12.  Although the relative expression of TNF-α, IL-10, and IL-12 have been investigated and 
α
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 The present studies, therefore, investigated the relationship between COX-2/PGE2 and 
TNF-α in cultured PBMC from healthy, malaria-naïve donors in the presence of physiologically 
relevant concentrations (10, 1.0, and 0.1 µg/mL) of hemozoin or β-hematin (Keller et. al. 2004).  
In addition, since erythropoietic maturation is enhanced by PGE2 and suppressed by TNF-α 
(Dupuis et. al. 1998, Skobin et. al. 2000), and PGE2 inhibits the production of TNF-α (Kunkel 
et. a
 
4.3.3.1. Study Participants:  Children (n = 41, age 2 to 7 years) were recruited from a 
longitudinal prospective study at the Albert Schweitzer Hospital in Lambaréné, Gabon in the 
Province of Moyen Ogooue.  In this area of hyperendemic malaria transmission, the primary 
clinical manifestations of severe childhood malaria are severe anemia and/or hyperparasitemia, 
with cerebral malaria occurring rarely (Kun et. al. 1998).  Classification of malaria was defined 
according to World Health Organization guidelines (World Health Organization 1990).  Children 
with mild MA were defined as those study participants with a Hb level between 9.0 and 10.9 
g/dL in the presence of any density parasitemia, and moderate MA cases were defined as those 
study participants with a Hb level between 5.1 and 8.9 g/dL in the presence of any density 
parasitemia.  Healthy, malaria-exposed subjects were defined as those participants with the 
antimalarials and/or antipyretics.  We 
used routine clinical evaluations and laboratory measures to evaluate the patients.  Children with 
l. 1988), we determined if plasma levels of bicyclo-PGE2 relative to TNF-α (the bicyclo-
PGE2/TNF-α ratio) were associated with MA [defined by hemoglobin (Hb) concentrations] in 
children with falciparum malaria.   
 
4.3.3. Subjects and Methods 
absence of a positive thick blood film for malaria, or any other illnesses, within the last 4 weeks.  
All blood samples were obtained prior to treatment with 
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 mala
 Healthy, malaria-naïve adult donors (n = 21) were recruited from the University of 
Pittsburgh, U.S.A.  The study was approved by the ethics committee of the International 
Foundation of the Albert Schweitzer Hospital, Duke University Medical Center Investigational 
 
. eral Blood Mononuclear Cells:  For in vitro 
ents in U.S. adults (n = 21), venous blood (40 mL) was drawn into EDTA-containing 
6
ria were given antimalarials and the appropriate supportive therapy as required.  Informed 
consent was obtained from the parents of participating children.   
 
Review Board, the University of Tübingen, and the University of Pittsburgh Institutional Review
Board.   
    
4.3.3.2 Isolation and Culture of Periph
experim
vials.  PBMC were prepared using ficoll/Hypaque as described earlier (Weinberg et. al. 1981), 
and plated at 1 X 10  cells per mL in Dulbecco’s modified Eagles medium (DMEM) containing 
10% pooled human serum (heat inactivated at 56˚C for 30 min; complete medium).  Cells were 
incubated with media alone (controls) or with varying concentrations of hemozoin (10, 1.0, and 
0.1 µg/mL) or β-hematin (10, 1.0, and 0.1 µg/mL).  For determining the effect of exogenous 
PGE2 on cytokine production, cultures were stimulated with HPLC-grade PGE2 [(1 x 10-5 M to 1 
x 10-9 M) Cayman Chem., Ann Arbor, MI].  For experiments with COX-2-specific inhibitors, 
PBMC in the absence and presence of β-hematin were cultured with varying concentrations of 
DuP-697 (1x10-10 – 1x10-6 M) or indomethacin (1x10-8 – 1x10-4 M). 
 
4.3.3.3. Preparation of Hemozoin and β-hematin:  A crude preparation of hemozoin was 
isolated as described earlier (Keller et. al. 2004).  Briefly, P. falciparum-infected red blood cells 
(pRBC) (strain Pf-D6, 3-5% parasitemia, predominately late trophozoites and early schizonts) 
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 were isolated from in vitro cultures and lysed with saponin.  Samples were spun at 14,000 rpm 
for 15 min, and the pelleted material was washed in PBS until free from the white-colored red 
lood cell (RBC) cellular components.  The final pellet was dried, weighed, and resuspended in 
filter-sterilized H2O at a final concentration of 1.0 mg/mL.  The final solution was extensively 
sonicated to disperse the hemozoin. 
 
an et. al. 2001).  Briefly, hemin chloride (Sigma, St. Louis, MO) was added to a 0.1 M 
ution of NaOH followed by the addition of HCl at 60oC.  A solution of acetate was then 
 end-metabolite of PGE2, 
icyclo-PGE2 by competitive EIA (Cayman, Ann Arbor, MI) according to our previously 
b
β-hematin was formed in a 4.5 M acidic acetate solution at pH 4.5 by the method of Egan 
et al. (Eg
sol
added, and the mixture was incubated for 150 min at 60oC without stirring.  The β-hematin was 
then spun at 14,000 rpm in a microcentrifuge, washed 3X with filter-sterilized H2O, and dried at 
60oC under vacuum.  The final pellet was weighed and resuspended at 1.0 mg/mL in filter-
sterilized H2O.  The resuspended β-hematin was sonicated extensively to disperse the 
preparation.  Under these preparation conditions, β-hematin has an identical infrared 
spectroscopy pattern as detergent-purified hemozoin, and β-hematin crystals appear 
morphologically similar to natural hemozoin crystals as evidenced by scanning electron 
microscopy (Egan et. al. 2001).   
 
4.3.3.4. Measurement of Prostaglandins and TNF-α:  To determine plasma PGE2 
concentrations in children with malaria, we measured the stable
b
described methods (Perkins et. al. 2001).  Since PGE2 is rapidly metabolized in biologic 
solutions, the most accurate means of measuring PGE2 in plasma is by converting PGE2 and the 
intermediary metabolites to the stable end product bicyclo-PGE2.  Briefly, plasma was 
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 precipitated in ethanol at 4oC and then purified by solid phase extraction with DSC-18 (octadecyl 
bonded silica, Suppelco, Bellefonte, PA).  PGs were eluted with ethyl acetate and dried under 
vacuum centrifugation.  Samples were derivatized overnight at 37°C followed by re-suspension 
in buffer.  Bicyclo-PGE2 was then determined by quantitative sandwich enzyme immunoassay 
(EIA) technique (Cayman Chemical Co., Ann Arbor, MI). 
.3.3.5. Immunoblot Analyses:  Cellular extracts were prepared according to our previously 
e
 
PGE2 was measured in the supernatants of cultured PBMC using a quantitative indirect 
sandwich EIA (Cayman Chem., Ann Arbor, MI) with a sensitivity of detection ≥ 7.8 pg/mL.  
Briefly, samples were incubated overnight in goat anti-mouse IgG-coated plates in the presence 
of a mouse IgG anti-PGE2 monoclonal antibody and a PGE2-acetylcholinesterase tracer.  After 
washing, the plates were incubated at room temperature with Ellman’s reagent, and absorbance 
readings were obtained at 550 nm.   
 
Concentrations of TNF-α in plasma from children and supernatants from cultured PBMC 
were determined by quantitative sandwich ELISA (sensitivity of detection (≥ 4.4 pg/mL), 
following the manufacturers specifications (Pharmingen, San Diego, CA).   
 
4
defined m thods (Perkins et. al. 1997).  Protein samples (30 µg) were fractionated on a 10% 
SDS-polyacrylamide gel, transferred to nitrocellulose membranes, and COX-2 antigen was 
measured by our previously defined methods (Perkins et. al. 2001).  Extracts of mouse 
macrophage cells (RAW 264.7), stimulated with lipopolysaccharide (E. coli LPS 0127B8, 1.0 
µg/mL) and IFN-γ (10 ng/mL) were used as a positive control.  Densitometry readings for COX-
100 
 2 protein expression were obtained using commercially available software (ScanImage, Scion 
Corporation).   
 
4.3.3.6. Quantitative real time RT-PCR:  Total RNA was isolated from PBMC by the GITC 
method (Chomczynski et. al. 1987).  Total RNA (1 µg) was reverse transcribed into cDNA, and 
OX-2 and TNF-α gene expression was analyzed by quantitative real time RT-PCR on an ABI 
Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA).  cDNA (100 ng) 
was amplified in duplicate with COX-2 specific primers and probe as follows: forward, 5'-CCT 
TCC TCC TGT GCC TGA TG-3'; reverse, 5'-ACA ATC TCA TTT GAA TCA GGA AGC T-3'; 
probe (FAM labeled), 5'-TGC CCG ACT CCC TTG GGT GTC A-3' [sequence information 
obtained from (Sales et. al. 2001)], or with specific primer/probe sets for TNF-α [Ascession 
Number NM_000594 (Applied Biosystems, Foster City, CA)].  The cDNA was amplified for 40 
cycles following the parameters specified by the manufacturer (Applied Biosystems, Foster City, 
CA).  To control for non-specific background fluorescence, no template controls were included 
in triplicate.  An endogenous control gene, β-actin [Ascession Number NM_001101 (Applied 
Biosystems, Foster City, CA)], was used as a reference gene to normalize cDNA loading 
between samples.  Data was compared using the -∆∆C  method as previously described (Keller 
et. al. 2004). 
performed by the Mann-Whitney U test.  Multiple group comparisons were performed using the 
C
T
 
4.3.3.7. Statistical Analyses:  Plasma concentrations of bicyclo-PGE2 (pg/mL) and TNF-α 
(pg/mL) and supernatant concentrations of PGE2 (pg/mL) and TNF-α (pg/mL) were measured in 
duplicate at several different dilutions.  Pairwise comparisons between conditions were 
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 Kruskal-Wallis test (statistical significance set at P ≤ 0.05).   Linear regression was used to 
determine the association between the bicyclo-PGE2/TNF-α ratio and hemoglobin (Hb) levels 
ith statistical significance set at P ≤ 0.05.    
 
4.3.4.1. Effect of Hemozoin and β-hematin on COX-2 Protein Expression:  Our 
previously published results showed that hemozoin or β-hematin suppress LPS- and IFN-γ-
PBMC (Keller et. al. 2004) and is highly expressed in ex vivo PBMC from healthy malaria-
 et. al. 2004).  Stimulation of PBMC with hemozoin or β-hematin 
µg/mL) reduced baseline COX-2 protein expression (Figures 21A and B), demonstrating that 
β
w
 
4.3.4. Results  
induced COX-2 mRNA and protein, and PGE2 production (Keller et. al. 2004).  Although COX-
2-derived PGE2 production is enhanced by cellular activation (e.g., LPS and IFN-γ stimulation), 
our previous results show that baseline COX-2 gene expression is detectable in cultured human 
exposed children (Perkins et. al. 2001).  In the current experiments, we sought to determine if 
hemozoin or β-hematin reduced COX-2-derived PGE2 production in mononuclear cells that were 
not primed with COX-2 inducing stimuli.  To accomplish this, the effects of hemozoin or β-
hematin on COX-2 protein expression were examined at 48 hrs, a time in which hemozoin is 
successfully phagocytosed by monocytes (Olliaro et. al. 2000, Schwarzer et. al. 2001), and does 
not alter cell viability (Keller
(10 
baseline levels of COX-2 protein in PBMC are reduced following phagocytosis of hemozoin and 
-hematin.   
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 4.3.4.2. Effect of Hemozoin and β-hematin on COX-2 and TNF-α Transcripts:    To 
determine if hemozoin- and β-hematin-promoted down-regulation of baseline COX-2 protein 
resulted from a suppression of COX-2 mRNA formation, PBMC were stimulated with media 
lone or a high concentration (10 µg/mL) of hemozoin or β-hematin for 48 hrs.  As shown in 
Figure 22A, the addition of hemozoin or β-hematin to cultured PBMC suppressed COX-2 
transcripts (P < 0.05 and P < 0.05, respectively).   
 
  
 < 0.05), illustrating that hemozoin and β-hematin can reduce spontaneous PBMC 
GE2 production in the absence of mitogenic stimulation. 
 
a
To examine if TNF-α transcripts were induced by hemozoin or β-hematin, PBMC were 
stimulated with media alone or a high concentration (10 µg/mL) of hemozoin or β-hematin for 
48 hrs.  Addition of hemozoin or β-hematin to cultured PBMC induced TNF-α transcripts (P < 
0.05 and P < 0.05, respectively, Figure 22B).  Taken together, these results illustrate that 
hemozoin and β-hematin can reduce COX-2 transcripts and induce TNF-α mRNA formation in 
the absence of mitogenic stimulation. 
 
4.3.4.3. Effect of Hemozoin and β-hematin on Baseline PGE2 and TNF-α Production: 
To determine if hemozoin- and β-hematin-promoted down-regulation of baseline COX-2 
transcripts and protein resulted in suppression of PGE2 biosynthesis, PBMC were stimulated 
with media alone or varying physiologically relevant concentrations of hemozoin (10, 1.0, and 
0.1 µg/mL) or β-hematin (10, 1.0, and 0.1 µg/mL,) for 48 hrs.  As shown in Figure 23A, the 
addition of hemozoin or β-hematin to cultured PBMC dose-dependently suppressed PGE2 
production (P
P
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 Previous studies indicate that hemozoin and β-hematin increase TNF-α production in 
human PBMC (Biswas et. al. 2001, Mordmuller et. al. 1998, Pichyangkul et. al. 1994, Sherry et. 
al. 1995).  Since PGE2 is known to inhibit TNF-α transcription (Choi et. al. 1996, Kunkel et. al. 
1988), we determined if TNF-α levels were elevated under experimental conditions that 
suppressed PGE2 formation.  TNF-α synthesis was determined in culture supernatants of PBMC 
stimulated with media alone or varying concentrations of hemozoin (10, 1.0, and 0.1 µg/mL) or 
-hematin (10, 1.0, and 0.1 µg/mL) for 48 hrs.  Addition of hemozoin and β-hematin to PBMC 
dose-dependently increased baseline TNF-α production (P < 0.01, Figure 23B).  Thus, these 
results show that hemozoin and β-hematin significantly elevate TNF-α production under the 
same experimental conditions that suppress COX-2-derived PGE2 production. 
 
Although the inverse pattern of PGE2 and TNF-α production suggested a potential 
biologic relationship, to further explore the association between PGE2 and TNF-α, both factors 
were measured in identical culture supernatants from hemozoin and β-hematin-treated PBMC 
and expressed as the PGE /TNF-α ratio.  The PGE /TNF-α ratio decreased with increasing 
concentrations of hemozoin (P < 0.01, Figure 23C), demonstrating that hemozoin induces an 
immunologic profile characterized by low levels of PGE α
 
4.3.4.4. Effect of Exogenous PGE  Addition on Hemozoin- and β-hematin-induced TNF-
α Production:  Since TNF-α production in monocytes is decreased by PGE  (Choi et. al. 1996, 
Kunkel et. al. 1988), and hemozoin induced low levels of PGE2 relative to TNF-α in our 
experimental paradigm, we determined if the exogenous addition of PGE2 could reduce TNF-α 
β
2 2
2 and elevated production of TNF- . 
2
2
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 produc
uction:  Since β-
hematin-induced suppression of PGE2 caused over-expression of TNF-α, we wished to 
determ
tly 
creased TNF-α production in unstimulated PBMC (P < 0.05, P < 0.05, and P < 0.05, 
tion in hemozoin- and β-hematin-treated PBMC.   To test this hypothesis, exogenous 
PGE2 (1 x 10-9 to 1 x 10-5 M) was added to PBMC treated with a high dose (10 µg/mL) of 
hemozoin or β-hematin, and TNF-α production was determined at 48 hrs.  Addition of hemozoin 
or β-hematin increased TNF-α production (P < 0.05), which was dose-dependently suppressed 
by the addition of exogenous PGE2 (P < 0.05, Figure 24).  Results presented here demonstrate 
that hemozoin- and β-hematin-induced TNF-α production is reduced by physiologically relevant 
concentrations of PGE2, illustrating that suppression of COX-2-derived PGE2 by hemozoin and 
β-hematin promotes high levels of TNF-α synthesis.  
 
4.3.4.5. Effect of COX-2 Inhibitors on β-hematin-induced TNF-α Prod
ine if further reductions in PGE2 by blockade of COX-2 enzymatic activity in the presence 
of β-hematin would further augment TNF-α production.  To test this hypothesis, PBMC were 
stimulated with media alone or a high concentration (10 µg/mL) of β-hematin in the absence or 
presence of COX-2-specific inhibitors, DuP-697 (1x10-10 - 1x10-6 M) or indomethacin (1x10-8 - 
1x10-4 M).  Supernatants were collected at 48 hrs for TNF-α determination.  Addition of high 
concentrations of DuP-697 (1x10-7 and 1x10-6 M) and indomethacin (1x10-4 M) significan
in
respectively, Figures 25A and C).  β-hematin significantly increased TNF-α production (P < 
0.05 and P < 0.05, respectively), and addition of DuP-697 or indomethacin to β-hematin-
stimulated cultures dose-dependently augmented TNF-α production, with high concentrations of  
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 DuP-697 (1x10-8 - 1x10-6 M) and indomethacin (1x10-5 and 1x10-4 M) significantly increasing 
TNF-α levels (P < 0.05 for all tests, Figures 25A and C).   
 
 To further examine the interaction between reduced PGE2 biosynthesis and increased 
TNF-α production, the IC50 concentration for PGE2 was calculated for DuP-697 and 
indomethacin for our in vitro system, and the corresponding TNF-α concentration was then 
determined.  To accomplish this, PGE2 levels were determined under the same experimental 
conditions when TNF-α was augmented.  β-hematin significantly suppressed PGE2 production 
(P < 0.05 and P < 0.05, respectively Figures 25B and D), and the addition of DuP-697 or 
indomethacin to unstimualted or β-hematin-stimulated cells dose-dependently suppressed PGE2 
(P < 0.05 for all tests, Figures 25B and D).   
 
Using the dose-response curve generated for TNF-α and PGE2 (Table 3), the IC50 was 
calculated for each of the COX-2-specific inhibitors (Table 4).  In our in vitro assays, the IC50 
2 50
2
2  
target COX-2 during malaria may lead to a further suppression in PGE2 formation. 
concentrations for DuP-697 and indomethacin were 7.50 x 10-9 and 2.73 x 10-7 M, respectively 
(Table 3).  The corresponding TNF-α concentrations at the PGE  IC  concentrations were 
166.33 and 112.11 pg/mL for DuP-697 and indomethacin, respectively (Table 4).  In our in vitro 
assays using COX-2-specific inhibitors, when one half of the PGE  production was suppressed, 
DuP-697 caused a greater than 100% induction in TNF-α levels over β-hematin alone, while 
indomethacin induced a 50% increase in TNF-α (Table 4).  These results illustrate that β-
hematin-induced TNF-α production, as a consequence of reduced PGE  biosynthesis, can be
further increased by inhibition of COX-2, suggesting that administration of compounds which 
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4.3.4.6. Clinical and Immunologic Parameters in Children with MA:  To determine if the 
 vitro findings reflected physiologically relevant changes in PGE2 and TNF-α during acute 
alaria, the relationship between PGE2
levels were also different between the groups (P < 
.01 and P < 0.001, respectively, Table 5).   
 
2
a
2
2
2
2 2
2
in
m  and TNF-α was examined in healthy, malaria-exposed 
children (n = 19), and children with mild (n = 10) and moderate MA (n = 12).  Characteristics of 
the study participants are summarized in Table 4.  There were no cases of severe MA (i.e., Hb < 
5.0 g/dL) available for the current analyses.  As shown in Table 5, age (years) between the 
different groups was not significantly different.  Children with moderate MA had higher 
admission temperature (P < 0.01), geometric mean parasitemia (parasites/µL, P < 0.05), and 
lower Hb concentrations (g/dL, P < 0.001) than children with mild MA (Table 5).  Plasma 
bicyclo-PGE2 (pg/mL) and TNF-α (pg/mL) 
0
4.3.4.7. Association of the Plasma Bicyclo-PGE /TNF-α Ratio with MA Disease Severity: 
Although measuring cytokines and effector molecules individually and comp ring their levels 
with disease pathogenesis is useful, expressing the cytokines and effector molecules in 
biologically relevant proportions (ratios) may better reflect immunologic correlates of disease.  
Since PGE  is known to inhibit TNF-α production from mononuclear cells (Kunkel et. al. 1988), 
and the PGE /TNF-α ratio was significantly reduced with increasing concentrations of 
hemozoin, we determined if plasma levels of bicyclo-PGE  relative to TNF-α (bicyclo-
PGE /TNF-α ratio) differed according to MA status.  The plasma bicyclo-PGE /TNF-α ratio 
decreased with increasing disease severity, with the lowest ratio present in children with 
moderate MA (P < 0.01, Figure 26).  The plasma bicyclo-PGE /TNF-α ratio also differed 
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 between the mild MA and moderate MA groups (P < 0.01, Figure 26).  These results show that 
terized by low levels of circulating PGE2 and high 
vels of TNF-α.    
increasing severity of MA is defined by a proportional decrease in circulating levels of bicyclo-
PGE2 relative to TNF-α.     
 
4.3.4.8. Association of the Plasma Bicyclo-PGE2/TNF-α Ratio with Hemoglobin 
Concentrations:  In vitro experiments with CD34+ stem cells show that elevated levels of TNF-
α suppress erythropoiesis (Skobin et. al. 2000), while the addition of PGE2 enhances 
erythropoiesis (Dupuis et. al. 1998).  We, therefore, hypothesized that the relative expression of 
bicyclo-PGE2 to TNF-α may be an important immunologic marker/mediator for MA.  As shown 
in Figure 27, the bicyclo-PGE2/TNF-α ratio was significantly correlated with Hb concentrations 
in children with MA (r = 0.62, P < 0.01).  These results illustrate that reduced Hb concentrations 
are present in an inflammatory milieu charac
le
 
4.3.5. Discussion 
 
Development of a protective versus pathogenic response to malaria is largely determined by 
host-mediated release of soluble factors that govern anti-parasitic activity.  Although the role of 
inflammatory-derived PGE2 in regulating host immunity to parasitic infections has been 
examined for a number of tropical pathogens [for review see (Daugschies et. al. 2000)], the 
functions of PGE2 in malarial immunity remains largely undefined.  Our previous studies in 
Gabonese children showed that plasma bicyclo-PGE2 levels and PBMC COX-2 gene expression 
are suppressed during acute malaria, with the lowest levels of COX-2/PGE2 associated with the 
most severe disease (Perkins et. al. 2001).  Additional studies in our laboratory demonstrated that 
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 phagocytosis of hemozoin by stimulated human blood mononuclear cells is responsible, at least 
in part, for decreased COX-2-derived PGE2 biosynthesis during malaria (Keller et. al. 2004). 
The molecular basis of redu
 
ced COX-2/PGE2 during malaria appears to be due to the ability of 
emozoin to inhibit COX enzymatic activity via binding of host-derived heme, a requisite co-
r 
Results presented here suggest that phagocytosis of hemozoin by blood mononuclear cells 
ible for suppression of PGE2 and over-production of TNF-α during 
h
factor fo maximal COX activity, which results in decreased COX-2 transcript formation (see 
Figures 19 and 20).  The effect of reduced COX-2-derived PGE2 on additional soluble mediators 
(i.e., TNF-α) that regulate innate immunity to malaria, however, was previously undefined.  
Results presented here in cultured, non-stimulated PBMC from healthy, malaria-naïve donors 
show that suppression of COX-2/PGE2 production by hemozoin and β-hematin promotes over-
production of TNF-α.  These in vitro findings were also investigated in children with P. 
falciparum-induced MA which revealed that the relative production of bicyclo-PGE2 to TNF-α 
(expressed as the bicyclo-PGE2/TNF-α ratio) is significantly associated with anemia.        
 
is, at least in part, respons
malaria.  Ιn agreement with previous reports (Biswas et. al. 2001, Mordmuller et. al. 1998, 
Pichyangkul et. al. 1994, Sherry et. al. 1995), results presented here show that ingestion of 
hemozoin and β-hematin by human blood mononuclear cells increases TNF-α production.  TNF-
α is a pleiotropic cytokine that can serve as a protective factor, by limiting malaria parasitemia 
(Kremsner et. al. 1995), and if over-expressed, a pathogenic molecule that can promote MA 
(Clark et. al. 1988).  It, therefore, appears that strict regulation of TNF-α synthesis during a 
malaria infection is essential.  Our previous studies showed that TNF-α promotes high levels of 
PGE2 production through induction of sustained COX-2 mRNA and protein expression (Perkins 
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 et. al. 1997).  Although TNF-α increases COX-2 gene expression, reciprocal interactions also 
occur in which PGE2 directly limits the actions of TNF-α by: 1) suppressing de novo TNF-α 
transcription (Kunkel et. al. 1988), and 2) regulating the secretion of soluble TNF-α receptors 
(Choi et. al. 1996).  Results presented here showing that exogenous PGE2 dose-dependently 
decreases TNF-α production in hemozoin-treated cells provides direct evidence that deceased 
PG production allows over-production of TNF-α.   
 
The relationship between suppression of PGE  and over-production of TNF-α in response 
to hemozoin appear biologically significant for the development of MA, since PGE  enhances 
burst forming unit erythroid (BFU-E) formation (Dupuis et. al. 1998), while TNF-α inhibits 
differentiation of CD34+ hematopoietic precursors into BFU-E (Skobin et. al. 2000).  The in 
vivo significance of the interactions between PGE
2
2
t study 
y the fact that reduced bicyclo-PGE2 and increased TNF-α in plasma are associated with 
decre 2
2
2 
2 and TNF-α are supported in the presen
b
asing Hb concentrations.  The effect of a low bicyclo-PGE /TNF-α ratio on the 
development of anemia may involve several mechanisms.  Since PGE  can inhibit the release of 
TNF-α from monocytes (Kunkel et. al. 1988), we propose that the low monocyte-derived PGE2 
production results in the inability of PGE to feedback and decrease TNF-α production.  This 
would result in high levels of TNF-α that may then induce intravascular and extravascular 
hemolysis of pRBC and non-pRBCs by the reticuloendothelial system, particularly those RBCs 
towards the end of their 120-day life span (Hillman et. al. 1996).  Once hemolysis of RBCs 
occurs during acute malaria, it is then necessary to increase erythropoiesis to restore the lost 
RBC population.  Thus, we propose a dual mechanism in which low levels of PGE2 relative to 
TNF-α contribute to increased hemolysis and decreased production of RBCs.   
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 While the role of PGs in MA remains only partially defined, it appears that COX-2/PGE2 
may be regulated differently in the central nervous system than in the periphery.  Previous 
studies showed that COX-2 protein levels are increased within Durck’s granulomas in patients 
with cerebral malaria (CM) (Deininger et. al. 2000).  Recent studies also illustrated that COX-2 
transcripts were significantly increased within the brain, but non-significantly decreased in 
PBMC of mice with CM (Ball et. al. 2004).  These experiments further demonstrated that 
ection with a parasite strain that causes anemia in the absence of cerebral complications (P. 
berghei  et. al.
Our recent studies in Tanzanian children showed that systemic levels of PGE  (measured as 
urinary bicyclo-PGE /creatinine) are suppressed during CM (Perkins et. al. 2005).  We have also 
demonstrated that naturally acquired hemozoin is associated with decreased PGE  production 
from cultured placental blood mononuclear cells from women with falciparum malaria during 
pregnancy (Perkins et. al. 2003).  Results presented here extend the previous findings by 
illustrating that decreased levels of inflammatory-derived PGs during malaria can influence 
additional mediators such as TNF-α that are known to be important in malaria pathogenesis.   
Additional biologic interactions between PGE2 and TNF-α are important for regulation of the 
febrile response.  This appears particularly relevant for malaria since the universal hallmark of 
2
2
2
inf
 K173) significantly decreased COX-2 transcripts in the periphery (Ball  2004).  
2
2
2
the disease is fever.  Results in our previous studies showed that the lowest levels of COX-
2/PGE  in circulation are observed in children with the highest fevers (Perkins et. al. 2001), an 
event that relies upon systemically derived pro-inflammatory cytokine (e.g., TNF-α) induction of 
COX-2/PGE  production within the preoptic area of the anterior hypothalamus (POAH) 
(Katsuura et. al. 1990).  Based on our previous results, and data presented here, it appears that 
hemozoin-induced suppression of COX-2/PGE  in circulating mononuclear cells may allow up-
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2
ation of TNF-α in the periphery, which may then increase COX-2/PGE2 in the POAH for 
generation of the febrile response.  Thus, low levels of COX-2/PGE2 in the periphery may result 
in pro-inflammatory-induced up-regulation of COX-2/PGE2 in the brain, an event that is 
supported by the findings to date (Ball et. al. 2004, Deininger et. al. 2000, Xiao et. al. 1999). 
 
In conclusion, we show that the relative production of PGE2 to TNF-α is significantly lower 
in children with malaria and that phagocytosis of hemozoin by PBMC may be responsible for the 
suppression of this ratio.  Furthermore, the PGE2/TNF-α ratio significantly correlates with Hb 
concentrations, indicating that this ratio may be an important immunologic marker and potential 
mediator of MA.  Although we propose that changes in PGE2 and TNF-α production contribute 
to the development of MA, and that the PGE /TNF-α ratio represents a valid immunologic 
correlate of disease, it is important to note that MA is a condition influenced by many complex 
genetic and immunologic factors.   
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igure 21.  Effect of hemozoin and β-hematin on baseline COX-2 protein expression. PBMC 
(1x106 cells/mL) were stimulated with media alone or a high concentration (10 µg/mL) of 
with lipopolysaccharide (E. coli LPS 0127B8, 1.0 µg/mL) and 
IFN-γ (10 ng/mL) were included.  (B) COX-2 antigen expression was quantified using 
commercially available software (ScnImage, Scion Corporation).   
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F
hemozoin or β-hematin.  Cells were harvested at 48 hrs for COX-2 protein determination by 
immunoblot analysis.  (A) Shown above is a representative immunoblot of four independent 
experiments in different individuals.  As a positive control (+), extracts of mouse macrophage 
cells (RAW 264.7), stimulated 
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Figure 22.  Effect of hemozoin and .  PBMC 
6 cells/mL) were stimulated with media alone or a high concentration (10 µg/mL) of 
emozoin or β-hematin.  Cells were harvested at 48 hrs for (A) COX-2 and (B) TNF-α mRNA 
etermination by Taqman real time RT-PCR.  Data were expressed as percent change of 
unstimulated conditions.  Values are the mean ± SEM, n=3.  Statistical significance was 
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determined by the Mann-Whitney U test.   *P < 0.05 compared to control (media alone), **P < 
0.01 compared to control (media alone). 
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Figure 23.  Effect of hemozoin and β-hematin on baseline PGE2 and TNF-α 
production.   
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Figure 23.  Effect of hemozoin and β-hematin on baseline PGE2 and TNF-α production.   PBMC 
(1x106 cells/mL) were stimulated with media alone or varying concentrations of hemozoin (10, 
1.0, and 0.1 µg/mL) or β-hematin (10, 1.0, and 0.1 µg/mL).  Supernatants were removed at 48 
hrs for (A) PGE2 and (B) TNF-α determination by EIA and ELISA, respectively.  (C) Data was 
expressed as the ratio of PGE2/TNF-α.  Values are the mean ± SEM, n=10.  Statistical 
significance was determined by the Mann-Whitney U test.   *P < 0.05 compared to control 
(media alone), **P < 0.01 compared to control (media alone). 
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ced TNF-
α production.  PBMC (1x106 cells/mL) were stimulated with media alone or a high 
concentration (10 µg/mL) of hemozoin or β-hematin.  Cells were treated with increasing 
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Figure 24.  Effect of exogenous PGE2 addition on hemozoin- and β-hematin-indu
concentrations of PGE2 (1x10-9-1x10-5M) in the presence of a high concentration (10 µg/mL) of 
hemozoin (solid black line) or β-hematin (dashed black line) and supernatants were collected at 
48 hrs for TNF-α determination.  Values are mean ± SEM and are representative of three 
independent experiments.  Statistical significance was determined by the Mann-Whitney U test.  
*P < 0.01 compared to control (media alone), **P < 0.05 compared to no exogenous PGE2, 
***P < 0.01 compared to no exogenous PGE2. 
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Figure 25. Effect of COX-2 inhibitors on β-hematin-induced TNF-α production and PGE2 
suppression.   
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igure 25. Effect of COX-2 inhibitors on β-hematin-induced TNF-α production and PGE2 
β-hematin. Cells were treated with increasing concentrations of (A and B) DuP-
97 (1x10-10 - 1x10-6M) or (C and D) indomethacin (1x10-8 - 1x10-4M) in the presence of media 
alone (dashed gray line) or (10 µg/mL) of β-hematin (dashed black line) and supernatants were 
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 col ean ± 
EM and are representative of 3 independent experiments.  Statistical significance was 
determined by the Mann-Whitney U test.   *P < 0.01 compared to control (media alone), **P < 
pared to no exogenous PGE2, ***P < 0.01 compared to no exogenous PGE2. 
lected at 48 hrs for (A and C) TNF-α and (B and D) PGE2 determination.  Values are m
S
0.05 com
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 Table 3.  Effect of COX-2-specific inhibitors on PGE2 and TNF-α production. 
 
 
 DuP-697 Indomethacin 
 PGE2a TNF-αa PGE2 TNF-α 
Control 323.22 17.07 306.56 16.55 
β-hematin 252.32 79.22 257.78 74.13 
Conc. (M)     
1x10-10 238.84 129.07 NDb NDb
1x10-9 205.39 142.31 NDb NDb
1x10-8 186.83 160.05 227.26 96.17 
1x10-7 172.17 199.39 198.33 93.11 
1x10-6 125.74 215.16 191.10 107.63 
1x10-5 NDb NDb 177.11 155.06 
1x10-4 NDb NDb 137.37 164.78 
 
aSupernatant concentrations of PGE2 (pg/mL) and TNF-α (pg/mL) in β-hematin-stimulated 
PBMC, values are representative of 3 independent experiments. 
bND = not determined for the indicated concentration. 
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Table 4.  PGE2 IC50 Concentrations for COX-2-specific inhibitors and corresponding TNF-α 
oncentrations. 
 DuP-697 ethacin 
c
 
 
Indom
PGE2 IC50 Conc. (M .50 x 10  x 10-7 )a 7 -9 2.73
TNF-α (pg/mL)b 166.33 112.11 
er β-hematin (%) 109.96 51.23 Increase ov
 
aPGE  IC2 50 values were determined by subtracting the concentration of PGE2 obtained with the 
 dose of CO ibitor  PGE obtained  lowest concentration.  
esponse curv uP-697 methacin were obtained by plotting the PGE2 levels 
) in Table 3 the con n of C hibitor E2 IC50 concentration 
h COX-2 inhi as then d ined against the dose-response curve. 
TNF-α concentrations at the PGE2 IC50 concentration were determined by subtracting the 
for DuP-697 and indomethacin 
against the concentration of 
OX-2 inhibitor.  The TNF-α concentration for the corresponding PGE2 IC50 concentration for 
ach COX-2 inhibitor was then determined against the dose-response curve. 
highest X-2 inh from the 2 value  at the
Dose-r es for D  and indo
(pg/mL  against centratio OX-2 in .  The PG
for eac bitor w eterm
 
b
concentration of TNF-α obtained with the lowest dose of COX-2 inhibitor from the TNF-α value 
obtained at the highest concentration.  Dose-response curves 
were obtained by plotting the TNF-α levels (pg/mL) in Table 3 
C
e
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 Table 5.  Clinical, parasitologic, laboratory, and immunologic parameters in study participants. 
ia. 
Statistical significance determined by Kruskal-Wallis test. 
Statistical significance determined by Mann-Whitney U test. 
haracteristic Healthy Children Mild MA
 a Moderate MA b P 
 
C
No. of subjects 19  10 12 
Age (years) 4.7 ± 0.  0.5 4.6 NS 
oC) 37.2 ± 0.2 7 ± 0.4 39.1 ± <0.01c
itemia     
< 0.001
icyclo-PGE2 (pg/mL) 29.0 ± 3.2 19.7 ± 2.5 12.0 ± 2.4 < 0.01c
5 4.9 ±  ± 0.5 
Admission temperature ( 38.  0.3 
Hyperparas
      ≥250,000 parasites/µL, n 0 2 5  
Parasitemia (/µL) 0 124,708 ± 40,452 
257,895 ± 
61,548 <0.05
d
Geomean parasitemia (/µL) 0 69,829  181,103  
Hemoglobin (g/dL) ND 9.9 ± 0.2 6.4 ± 0.2 d
B
 
NOTE.  Data represent the mean ± SEM unless otherwise noted.  None of the subjects had 
cerebral malaria or severe MA.  ND, not determined.  NS, not significant. 
aMild MA cases were defined as Hb between 9.0 and 10.9 g/dL with any density parasitemia. 
bModerate MA cases were defined as Hb between 5.1 and 8.9 g/dL with any density parasitem
c
TNF-α (pg/mL) 85.5 ± 13.8 173.2 ± 55.3 252.9 ± 41.6 < 0.001c
d
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F atio with disease severity.  Plasma 
as obtained from healthy, malaria-exposed children (HC, n = 19), children with mild MA 
dMA, n = 10), and children with moderate MA (ModMA, n = 12) and bicyclo-PGE2 and 
NF-α levels were determined by EIA and ELISA, respectively.  Data are expressed as the ratio 
of bicyclo-PGE2/TNF-α production.  Values are the mean ± SEM for each group.  Statistical 
hitney U test.  *P < 0.05 compared to HC, **P < 
0.01 compared to HC, ***P < 0.05. 
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ISA, respectively.  Hb 
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Figure 27.  Association of the plasma bicyclo-PGE2/TNF-α ratio with h
concentrations.  Plasma was obtained from children with mild and mo
bicyclo-PGE2 and TNF-α levels were determined by EIA and EL
c
examine the relationship between plasma bicyclo-PGE2/TNF-α ratios and Hb levels. 
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 4.4. SPECIFIC AIM 2, HYPOTHESIS 4:  POLYMORPHISMS IN THE PROMOTER 
OF COX-2 CONDITION THE CLINICAL OUTCOMES IN CHILDREN WITH MA. 
alarial anemia (MA) is a consequence of many underlying etiologies, however, previous 
orphisms (SNPs) in key immunoregulatory genes 
that are associated with susceptibility to or protection against severe disease.  In particular, SNPs 
in the promoter regions of inducible immune response genes can regulate the production of 
effector molecules during an inflammatory event, and thereby mediate disease severity during 
lood-stage malaria.  Three SNPs in the promoter region of the TNF-α gene (G-238A, G-308A, 
nd G-376A) have been separately associated with increased severe malaria when the A allele is 
resent (McAlpine et. al. 1992, McGuire et. al. 1994, McGuire et. al. 1999).  Previous studies 
the role of 
NPs in the COX-2 gene with malaria disease severity.   
 
To investigate the role of SNPs in the promoter region of COX-2, we sequenced the 
OX-2 promoter region for genetic variability in DNA isolated from children (n = 16) with 
varying degrees of malaria severity [defined as protected (absence of SMA or HDP during the 
first year of life) or susceptible (presence of SMA or HDP during the first year of life)].  Of the 
 
4.4.1. Introduction 
 
M
studies have identified single nucleotide polym
b
a
p
conducted in Gabonese children with malaria illustrated that a SNP in the NOS2 promoter 
(NOS2 G-954C, or NOS2Lamberéné) provided protection from severe malaria (Kun et. al. 2001, 
Kun et. al. 1998).  Although the role of SNPs in the promoters of TNF-α and NOS2 have been 
examined in the context of malaria, there have been no studies to date examining 
S
C
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 s e  
-5 r 
ablates a nuclear factor (NF)-E site and a potential glucocorticoid response (GR) binding site 
(Table 6), suggesting that the T allele may decrease COX-2 gene expression and the subsequent 
production of PGE2.   
4.4.2. Subjects and Methods   
 
4.4.2.1. Study Participants: Genomic DNA samples were obtained from the Centers for 
Disease Control and Prevention (CDC).  Children were enrolled as part of the Asembo Bay 
Cohort Project (ABCP) from 1992 to 1996 and followed every 2 weeks for the presence and 
severity of P. falciparum malaria (Bloland et. al. 1999).  We received the samples in a “blinded 
fashion” such that the clinical variables of each participant were unknown during the time of 
genotyping.  Furthermore, only data on the length of time each child had high-density 
parasitemia (HDP, ≥10,000 parasites/µL), malarial anemia (MA, Hb < 8.0 g/dL and any density 
parasitemia), and severe MA (SMA, Hb < 5.0 g/dL and any density parasitemia) were made 
available on a subset of the children (i.e., 394 out of 877).  All subjects were given standard 
treatment according to Kenya Ministry of Health guidelines.  The study was approved by the 
ethics committees of the University of Pittsburgh, the Centers for Disease Control and 
Prevention, and the Kenya Medical Ethics Review Board. 
 
4.4.2.2. Genotyping:  The COX-2 C-512T polymorphism was analyzed by sequence-specific 
PCR followed by restriction nuclease digest with HPY188 III.  The PCR reaction conditions 
were as follows: 1X PCR buffer, 2.5 mM MgCl2, 320 uM each of dATP, dCTP, dGTP, and 
ix nov l polymorphisms identified in the COX-2 promoter region, a C to T transition at position
12 was analyzed in the present studies.   Furthermore, the -512T allele in the COX-2 promote
 
127 
 dTTP, 0.625 U Taq DNA polymerase (all reagents obtained from Applied Biosystems, Foster 
City, CA), 200 nM forward primer, 5' - GCT TCC TCT CCA GGA ATC - 3', and 200 nM 
reverse primer, 5' - GAG CAG ATA TAC AGC CTA - 3'.  The cycle conditions were: 94oC for 5 
min, 40 cycles of 94oC for 30 sec, 58oC for 30 sec, and 72oC for 30 sec, followed by 72oC for 7 
min.  PCR products (10 µL) were digested in 20 µL volume with 1.5 U of HPY188 III, 100X 
BSA, and 1X NEB buffer 4 (all reagents obtained from New England Biolabs, Beverly, MA) 
overnight (~18 hrs) at 37oC followed by deactivation of enzyme at 65oC for 20 min.  Genotypes 
 agarose gel.  Enzyme digest of the 200 bp 
HDP, MA, and SMA.  The CC genotype was used as the baseline since this genotype was the 
most prevalent in the present study population. 
t of children (n = 877) from western 
Kenya as part of the Asembo Bay Cohort Project (ABCP).  The frequency of the polymorphism 
were then analyzed by electrophoresis using a 3%
PCR product with HPY188 III specifically digests the C allele, resulting in 117 and 82 bp 
fragments.  
 
4.4.2.3. Statistical Analyses:  The distribution of CC, CT, and TT genotypes according to 
disease severity (i.e., HDP, MA, and SMA) was determined using Chi-square analyses.  Logistic 
regression was used to determine the association of the COX-2 C-512T polymorphism with 
 
4.4.3. Results 
 
This COX-2 C-512T SNP was analyzed in a birth cohor
in the study population was 83.24%, 11.40%, and 5.36% for the C/C, C/T, and T/T genotypes, 
respectively (Table 7).  The allelic distribution was 0.889 and 0.111 for the C and T alleles, 
respectively.  To assess the association of the COX-2 -512 polymorphism with malaria disease 
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 severity, children were grouped according to the presence or absence of HDP (≥10,000 
parasites/µL), MA (Hb < 8.0 g/dL and any density parasitemia), or SMA (Hb < 5.0 g/dL and any 
density parasitemia) during the first year of follow-up.  Of the 877 children genotyped, 394 had 
complete clinical data, and of these, 94.41% (372 of 394), 81.47% (321 of 394), and 34.26% 
(135 of 394) had HDP, MA, and SMA, respectively (Table 8).  When categorized according to 
the CC, CT, and TT genotypes, 94.46% (307 of 325), 90.24% (37 of 41), and 100% (28 of 28), 
respectively, had HDP, 80.92% (263 of 325), 78.05% (32 of 41), and 92.86% (26 of 28) had 
MA, and 34.15% (111 of 325), 31.71% (13 of 41), and 39.29% (11 of 28) had SMA (Table 8).  
There were no significant differences in the proportion of genotypes for HDP, MA, or SMA (P = 
0.22, P = 0.25, P = 0.81, respectively, Table 9).   
4.4.4. Discussion 
 
E2 are important factors associated with malaria 
disease severity (Keller et. al. 2004, Perkins et. al. 2005, Perkins et. al. 2001), therefore, 
identifying polymorphisms that regulate the production of COX-2 gene expression during 
 
Polymorphisms that regulate the production of key immunoregulatory genes, such as TNF-α and 
IL-10, have been associated with malaria disease severity, suggesting that genetic variability 
plays a major role in the acquisition of protective immunity to malaria.  Our previous studies 
illustrate that circulating PBMC COX-2 and PG
 
malaria will likely yield important information.  
 
Results presented here show that a novel polymorphism in the COX-2 promoter, COX-2 C-
512T, is present in African children.  Although non-significant in these studies, the CT genotype 
was protective against HDP relative to the CC genotype.  Our previous studies showed that 
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 increased production of COX-2 and PGE2 was associated with protection against severe malaria 
(defined by SMA and/or HDP) in Gabonese children (Perkins et. al. 2001).  The COX-2 -512T 
allele ablates a potential GR binding site, and since glucocorticoids down-regulate COX-2 
transcript formation, the presence of a T allele may promote increased levels of COX-2, and 
subsequent PGE2 production, through ablation of this negative signaling cascade.   Alternatively, 
the loss of an NF-E binding site in the presence of the T allele may decrease the promotion of 
COX-2 transcript formation.  Although the CT genotype protected against HDP, all children with 
the TT genotype had HDP, suggesting that homozygotes may not be able to limit parasitemia.  
Furthermore, the TT genotype appears to be associated with an increased risk of MA relative to 
both the CC and CT genotypes (OR = 3.06 and OR = 3.66, respectively, see Table 9).  Further 
studies in a larger cohort with a higher number of polymorphic heterozygotic individuals will 
likely yield important information on the association of the COX-2 C-512T polymorphism with 
malaria disease severity. 
130 
 Table 6.  Known transcription factor binding sites associated with COX-2 -512. 
 
Polymorphism -512  (C-T) 
(C) 
NF-E 
(ctgtc) 
 
GR 
(tgtccc) 
(T) (ttcc) 
-TF binding sites identified by Transfac database at: 
http://bimas.dcrt.nih.gov/molbio/signal/
 
 
 
 
Known TF Binding Site 
Known TF Binding Site unknown 
 
 
 
 
 
 
 
Table 7.  Number and frequency of COX-2 -512 genotypes. 
 
 
 Number of children, (%) 
CC 730 (83.24) 
CT 100 (11.40) 
TT 47 (5.36) 
Total 877 (100) 
 
The COX-2 C-512T polymorphism was determined in genomic DNA from children (n = 877) 
residing in a holoendemic area of malaria transmission.  Data are n (%). 
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 Table 8.  Number and percentage of COX-2 genotypes with HDP, MA, and SMA. 
 All Childr(n = 394) (n = 325) (n = 
TT 
(n = 28) p 
 
en CC CT 
41) 
72 307 (94.46) .24) 
263 (80.92) 05) 
35 111 (34.15) 31.71) 
HDP 3 37 (90 28 (100) 0.22 
MA 321 32 (78. 26 (92.86) 0.25 
SMA 1 13 ( 11 (39.29) 0.81 
 
he COX-2 C-512T
residing in a holoendem
ver the first year of life and examined for the presence of HDP (≥ 10,000 parasites/µL), MA 
b < 8.0 g/dL), or SMA (Hb < 6.0 g/dL).  Data are n (%) of children with each genotype who 
ad HDP, MA, or SMA at any one visit.  Statistical significance between the proportions of 
enotypes within each clinical variable was determined by Chi-square analysis. 
T  polymorphism was examined in genomic DNA from children (n = 394) 
ic area of malaria transmission.  Participants were visited every 2 weeks 
o
(H
h
g
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able 9.  Association of COX-2 -512 polymorphism with malaria disease severity. 
 
 
 HDP (n = 372)  (n = n = 13
T
MA 321) SMA ( 5) 
OR  CI OR 9 CI P R 95%
0.54 0.84 0.3 1.85 0.66 .90 0.45 – 0 0
- - 3.06 0.7 3.26 0.13 .25 0.56 – 6 0
 95% P 5% O  CI P 
CTa  0.47 – 1.69 0.29 8 –  0  1.8 .76 
TTa 0.99 1 – 1  1  2.7 .58 
TTb - - 0.99 3.66 0.73 – 18.42 0.12 1.39 0.51 – 3.80 0.52 
 
The COX-2 C-512T polymorphism was examined in genomic DNA from children (n = 394) 
residing in a holoendemic area of malaria transmission.  Participants were visited every 2 weeks 
over the first year of life and examined for the presence of HDP (≥ 10,000 parasites/µL), MA 
(Hb < 8.0 g/dL), or SMA (Hb < 6.0 g/dL).  Odds Ratios (OR) and 95% confidence intervals (CI) 
were determined by logistic regression analyses. 
a Odds ratio relative to CC. 
b Odds ratio relative to CT. 
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5. CHAPTER 5, SPECIFIC AIM 3   
 
 
pecific Aim 3:  To determine if children with MA have altered NO production and 
ar if increased levels of circulating NO are protective or pathogenic 
in acute malaria.  Previous studies in adults and children with malaria have illustrated a 
protective role for elevated NO during acute malaria (Kremsner et. al. 1996), and in healthy 
children with a history of mild malaria (Perkins et. al. 1999).  The association of NO with MA, 
however, has not been investigated.  Both hypotheses of Specific Aim 3 have been addressed in 
the following manuscript which has been published in the journal Infection and Immunity.  
 
 
 
 
 
S
to determine if ingestion of malarial products (hemozoin) regulates NO 
production through changes in induction of de novo NOS2 transcripts. 
 
 
At present, it is uncle
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5.1. PRESENTA N O ITRIC OXIDE 
PRODUCTION IN CHILDREN WITH MALARIAL ANEMIA: HEMOZOIN-
INDUCED NITRIC OXIDE SYNTHASE TYPE 2 TRANSCRIPTS AND NITRIC 
OXIDE IN BLOOD MONONUCLEAR CELLS. 
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 5.1.1. Abstract  
Experiments outlined here investigate the role of nitric oxide (NO) in the pathogenesis of 
Plasmo o and in 
vitro N ificantly 
eleva itional 
experiments in PBMC at physiologic amounts 
P. falciparum-derived hemozoin augment NOS2 transcripts and NO production.  Results here 
illustrate that elevated NO production in children with MA is associated with decreased 
ozoin can induce NOS2-derived NO formation in 
cquired immunity to Plasmodium falciparum malaria in young children appears to 
e high rate of morbidity and mortality from malaria in endemic areas of sub-Saharan 
man et. al. 2001).  In areas of high transmission, the predominate manifestations of 
echanisms responsible for effective malarial immunity remain elusive, 
production of nitric oxide (NO) appears to be an important marker and potential mediator of 
disease severity.  Previous studies show that elevated plasma levels of NO metabolites [NO2- 
plus NO3- (NOx)] are associated with enhanced parasite clearance time in Gabonese adults and 
children with malaria (Kremsner et. al. 1996).  In addition, our previous results show that 
healthy, malaria-exposed Gabonese children with a history of mild malaria have significantly 
elevated levels of peripheral blood mononuclear cell (PBMC) NO production and nitric oxide 
 
dium falciparum-induced malarial anemia (MA).   These results show that ex viv
O synthase (NOS) activity in peripheral blood mononuclear cells (PBMC) is sign
ted in children with MA, and inversely associated with hemoglobin levels.  Add
 from non-malaria exposed donors demonstrate th
of 
hemoglobin concentrations, and that hem
cultured blood mononuclear cells. 
 
5.1.2. Manuscript 
 
A lack of a
underlie th
Africa (Bre
severe malaria are hyperparasitemia and malarial anemia (MA) (Breman et. al. 2001).  Although 
the molecular m
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 synthase (NOS) enzyme activity compared to their age-matched cohorts with a history of severe 
alaria (Perkins et. al. 1999).  Protection against severe malaria in this population of children 
appears to be, at least in part, related to a polymorphism in NOS type 2 gene [NOS2, inducible 
NOS, iNOS)] which produces high levels of NO during an inflammatory event.  For example, we 
have recently shown that a single nucleotide polymorphism in the promoter region of the NOS2 
gene [NOS2  (NOS2 G-954C)] is associated with increased in vivo and in vitro baseline 
NO production, and protection against malaria (Kun et. al. 1998, Kun et. al. 2001).  Although 
increased NO production appears to be associated with protection against malaria in the 
Gabonese children we have previously investigated, elevated levels of NO can suppress 
erythropoiesis (Shami et. al. 1996), and induce apoptosis in cultured CD34+ cells (Reykdal et. 
al. 1999).  Moreover, since the studies examining the functional significance of the NOS2Lamberéné 
n, we extended our previous investigations by 
xamining the association between NO production and anemia during acute P. falciparum 
malaria.            
 
5.1.2.1. NOS Enzyme Activity in Ex Vivo PBMC:  To determine if NO production is 
altered in children with MA, NOS enzyme activity was measured in ex vivo PBMC from 
healthy, malaria-exposed children (n = 26) and children with mild (n = 19) or severe malaria (n = 
14) according to our previously described methods (Weinberg et. al. 1994).  PBMC were 
selected for investigation since monocytes are a primary source of NO during blood-stage 
malaria.  Furthermore, measurement of NOS enzyme activity was selected as the index for 
determining NO production since this assay, unlike measurement of plasma NOx, is not 
influenced by dietary intake of nitrates.  Participants were recruited from a longitudinal 
prospective study at the Albert Schweitzer Hospital in Lambaréné, Gabon in the Province of 
m
Lamberéné
polymorphism were conducted in healthy childre
e
137 
 Moyen Ogooue.  Severe malaria cases were defined according to World Health Organization 
guidelines [parasitemias > 250,000 parasites/µL and/or the presence of severe anemia (i.e., 
hemoglobin (Hb) ≤ 5.0 g/dL)].  Mild malaria cases were defined by parasitemias < 100,000 
parasites/µL and the absence of any signs or symptoms of severe malaria.  Routine clinical 
evaluations and laboratory measures were used to evaluate the subjects; all blood samples were 
obtained prior to treatment with antimalarials and/or antipyretics.  Children with acute malaria 
were given antimalarials and the appropriate supportive therapy as required.  Healthy children 
were defined as those participants with a previous episode(s) of malaria and the absence of a 
positive thick blood film for malaria, or any other illnesses, within the last 4 weeks.  Informed 
consent was obtained from the parents of all participating children.  The study was approved by 
the ethics committees of the International Foundation of the Albert Schweitzer Hosp  
Lambaréné, the University of Tübingen, Duke University Medical Center Investigational Review 
Board, and the University of Pittsburgh Institutional Review Board. 
 
ital in
As shown in Figure 28, relative to healthy children, NOS enzyme activity was  
significantly higher in ex vivo PBMC from children with mild (P < 0.01) and severe (P < 0.01) 
malaria.  Although the severe malaria group had higher NOS enzyme activity than the mild 
malaria group, the difference between the two groups was not significant (P = 0.14, Figure 28).  
As a control, PBMC lysates were incubated with specific (L-NIL) and non-specific NOS2 
inhibitors (L-NMMA) which demonstrated that the NOS enzyme activity in the assays was 
NOS2 specific.  Taken together, these experiments are the first reports illustrating that NOS 
enzyme activity is significantly elevated in circulating mononuclear cells from children with 
acute MA.   
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 5.1.2.2. Association of NOS Enzyme Activity with Malarial Anemia:  To further assess the 
relationship between elevated NO production and MA, we examined the association between ex 
vivo NOS enzyme activity and hemoglobin (Hb) levels in children with mild and severe MA.  
There was a significant inverse correlation between NOS enzyme activity and Hb concentration 
(r = -0.57, P < 0.05, Figure 29), illustrating that elevated PBMC NO production is associated 
with MA.  Consistent with previous observations in asymptomatic, malaria-exposed children 
(Anstey et. al. 1999), the significant association between elevated NO production and decreased 
Hb levels in children with acute malaria shown here illustrates that increased NO production may 
be involved in the pathogenesis of MA.  Since NO can inhibit erythropoiesis (Shami et. al. 1996) 
and induce apoptosis (Reykdal et. al. 1999) in hematopoietic precursors, we postulate that 
excessively high levels of NO during acute malaria may contribute to suppression of 
erythropoiesis.  However, based on the current study design, it cannot be ruled out that there is a 
non-causal relationship between increased NO production and decreased Hb concentrations in 
hildren with MA. 
n serum (heat inactivated at 56˚C for 30 min).  PBMC were cultured from healthy 
c
 
5.1.2.3. Baseline and Stimulated Levels of NOS Enzyme Activity in Cultured PBMC:  
Since elevated ex vivo PBMC NOS enzyme activity could arise from stimulation by both host-
derived inflammatory cytokines and parasitic products, PBMC isolated from children with and 
without malaria were cultured for 7 days according to our previously described methods 
(Weinberg et. al. 1981).  This length of time in culture should remove the influence of the in 
vivo milieu on NO production.  Briefly, PBMC were plated in Dulbecco’s modified Eagles 
medium (DMEM) supplemented with 10 mM HEPES, 10 mM penicillin/streptomycin, and 10% 
pooled huma
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 children (n = 26) and children with MA (n = 14, Hb ranging from 6.2 – 10.7 g/dL) under 
baseline conditions [media alone (controls)] and following NO-inducing stimuli [LPS, 100 
ng/mL (Alexis Corp., San Diego, CA) and IFN-γ, 200 U/mL (BD Pharmingen, San Diego, CA)].  
PBMC cultures were not prepared from children with severe MA (Hb < 5.0 g/dL) since the 
anemia precluded drawing enough blood for our in vitro experimental design.  We have 
previously shown that stimulation of cultured human PBMC with LPS and IFN-γ increases NO 
production in culture supernatants through augmentation of NOS enzyme activity in immune 
activated patients with rheumatoid arthritis (Sharara et. al. 1997, St. Clair et. al. 1996).  Children 
with malaria had significantly higher baseline (P < 0.05) and LPS- and IFN-γ-promoted NOS 
enzyme activity, relative to malaria-exposed healthy control children (P < 0.01, Figure 30).  
However, LPS- and IFN-γ-stimulation failed to increase NOS enzyme activity in PBMC from 
healthy children.  This may be a consequence of the absence of in vivo immune 
activation/priming of PBMC in healthy children.  As noted above, specific (L-NIL) and non-
specific NOS2 inhibitors (L-NMMA) were used to demonstrate that the NOS enzyme activity 
as NOS2 specific. These results demonstrate that cultured PBMC from children with MA have w
significantly elevated baseline and stimulated NO production during acute disease.   
 
5.1.2.4. Estimated Hemozoin Concentrations in Children with Malaria:  Since PBMC 
from children with MA were cultured for 7 days, and therefore no longer influenced by positive 
and negative in vivo NOS2 regulatory factors (e.g., cytokines), we postulated that a malarial 
product(s) encountered in vivo may be responsible for elevated levels of NOS enzyme activity in 
children with acute malaria.  Based on our previous studies illustrating that the in vivo 
acquisition of hemozoin (malarial pigment) alters the production of cytokines and effector 
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 molecules (Luty et. al. 2000, Perkins et. al. 2003), we investigated hemozoin as a potential 
mediator of augmented NO production in children with MA.  Since there are presently no reports 
defining the concentrations of hemozoin in phagocytic cells in children with varying degrees of 
malaria disease severity, we estimated the hemozoin content in children with mild and severe 
malaria to ensure that the amount of hemozoin used for the in vitro experiments was 
physiologically relevant.  Table 10 illustrates our methodology for calculating the concentration 
of hemozoin in circulating blood in children with malaria.  The geometric mean parasitemia used 
for our calculations was based on our previous studies in Gabonese children with mild and 
severe malaria (Perkins et. al. 2000).  The concentration of hemozoin per parasitized RBC 
(pRBC) was derived from previous studies using in vitro cultures of P. falciparum (Egan 2002).  
Estimated concentrations of hemozoin were determined by multiplying the geometric mean 
parasitemia in children with mild and severe malaria (41,369 and 275,005, respectively) by the 
concentration of isolated hemozoin per pRBC (47 fg/pRBC, Table 10).  Based on these 
calculations, children with mild malaria would have 1.9 µg of hemozoin per mL of circulating 
blood, while children with severe malaria would have 12.9 µg of hemozoin per mL of circulating 
blood.  Based on these calculations, the estimated physiological concentrations of hemozoin 
lected for the in vitro experiments were 10, 1.0, and 0.1 µg/mL. se
 
5.1.2.5. Effect of Hemozoin on PBMC NOx Production:  Hemozoin is an insoluble 
coordinated polymer of heme subunits formed during the detoxification of heme by Plasmodia 
(Slater 1992).  Upon rupture of pRBC, hemozoin is released into the circulation and is rapidly 
phagocytosed by mononuclear cells (Schwarzer et. al. 1998).  Hemozoin exists as a coordinated 
heme polymer containing a conglomeration of host- and parasite-derived lipids and proteins 
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 (Ashong et. al. 1989, Goldie et. al. 1990).  Therefore, we used a crude isolate of hemozoin that 
was not subjected to proteinase K treatment and/or acetone washing, which more closely mimics 
the moiety acquired during a natural infection.  Crude hemozoin was isolated from in vitro 
cultures of P. falciparum-infected RBC (strain Pf-D6) when the parasitemia was 3-5% and late 
trophozoites and early schizonts were the predominate forms.  RBC were spun at 2,000 rpm for 
10 min, and the resulting pellet was resuspended in 40 mL of 0.01 M PBS (pH 7.2) with 2 mL 
saponin for 10 min.  The solution was then spun at 14,000 rpm for 15 min, and the pelleted 
material was washed in PBS until the resulting pellet was dark red and free from the white-
colored RBC cellular components (4-7 times).  The final pellet was dried, weighed, and 
resuspended in filter-sterilized H2O at a final concentration of 1.0 mg/mL, and the final solution 
was extensively sonicated to disperse the hemozoin.  Since larger volumes of blood were 
required for the in vitro assays, experiments with hemozoin were conducted in cultured PBMC 
from healthy, non-malaria-exposed U.S. adults  Cultured PBMC were stimulated with media 
alone, LPS and IFN-γ, or LPS and IFN-γ in the presence of hemozoin (10, 1.0, and 0.1 µg/mL) 
for 48 hrs.  Stimulation of cells with hemozoin was performed in the presence of LPS and IFN-γ 
since cultured human blood mononuclear cells typically require priming/activation to produce 
NO (Weinberg 1998).  Production of NO was determined by measuring NOx in culture 
upernatants according to our previously described methods (Perkins et. al. 1999). It was also 
d 
s
confirme that hemozoin does not interfere with the Griess reaction.  LPS- and IFN-γ-
stimulation non-significantly increased NOx (Figure 31).  The addition of a high dose (10 
µg/mL) of hemozoin to LPS- and IFN-γ-stimulated PBMC significantly augmented NOx (P < 
0.01), while the intermediate and low doses of hemozoin (1.0, and 0.1 µg/mL, respectively) 
failed to significantly elevate NOx (Figure 31).  Moreover, additional experiments revealed that 
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 hemozoin alone, in the absence of stimulation, failed to significantly increase NOx (data not 
shown).  Results presented here illustrate that a crude preparation of hemozoin increases NO 
production in human PBMC. 
 
5.1.2.6. Effect of Hemozoin on NOS2 Transcripts:  To determine if hemozoin increased 
NOx by induction of NOS2 mRNA, we cultured PBMC from healthy, malaria-naïve U.S. adults 
with media alone, LPS and IFN-γ, or LPS and IFN-γ in the presence of hemozoin (10, 1.0, and 
0.1 µg/mL) for 48 hr followed by measurement of NOS2 mRNA by real time RT-PCR.  To 
accomplish this, total RNA was isolated from cultured PBMC by the GITC method 
(Chomczynski et. al. 1987), and reverse transcribed into cDNA.  NOS2 gene expression was 
analyzed by quantitative real time RT-PCR on an ABI Prism 7700 sequence detection system 
(Applied Biosystems, Foster City, CA) with NOS2-specific primers and probe [Assay ID 
Hs00167248_m1 (Applied Biosystems, Foster City, CA)] following the parameters specified by 
the manufacturer.  To control for non-specific background fluorescence, no template controls 
were included in triplicate.  An endogenous control gene, β-actin [Assay ID 4326315E (Applied 
Biosystems, Foster City, CA)], was used as a reference gene to normalize cDNA loading 
between samples.  Stimulation of PBMC with LPS and IFN-γ non-significantly elevated NOS2 
transcripts at 48 hrs (Figure 32).  Addition of both high (10 µg/mL) and intermediate (1.0 
µg/mL) amounts of hemozoin significantly augmented LPS- and IFN-γ-induced NOS2 
transcripts (P < 0.05, Figure 32).  Previous studies have reported difficulties in detecting NOS2 
transcripts in human mononuclear cells [for review see (Weinberg 1998)], however, using 
sensitive quantitative methods such as real time RT-PCR, we were able to detect NOS2 message.  
Although NOS2 transcripts were not highly abundant in cultured PBMC, the addition of 
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 hemozoin significantly increased de novo NOS2 message, demonstrating that hemozoin-induced 
NO production can occur through increased NOS2 transcription. 
 
   Results presented here show that NOS enzyme activity is elevated in children with mild 
and severe MA, and that high levels of NOS enzyme activity are associated with anemia.  The 
role of NO in malaria pathogenesis remains controversial since studies in subjects with cerebral 
malaria have shown that NO is associated with protection (Anstey et. al. 1996, Kremsner et. al. 
1996, Perkins et. al. 1999, Rockett et. al. 1991), while others have found either no effect or 
adverse consequences of elevated NO production (Agbenyega et. al. 1997, Al-Yaman et. al. 
1997, Al-Yaman et. al. 1996, Maneerat et. al. 2000, Taylor et. al. 1998).  However, this is the 
first report that has directly examined the association of NO production with acute MA.  
Although polymorphisms in the NOS2 promoter [NOS2  (NOS2 G-954C) and C-1173T] 
have been associated with protection against malaria (Hobbs et. al. 2002, Kun et. al. 2001, Kun 
et. al. 1998) there were not enough children in our sample population with these particular 
polymorphisms to provide meaningful statistically valid comparisons (data not shown).  
  
Lamberéné
As shown here, cultured PBMC from children with MA have higher baseline and 
stimulated NOS enzyme activity relative to healthy, malaria-exposed children.  Furthermore, a 
crude isolate of P. falciparum-derived hemozoin enhances NOS2 transcripts and NO production 
in cultured human PBMC, suggesting that ingestion of hemozoin may account for increased 
NOS activity in children with acute malaria.  These results are in agreement with a recent report 
showing that a purified preparation of hemozoin and a synthetic preparation of hemozoin (β-
hematin) increased IFN-γ-induced NOS2 transcripts and NO production in a murine macrophage 
cell line (Jaramillo et. al. 2003).  Although concentrations of hemozoin used in those studies 
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 were 2.5 to 5 times higher than the estimated concentrations for children with mild and severe 
malaria presented here (Table 10), the present studies demonstrate that ingestion of 
hysiologically relevant concentrations of hemozoin (10 and 1.0 µg/mL) significantly enhance 
LPS- and IFN-γ-promoted NOS2 transcripts and NO production in human PBMC.  These results 
are in contrast to several studies in cultured murine peritoneal macrophages in which P. vinckei-
derived hemozoin reduced NO production (Prada et. al. 1996), and β-hematin decreased LPS-
induced NO and TNF-α production (Taramelli et. al. 2000).  The apparent discrepancy between 
 results 
esent
 
p
those results and results presented here may be a consequence of the murine origin of 
macrophages and/or the concentration of β-hematin, which was 10-fold higher than 
concentrations used in the present study.  Moreover, since regulation of the human NOS2 gene is 
substantially different than that of the murine NOS2 gene (de Vera et. al. 1996), hemozoin-
induced activation and regulation of NOS2 and subsequent NO production may be different in 
human and murine systems. 
 
Based on our previous results (Kun et. al. 2001, Perkins et. al. 1999) and
pr ed here, we propose that elevated baseline levels of NO in healthy children, and increased 
levels of NO during the early phases of the immune response to acute malaria, protect against the 
development of severe disease.  However, if parasite growth is not effectively limited during the 
early phases of the immune response, sustained overproduction of NO may lead to the 
development of SMA.  We are currently testing this hypothesis in a hospital-based study in 
Kenyan children with SMA.        
 We thank the staff members of the Albert Schweitzer Hospital in Lambaréné, Gabon for 
their cooperation and technical assistance: Anita van den Biggelaar, Judith Jans, Hanna Knoop, 
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 Doris Luckner, Barbara Moritz, Anselme Ndzengue, Marcel, Nkeyi, Daniela Schmid, and 
Milena Sovric.  Furthermore, we would like to thank Dr. Venkatachalam Udhayakumar for his 
scientific input. 
146 
  
  
60
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28.  NOS enzyme activity in ex vivo (non-cultured) PBMC.  PBMC were collected from 
healthy Gabonese children (HC, n = 26) and children with mild malaria (MM, n = 19) or severe 
malaria (SM, n = 14).  Cell lysates were prepared and ex vivo NOS enzyme activity (pmol 
citrulline/mg protein) was determined by measuring the conversion of 14C-L-arginine to 14C-L-
citrulline.  The graph shows the mean ± SEM for each of the groups.  Statistical significance was 
determined by the Mann-Whitney U test.  *P < 0.01 compared to HC. 
0
100
200
300
400
500
0
N
O
S 
en
zy
m
e 
ac
tiv
ity
(p
m
ol
 c
itr
ul
lin
e/
m
g 
pr
ot
ei
n)
HC MM SM
*
*
147 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29.  Association of NOS enzyme activity with hemoglobin.  PBMC were collected from 
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children (n = 13) with malaria and cell lysates were prepared for ex vivo NOS enzyme activity 
(pmol citrulline/mg protein) determination.  Hemoglobin was measured using a HemocueTM.  
Statistical significance was determined by linear regression. 
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Figure 30.  NOS enzyme activity in cultured PBMC.  PBMC (1 x 106 cells/mL) were collected 
graph shows the mean ± SEM for 
each of the groups.  Statistical significance was determined by the Mann-Whitney U test.  *P < 
0.05 compared to HC, **P < 0.01 compared to unstimulated MAL. 
 
from healthy Gabonese children (HC, n = 26) and children with malaria (MAL, n = 14).  
Cultures were prepared and incubated for 7 days with media alone (Con) or LPS (100 ng/mL) 
and IFN-γ (200 U/mL).  Cell lysates were prepared from cultured PBMC and NOS enzyme 
activity (pmol citrulline/mg protein) was determined.  The 
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Table 10.  Estimated hemozoin concentrations in children with malaria. 
 
 
 
 
 
 
 
 
 
 
 
 
a From  et. al. 2000). 
b From
c Estim laria were determined by 
multiply e 
geom laria. 
 Mild malaria Severe malaria 
Geometric mean parasitemia /µLa 41,369 275,005 
Hemozoin concentration per pRBCb 47 fg/pRBC 47 fg/pRBC 
stimated hemozoin concentration 
 children with malariac 1.9 µg/mL 12.9 µg/mL 
E
in
 
 children with mild (n = 17) and severe (n = 12) malaria (Perkins
 cultured parasites (Egan 2002). 
ated concentrations of hemozoin in children with ma
ing the concentration of hemozoin (fg/pRBC) obtained from cultured parasites by th
etric mean parasitemia (/µL) in children with mild and severe ma
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Figure 31.  Effect of hemozoin on NOx production in cultured PBMC.  PBMC (1 x 106 
cells/mL) from healthy, malaria-naïve U.S. donors were stimulated with media alone, 
LPS (100 ng/mL) and IFN-γ (200 U/mL), or LPS and IFN-γ in the presence of hemozoin 
(10, 1.0, and 0.1 µg/mL).  NOx was determined in culture supernatants at 48 hrs via the 
Griess reaction.  Values are the mean ± SEM, n = 10.  Statistical significance was 
determined by the Mann-Whitney U test. *P < 0.05 compared to stimulated conditions. 
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Figure 32.  Effect of hemozoin on NOS2 mRNA expression.  NOS2 mRNA was 
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quantified for three individuals by Real time RT-PCR.  PBMC (1 x 106 cells/mL) were 
cultured with media alone, LPS (100 ng/mL) and IFN-γ (200 U/mL), or LPS and IFN-γ 
in the presence of hemozoin (10, 1.0, and 0.1 µg/mL).  Cells were collected at 48 hrs 
for NOS2 mRNA determination.  Values are the mean ± SEM, n = 3.  Statistical 
significance was determined by the Mann-Whitney U test. *P < 0.05 compared to 
stimulated conditions. 
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laria. 
Increased production of IL-12p70 during the erythrocytic stage of malaria offers 
prote e 
(Stevenson
steril l. 
1994 te 
inocu 0 
levels in plasma are reduced in children with severe malaria (Chaiyaroj et. al. 2004, Luty et. al. 
2000, Malaguarnera et. al. 2002, Malaguarnera et. al. 2002, Musumeci et. al. 2003, Perkins et. 
al. 2000), illustrating that increased production of IL-12p70 during acute P. falciparum malaria 
 
6.  DISCUSSION 
Protection against severe malaria is regulated, at least in part, by the coordinated production of
pro-inflammatory cytokines, which help to limit parasitemia, and anti-inflammatory cytokine
that down-regulate the pro-inflammatory response.  While a controlled pro-inflammatory 
response is associated with an increased parasite clearance (Kremsner et. al. 1995), an overly 
robust pro-inflammatory response is associated with increased severity of malaria (Luty
2000, Perkins et. al. 2000).  Since anti-inflammatory cytokines, such as IL-10, reduce pro-
inflammatory cytokine production, the relative production of pro- and anti-inflammatory 
cytokines in the inflammatory milieu ultimately determines clinical outcomes to severe ma
  
ction against severe disease, at least in part, through initiating a type 1 immune respons
 et. al. 2004).  The importance of IL-12 in severe malaria is further evidenced by the 
e protection of both non-human primates (Hoffman et. al. 1997) and mice (Sedegah et. a
) against lethal malaria following administration of recombinant IL-12p70 prior to parasi
lation.  Furthermore, previous studies, as well as data presented here, show that IL-12p7
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 is associated with protection against severe disease.  Although a previous study showed that IL-
12p70 levels are not decreased during acute malaria (Lyke et. al. 2004), this study was 
performed in a population with a mixed phenotype of disease that included patients with CM, 
SMA, HDP, and hypoglycemia.  Findings presented here demonstrate that reductions in IL-
2p70 during acute SMA may be responsible for an inability to initiate an adequate malaria-
ecific immune response during blood stage malaria.   
during acute malaria is beneficial, while over-production of TNF-α leads to enhanced 
pathogenesis. 
 
Anti-inflammatory cytokines, such as IL-10, negatively regulate both IL-12 and TNF-α 
production by decreasing de novo transcript formation (Aste-Amezaga et. al. 1998, Fiorentino et. 
al. 1991).  Our previous studies have shown that IL-10 increases with increasing disease severity 
(Luty et. al. 2000, Perkins et. al. 2000), in agreement with results presented here in children with 
acute HDP.  As mentioned above, despite conflicting observations of plasma cytokine levels in 
children with malaria from different geographic locations, the relative production of pro- and 
anti-inflammatory cytokines is consistent across populations with differing malaria endemicities 
1
sp
 
Another pro-inflammatory cytokine that has been extensively studied in malaria is TNF-
α.  Results presented here, as well as previous studies (Luty et. al. 2000, Perkins et. al. 2000), 
show that elevated TNF-α production during acute malaria is associated with severe disease.  
However, increased plasma levels of TNF-α have been correlated with a decreased parasite 
clearance time (Kremsner et. al. 1995).  These findings suggest that there is an optimal range of 
TNF-α production that protects against severe malaria in which elevated TNF-α production 
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 and is a good index for determining the association between cytokine dysregulation and disease 
severity.  Consistent with these observations (Perkins et. al. 2000, Rhee et. al. 2001), results 
presented here illustrate that the ratio of IL-10/IL-12p70 is highest in children with severe 
malaria, suggesting that a more robust anti-inflammatory response, relative to a pro-
inflammatory response, is associated with increased pathogenesis. 
 
One important function of cytokines, such as TNF-α, during an inflammatory response is 
to indu
 production during acute P. falciparum malaria.  Thus, during severe malaria, the 
pattern of cytokine production results in a reduction of PGE2 and increased NO formation.  This 
appears
ce the production of effector molecules, such as COX-2-derived PGE2 and NOS2-
dependent NO that regulate immunity (Perkins et. al. 1997, Perkins et. al. 1998).  Previous 
studies illustrated that COX-2 transcripts and protein, and subsequent PGE2 production, were 
reduced in Gabonese children with severe malaria (Perkins et. al. 2001).  Suppression of PGE2 
during acute malaria has also been shown to occur during placental malaria (Perkins et. al. 2003) 
and CM (Perkins et. al. 2005).  Results presented here extend these findings by illustrating that 
PBMC are the cellular source of suppressed COX-2-derived PGE2 and increased NOS enzyme 
activity and NO
 important since PGE2 augments BFU-E proliferation (Dupuis et. al. 1998) and increased 
NO suppresses BFU-E formation (Shami et. al. 1996), suggesting that the relative production of 
effector molecules during acute childhood malaria may lead to decreases in erythropoiesis.   
 
Although our results have shown that IL-12p70 and PGE2 are decreased during severe 
malaria (Luty et. al. 2000, Perkins et. al. 2001, Perkins et. al. 2000), and IL-10, TNF-α, and NO 
are increased (Keller et. al. 2004, Luty et. al. 2000, Perkins et. al. 2000), it was unclear at the 
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 time of these studies if dysregulation in cytokine and effector molecule production during severe 
malaria was a consequence of the host-immune response, or if a parasite antigen(s) was 
responsible for the observed pattern of immune production.   
 
Ingestion of hemozoin by cultured human PBMC has been shown to induce pro-
inflamm tory cytokines, such as TNF-α and IL-1β (Biswas et. al. 2001, Mordmuller et. al. 1998, 
Pichyan
 
Recent studies illustrate that hemozoin suppresses IFN-γ production in cultured human PBMC 
(Deshpande et. al. 2004), which may be a consequence of reduced IL-12p70 production reported 
here and elsewhere (Deshpande et. al. 2004).  However, it is highly interesting that pro-
inflammatory molecules, such as TNF-α and NO, are increased in response to hemozoin 
a
gkul et. al. 1994, Sherry et. al. 1995), and chemokines, such as MIP-1α and MIP-1β 
(Sherry et. al. 1995).  Results presented here support these findings for TNF-α, and further 
illustrate that hemozoin augments IL-10 and NO production, and decreases IL-12p70 and PGE2 
formation.  As mentioned above, cytokine production in children with severe malaria is 
characterized by increased TNF-α, IL-10, and NO production, and decreased synthesis of IL-
12p70 and PGE2.  Furthermore, our recent observations illustrate that circulating MIP-1α and 
MIP-1β levels are reduced in Gabonese children with severe malaria relative to children with 
mild disease (Ochiel et. al. 2005).  Thus, it appears that immune dysregulation during severe 
childhood malaria is, at least partially, due to ingestion of hemozoin by PBMC. 
 
One mechanism by which hemozoin may increase malaria disease severity is through 
suppression of IL-12p70, which is thought to initiate the immune response to malaria, at least in 
part, through induction of IFN-γ from CD4+ T cells [for review see (Stevenson et. al. 2004)]. 
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 phagocytosis (Biswas et. al. 2001, Keller et. al. 2004, Mordmuller et. al. 1998, Pichyangkul et. 
al. 1994, Sherry et. al. 1995), since IL-12p70-induction of IFN-γ appears to play a major role in 
increasing gene expression of these molecules during blood stage malaria [for review see 
(Stevenson et. al. 2004)].   
, indicating the 
importance of this lipid mediator in promoting RBC formation.  The low bicyclo-PGE2/TNF-α 
ratio re
 
Hemozoin may promote severe malaria through suppression of erythropoiesis.  In 
response to acute anemia elicited by intravascular and extravascular hemolysis of both 
parasitized RBC (pRBC) and non-pRBC (Hillman et. al. 1996), increased production of new 
RBC is essential for recovery.  Erythropoiesis is regulated by growth factors, such as hormones 
and cytokines [for review see (Means 2004)], and the inflammatory pattern during SMA most 
likely leads to suppression of the erythropoietic response [for review see (McDevitt et. al. 
2004)].  This is further evidenced by the suppression of BFU-E formation by high levels of TNF-
α (Skobin et. al. 2000), IL-10 (Oehler et. al. 1999), and NO (Shami et. al. 1996) and by 
reductions in IL-12p70 (Mohan et. al. 1998).  Furthermore, exogenous PGE2 enhances BFU-E 
formation and proliferation in cultured CD34+ cells (Dupuis et. al. 1998)
ported here, and the high ratio of IL-10/IL-12p70 (Perkins et. al. 2000), in children with 
severe malaria suggests that the circulating cytokine milieu may promote suppression of 
erythropoiesis due to dysregulation in the immune response promoted by phagocytosis of 
hemozoin.  The fact that hemozoin is present in large amounts in tissue macrophages from 
children with prolonged exposure to P. falciparum, and is present in high quantities in bone 
marrow from malaria-infected adults (Abdallah 1990), further suggests that local production of 
inflammatory mediators in bone marrow stromal cells may further suppress erythropoiesis.   
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 Table 11.  Effect of hemozoin ingestion on cytokine and effector molecule production in cultured 
 
Cytokine Cell Type Effect of Hz REF 
IFN-γ Hu
mononuclear cells.  
 
    
man Decrease (Deshpande et. al. 2004) 
IL-1β Human Increase (Pichyangkul et. al. 1994) 
 Human Increase (Biswas et. al. 2001) 
 Human Increase (Deshpande et. al. 2004) 
 
IL-2 Human Decrease (Deshpande et. al. 2004) 
IL-10 Human Increase (Mordmuller et. al. 1998) 
 Human Increase (Deshpande et. al. 2004) 
 Human Decrease (see Figure 5A) 
MIF Murine Increase (Martiney et. al. 2000) 
 Murine Increase (Jaramillo et. al. 2005) 
MIP-1β Human Increase (Sherry et. al. 1995) 
 Human Increase (Ochiel et. al. 2005) 
MCP-1 Murine Increase (Jaramillo et. al. 2005) 
 Murine Decrease (Prada et. al. 1996) 
 Human Increase (Keller et. al. 2004) 
PGE2 Human Decrease (Keller et. al. 2004) 
 Murine Decrease (Taramelli et. al. 1995) 
 Human Increase (Mordmuller et. al. 1998) 
 Human Increase (Biswas et. al. 2001) 
 Human Increase (see Figure 5E) 
Murine No effect (Taramelli et. al. 1995) 
IL-6 Murine Decrease (Prada et. al. 1995) 
 Human Increase (Keller et. al. 2004) 
IL-12p70 Human Increase (Mordmuller et. al. 1998) 
 Human Decrease (Deshpande et. al. 2004) 
MIP-1α Human Increase (Sherry et. al. 1995) 
 Human Increase (Ochiel et. al. 2005) 
 Murine Increase (Jaramillo et. al. 2005) 
MIP-2 Murine Increase (Jaramillo et. al. 2005) 
NO Murine Decrease (Taramelli et. al. 1995) 
 Murine Increase (Jaramillo et. al. 2003) 
Oxidative burst Human Decrease (Schwarzer et. al. 1993) 
TNF-α Murine Increase (Prada et. al. 1995) 
 Human Increase (Sherry et. al. 1995) 
 Human Increase (Pichyangkul et. al. 1994) 
 Human Increase (Deshpande et. al. 2004) 
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 Hemozoin elicits a different pattern of cytokine and effector molecule production in 
cultured human and murine mononuclear cells.   Table 11 depicts the effects of hemozoin on 
irculating mo ells i  and murine models.  Induction of IL-1β 
n shown in huma  treated w s de et. al. 
004, Pichyangkul et. al. owever, ot altered elli et. al. 
995).  Results presente ow that induces N d human 
 (Keller et. al. 2004), while conflicting results have been reported on the effect of 
emozoin on NO production in murine cell lo et. al. 20 , Taramelli 
5).  Furtherm mber of ve show  TNF-α 
roduction in cultured h nonuclea swas et. al. 1998, 
kul et. al. 1994  19 ite contrad ne systems 
Prada et. al. 1995, T et. al. 1995).  These discrepancies could arise from the 
oncentrations of hemo  in the in vitro m using the 
d concentration oin that found in laria (i.e., 
g/mL) (Keller et. al. e have s that hemo d TNF-α, 
nd suppresses PGE2 fo Keller et ).  Recent nt women 
e shown tured inte ood mononuclear cells (IVBMC) that have 
 hemozoin in vi ce less I F-α, and PG 2003). This 
ppression was correla the percentage of pigmented  al. 2003), 
ggesting that higher c ions, or a of hemo ifferent 
attern of inflammatory n.  Altern e varyin could be 
ue to treatment of crude hemozoin with chemicals, such as acetone or proteinase K that would 
ove host- and parasite-derived lipids and protein, respectively, which could dramatically 
cultured c nonuclear c n both human
has bee n PBMC ith hemozoin (Bi was et. al. 2001, Deshpan
2  1994), h IL-1β is n in murine cells (Taram
1 d here sh hemozoin O production in culture
PBMC
h s (Jaramil 03, Prada et. al. 1996
et. al. 199 ore, a nu studies ha n that hemozoin augments
p uman mo r cells (Bi al. 2001, Mordmuller et. 
Pichyang , Sherry et. al. 95), desp icting reports in muri
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acquired vo produ L-10, TN E  (Perkins et. al. 2
su ted with IVBMC (Perkins et.
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 impact on the immune response.  In our in vitro model system, isolated hemozoin is not 
subjected to purification, thus the moiety used in these studies most likely resembles the pigment 
that would be acquired during a natural malaria infection.  Results obtained in murine systems 
using high concentrations of highly purified hemozoin may therefore not accurately reflect the 
immune profile that is elicited by in vivo acquisition of hemozoin during childhood malaria.  
 
Although not directly investigated here, other parasite-derived antigens, such as 
glycosylphosphatidylinositol (GPI), have been shown to influence cytokine and effector 
molecule production in cultured PBMC.  Initial studies revealed that purified and concentrated 
GPI augmented TNF-α, IL-1, and NO production in cultured murine macrophages (Schofield et. 
al. 1993, Tachado et. al. 1996).  Recent studies have also shown increased IL-12 and IL-6 in 
response to malaria-specific GPI (Zhu et. al. 2005), which is dependent on NF-κB-mediated 
signaling through Toll-like receptor (TLR) 2 and TLR4 (Krishnegowda et. al. 2005).  Despite a 
similar pattern of inflammatory production in response to GPI, the concentrations of GPI used in 
these experiments are much higher than concentrations seen in normal in vivo infections.  
However, GPI antibodies have been noted in malaria-immune adults (Naik et. al. 2000), 
suggesting that malaria-specific GPI function as important signaling molecules during blood-
stage malaria. 
 
 The immune response elicited by PBMC ingestion of hemozoin is likely dependent on 
the phagocytic pathway by which hemozoin is acquired.  Previous studies illustrated that 
detergent-treated hemozoin and β-hematin were present in large clusters in the absence of 
cellular membranes (Olliaro et. al. 2000), and in these studies, was found to occur independently 
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 of coated pit formation in the absence of a specific receptor (Olliaro et. al. 2000).  Confocal 
microscopy studies examining ingestion of hemozoin by PBMC showed contrasting results in 
which serum-opsonized hemozoin was associated with lysosmal formation (Schwarzer et. al. 
2001), thus suggesting that phagocytosis of hemozoin is receptor-mediated.  Alternatively, 
opsonization of hemozoin could cause phagocytosis through scavenger receptors, which would 
ccount for the discrepancy between these studies.  Recent studies in mice injected with P. 
falcipa
While phagocytosis of circulating hemozoin may occur through receptor recognition, 
a
rum-derived hemozoin identified TLR9 as a putative recognition receptor for 
phagocytosis of hemozoin (Coban et. al. 2005).  This is highly interesting as TLR9 is the pattern 
recognition receptor for CpG methylated DNA of bacterial origin (Krieg 2002), and in the 
previous studies, highly purified hemozoin and β-hematin were used to illustrate TLR9-
dependent phagocytosis, however, both of these compounds do not contain DNA (Coban et. al. 
2005).  Removal of host- and parasite-derived components, such as proteins, lipids, and nucleic 
acids, from crude hemozoin that would be obtained during a natural infection, yields β-hematin, 
which was also used in these studies.  Further experiments using non-treated hemozoin that 
would contain host- and parasite-derived components, such as proteins, lipids, and nucleic acids, 
in cultured human mononuclear cells will likely yield important information on the mechanism 
of ingestion of free hemozoin. 
  
such as TLR9, phagocytosis of RBC membrane-associated hemozoin, or phagocytosis of intact 
pRBC that contain large amounts of hemozoin (Celada et. al. 1983), most likely occurs through 
the scavenger receptor, CD36 [for review see (Serghides et. al. 2003)].  CD36 is a class B 
surface scavenger receptor that is involved in phagocytosis of pRBC by human monocytes 
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 (McGilvray et. al. 2000).  Ingestion of pRBC through CD36 is not associated with increased 
TNF-α production (McGilvray et. al. 2000), in contrast to results presented here for ingestion of 
free hemozoin and β-hematin by cultured human PBMC.  Thus, although phagocytosis of free 
hemozoin elicits dysregulation of mononuclear cytokine and effector molecule production, it 
remains to be determined if acquiring hemozoin through CD36-mediated uptake of intact pRBC 
leads to altered inflammatory production. 
 
 The specific signaling cascades that are activated upon ingestion of hemozoin may lead 
to further understanding of hemozoin-induced dysregulation of inflammatory mediator 
production.  The first series of experiments examining the effect of hemozoin on cellular 
signaling illustrated that protein kinase C (PKC) activation was reduced in hemozoin-containing 
cells, which caused reduction in oxidative burst (Schwarzer et. al. 1993).  Several recent 
observations in a cultured murine macrophage cell line, B10R, suggest that ingestion of β-
hematin elicits activation of the extracellular signal-related kinase (ERK) 1/2 and NF-κb 
signaling pathways, which is responsible for induction of NOS2 and upregulation of chemokine 
expression (Jaramillo et. al. 2005, Jaramillo et. al. 2003).  These studies support previous 
observations in our laboratories illustrating that the β-chemokines macrophage inflammatory 
α and MIP-1β are upregulated in severe malaria, which is regulated at least 
partiall
expression of peroxisome proliferator-activator receptor (PPAR)-  (Skorokhod  2004).  The 
discrepancy between these results illustrates the differences between human and murine models 
protein (MIP)-1
y by PBMC ingestion of hemozoin (Ochiel et. al. 2005).  However, experiments in 
cultured human monocyte-derived dendritic cells (DC) found that NF-κb was not induced in 
response to phagocytosis of hemozoin, but that DC activation was mediated through increased 
γ  et. al.
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 of malaria, in which different signaling cascades regulate the production of inflammatory 
mediators.  Further studies in cultured human PBMC examining signaling cascades that are 
altered in response to phagocytosis of hemozoin may help to reveal the mechanism(s) by which 
hemozoin augments both NOS2-dependent NO production and chemokines levels.  
 
In conclusion, data presented as part of this dissertation have illustrated that ingestion of 
emozoin by cultured human mononuclear cells results in a similar pattern of cytokine and 
importance.  For successful malaria vaccine designs, the pattern of soluble immune mediator 
production that defines protection against severe malaria must be taken into account.  Therefore, 
h
effector molecule production to that observed in plasma and cultured PBMC from children with 
severe malaria.  These studies illustrate that hemozoin induces over-production of IL-10 and 
TNF-α, and that hemozoin-induced IL-10 production suppresses de novo IL-12p70 production 
(Figure 33).  Furthermore, independently of IL-10 over-production, hemozoin suppresses COX-2 
transcripts and protein, and the subsequent production of PGE2, which causes over-production of 
TNF-α (Figure 33).  Lastly, hemozoin induced NOS2 transcripts and NO production in cultured 
human mononuclear cells (Figure 33).  Taken together, these results show that hemozoin is 
capable of eliciting a pattern of inflammatory production consistent with that observed in 
children with severe malaria, suggesting that blockade of hemozoin formation during blood stage 
malaria protects against severe disease by reducing circulating monocyte-induced cytokine 
dysregulation. 
 
 The majority of childhood morbidity and mortality in sub-Saharan Africa is due to 
infection with P. falciparum, thus treatment and/or prevention of malaria is of great public health 
163 
 understanding the immune response that is associated with protection against severe malaria will 
greatly impact on the design and testing of malaria-specific vaccines.  Although the acquisition 
of protective malarial immunity is not currently well defined, the present work has identified 
specific cytokines and effector molecules whose production is dysregulated during severe 
hildhood malaria, which furthers the understanding of a beneficial immune pattern during blood 
stage m
c
alaria to aid in malaria-specific vaccine strategies. 
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Figure 33.  Effect of hemozoin on immune dysregulation.   (1) Ingestion of hemozoin by human 
PBMC elicits elevated production of the anti-inflammatory cytokine, IL-10, and the pro-
inflammatory cytokine, TNF-α.  Elevated IL-10, but not TNF-α, is responsible for decreased IL-
12 production.  (2) Hemozoin suppresses COX-2 transcript and protein formation, which leads to 
decreased PGE2 production, which is not due to increased IL-10.  Hemozoin-induced 
suppression of PGE2 causes over-production of TNF-α.  (3) Hemozoin induces NOS2 expression 
and NO production in cultured human PBMC. 
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